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This thesis reports on research by way of a systematic review carried out during my Masters 
of Clinical Science candidature at the University of Adelaide, Adelaide, South Australia from 
February 2016 to May 2018.  
This thesis consists of 4 chapters. Chapter 1 presents the background and context of the review, 
which develops the foundation for the study aims. Chapter 2 provides a description of the 
methodology for the systematic review. Chapters 3 presents the results of the study. Finally, 
Chapter 4 presents an overall discussion of the findings, its clinical implications, summarises 





 Hip arthroplasty is a commonly performed orthopaedic intervention employed in the 
management of various hip pathologies. Australian registry data indicate that over 42,000 
primary hip arthroplasties including a stemmed femoral prosthesis were performed during 
2016 (Australian Orthopaedic Association 2017). Post-operative peri-prosthetic femur 
fractures (PFFs) around hip arthroplasties have an incidence around 0.4% to 4% and although 
infrequent, are a significant complication imparting a heavy burden upon patient, orthopaedic 
surgeon and the health care system, costing on average around AUD 40,000 per patient, per 
fracture to manage (Phillips, Boulton et al. 2011). The Vancouver classification system, 
devised by Brady and colleagues is the most commonly utilised system for classifying PFFs, 
with Type B fractures occuring at the level of or just below the femoral stem, further 
subdivided according to stem stability and bone stock, with our study population, type B2 
exhibiting an unstable stem with preserved proximal bone stock (Brady, Garbuz et al. 1999). 
Although revision arthroplasty is currently recommended for management of Vancouver 
Type B2 PFFs, open reduction internal fixation (ORIF) has been shown in some small studies 
to yield similar outcomes when compared to revision. If selected Vancouver type B2 
fractures were shown to be amenable to ORIF alone rather than revision, it would be 
beneficial given that much intra-operative risk would be mitigated by way of shorter 
operative times, and a reduction in skill set demands upon the surgeon, reduce implant costs, 
and allow for subsequent revision in arthroplasty in younger individuals. The objective of this 
thesis was to identify the effectiveness of operative interventions for individuals who have 
undergone a hemi or total hip arthroplasty who sustain a Vancouver type B2 peri-prosthetic 
femoral fracture or equivalent, by conducting a systematic review. Specifically, the review 
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investigated open reduction and internal fixation and femoral revision arthroplasty with or 
without internal fixation.  
 
Unpublished and published studies across PubMed Medline, EMBASE, CINAHL, The 
Cochrane Central Register of Controlled Trials (CENTRAL), Web of Science, 
ClinicalTrials.gov and Proquest Theses and Dissertations were considered for the systematic 
review. We assessed both experimental and observational studies written in English from 
1990 or later, which reported on five or more Vancouver B2 periprosthetic fractures and 
assessed at least one outcome of interest, including intra-operative (e.g. surgical time, 
bleeding), radiographic (e.g. subsidence), clinical (e.g. union, mortality, parker mobility) and 
patient reported outcomes (e.g. functional status and health-related quality of life). The 
quality assessment of the papers was performed by two independent reviewers using 
standardised critical appraisal instruments according to the study design from the Joanna 
Briggs Institute. The critical appraisal was compared and in case of disagreement a third 
reviewer’s opinion was sought for further discussion. Data was extracted from papers 
included in the review using the standardised data extraction tool from the JBI-System for the 
Unified Management, Assessment and Review of Information (SUMARI). 
From the electronic searches, 1805 potential articles were found, of which 860 duplicates 
were removed. In the first screening, 213 studies were selected for full text reading. The 
reference lists of these articles revealed another 45 articles, and a total of 258 studies were 
selected for full-text reading. After the evaluation, 37 studies were finally included in the 
systematic review. There were 27 retrospective case series and 10 retrospective cohort 
studies, which together evaluated outcomes of 926 Vancouver B2 fracture cases. With 
regards to the intervention, 25 studies evaluated revision with or without wires, cables or 
cerclage, while three studies investigated revision plus ORIF with plate. There were three 
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studies that analysed revision and cortical strut allografts. There were 11 studies that 
evaluated revision with mixed methods or without specifying the revision technique. Ten 
studies assessed ORIF with plate. Two studies evaluated ORIF with wires, cerclage or cables. 
Three studies evaluated ORIF with mixed methods or without specifying ORIF technique. 
One study evaluated a non-operative intervention. Among the 37 included studies, 24 papers 
evaluated one intervention of interest, six articles included two interventions, five studies 
included three interventions and two studies investigated four interventions of interest. 
Comparative meta-analysis revealed small differences between management strategies across 
different outcomes. While the surgical time was shorter and the transfusion requirement was 
less for ORIF with plate vs Revision +/- wires, cerclage and cables, pre and post-operative 
parker mobility scores, subsidence, union, mortality, dislocation and infection rates were 
similar. Regarding Revision via any method vs ORIF any method, union, malunion and 
infection rates were similar, however, mortality rates were lower for ORIF and re-operation 
rates were lower for revision. Overall, no management strategies have been shown to be 
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Peri-prosthetic femoral fractures (PFF) around hip arthroplasties may occur intra or post-
operatively, and although infrequent, their incidence is rising and are a significant 
complication imparting a heavy burden upon the patient, orthopaedic surgeon and the health 
care system (Lindahl 2006 and Phillips et al. 2011). In 1999, Brady and colleagues devised a 
classification system known as the Vancouver classification in conjunction with the 
development of a treatment algorithm for post-operatively sustained fractures which is based 
on location of the fracture, whether or not the stem is loose and the quality of bone stock in 
the proximal femur (Brady, Garbuz et al. 1999). PFFs where the fracture is at the level of the 
stemmed femoral prosthesis, where the femoral component is loose and there is 
uncompromised proximal femoral bone stock are referred to as Vancouver B2 fractures. 
There is a modest amount of literature assessing the outcomes of management by way of 
open reduction internal fixation (ORIF) vs femoral revision, with or without internal fixation 
with some studies suggesting ORIF is a viable alternative to the current gold standard femoral 
revision.  
Review objective 
The general aim of this thesis was to identify the effectiveness of operative interventions in 
individuals with a hemi or total hip arthroplasty who sustain a Vancouver type B2 peri-
prosthetic femoral fracture (PFF) or equivalent. Specifically, this thesis aimed to investigate 







Generally speaking, hip arthroplasty (also known as hip replacement) involves open 
surgery to the hip joint, resection of the diseased femoral head or defunct femoral head/neck 
junction, along with implantation of a stemmed femoral prosthesis and prosthetic femoral 
head, with or without additional acetabular preparation and replacement. Globally, the goals 
of hip arthroplasty are to restore pre-morbid, stable, pain-free hip joint motion and effective 
load transfer from pelvis to femur to enable long-term repetitive ambulation. These 
procedures may be primary interventions, including those performed on a native hip joint 
without any prior surgery, or revision interventions, where patients have had previous hip 
arthroplasty procedure(s) and existing implants are replaced (femoral stem, femoral head or 
neck, acetabular cup or liner) or the construct changed (e.g. conversion of hemi to total hip 
arthroplasty).  
In Australia, hip arthroplasty is a commonly performed orthopaedic intervention 
employed in the management of various hip pathologies, most commonly, osteoarthritis and 
fractured neck of femur. (Jones, Beaupre et al. 2005). The Australian national joint registry 
indicates that from September 1999 to December 2016, over half a million hip arthroplasties 
in around 430,000 patients were recorded. Furthermore, as at the end of December 2016, in 
Australia 310,630 living patients had one or more hip prostheses in situ, accounting for 
1.27% of the population (ABS data end 2016 population 24,385,600) (Australian Orthopeadic 
Association 2017).  
During 2016, The Australian national joint registry data indicated 47,171 hip 
arthroplasty procedures were performed including; primary (partial and total) and revision 
procedures, accounting for 91% (n=41,860) and 9% (n=4,197), respectively. This was an 
increase by 1,639 (3.7%) compared with 2015 (Australian Orthopeadic Association 2017). 
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The National Joint Registry for England, Wales, Northern Ireland and the Isle of Man 
reported over 100,000 hip arthroplasty procedures were performed during 2016 (an increase 
of 3.5% from 2015), including over 90,000 primary hip replacements and almost 8,000 
revision procedures (The National Joint Registry for England, Wales, Northern Ireland and 
the Isle of Man 2017). 
Furthermore, The American joint replacement registry (AJRR) reported 178,362 hip 
arthroplasty procedures were performed during 2016 including; primary (partial and total) 
and revision procedures, accounting for 89.6% (n=159,696) and 10.4% (n=18,666), 
respectively. It should be noted the reporting to the AJRR is voluntary, and 2016 data 
estimates the registry covers approximately 28% of the estimated annual procedural volume 
in the US (The American joint replacement registry 2017).  
Hip hemi-arthroplasty (HA) 
 
Of the primary hip arthroplasty procedures performed in Australia during 2016, 15% 
(5,519) were hip hemi-arthroplasty (HA), which incorporates a system where a prosthetic 
femoral head (attached to a stemmed femoral prosthesis) articulates with the patient’s native 
acetabulum. In over 90% of cases, fractured neck of femur was the principal diagnosis and 
mean patient age was around 80 to 85 years depending on subcategory of HA system 
employed. Furthermore, global registry data for partial hip replacement indicates females 
account for over 70% of the cohort.  
Total hip arthroplasty (THA) 
Of the primary hip arthroplasty procedures performed in Australia during 2016, 85% 
(36,341) were total conventional hip arthroplasty (THA) which incorporates the components 
of a HA with the addition of acetabular replacement, which includes preparation of the 
acetabular surface and implantation of a cup and liner, resulting in the prosthetic femoral 
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head articulating with prosthetic liner (Table 1). The two most common indications for 
primary THR were osteoarthritis and fracture, accounting for 88.8% and 4.3% of cases, 
respectively. Mean age was 67.7 and around 55% were female (Australian Orthopeadic 










Revision (n) Primary (n) Primary hip arthroplasty 
Primary partial/HA 
(n) 
Primary THA (n) 
AOANJRR 47,171 4,197 (9%) 41,860 (91%) 5,519 (15%) 36,341 (85%) 
NJR 101,651 7,938 (7.8%) 93,713 (92%) N/A N/A 
AJRR* 178,362 18,666 (10.4%) 159,696 (89.6%) 15,672 (9.8%) 144,024 (90.2%) 





The core prosthetic components that are used in HA are a femoral head and stemmed 
femoral prosthesis, and additionally an acetabular cup and liner in THA. Given that our 
review investigates peri-prosthetic femoral fracture (PFF) only, acetabular cup and liner 
prostheses will not be discussed in further detail.  
Femoral stem 
The stemmed femoral prosthesis transfers load from the prosthetic femoral head to the 
native femur and comes in two broad categories, including cemented and press-fit 
(cementless) stems. Femoral stem prosthesis behaviour within the femoral canal is impacted 
by many factors including both implant (prosthesis and instrumentation) and patient bone 
quality. Implant factors include; stem finish (polished or roughened/coated), stem geometry, 
encompassing shape (straight or anatomical), cross-section (oval or square), collared or 
collarless, stem tip shape, length of stem, the degree of rounding of edges and preparation of 
femoral canal. (Scheerlinck and Casteleyn 2006, Khanuja, Vakil et al. 2011). In the case of 
cemented femoral systems, this load traverses the stem-cement and cement-bone interface.  
During 2016, AOANJRR data reports that regarding HA, 35 different types of 
femoral stem were implanted with over two-thirds of these being cemented. Furthermore, 
regarding THA, 10 different types of femoral stem accounted for over two-thirds of the 
femoral stems implanted (Australian Orthopeadic Association 2017). In contrast to HA 
procedures, approximately two thirds of the femoral systems used in primary conventional 
THA were cementless. This Australian registry data indicates there is a substantial variation 
in the character of hip arthroplasty implants currently in use. It is important to recognise, 
these characteristics may ultimately impact performance on an ‘implant to implant’ basis, let 
alone the consideration of inter-surgeon variability.  
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Cemented femoral systems 
In cemented systems, the stem shape should optimise transmission of axial and 
torsional forces to cement and to bone without causing damage to either interface and is 
required to maintain long-term mechanical stability in the face of repetitive loading. The two 
most common methods to achieve this are ‘Loaded-taper’ fixation e.g. Exeter and CPT 
(double taper) and C-stem (triple taper) and ‘Composite-beam’ fixation concept e.g. 
Charnley. (Scheerlinck and Casteleyn 2006). 
In ‘Loaded-taper’ fixation the stem shape allows the prosthesis to become wedged in 
the cement mantel, hoop stresses transmitting force to bone and an air-filled centraliser 
facilitates subsidence to a stable position without compromising the distal cement mantle. 
Stem finish is preferably polished for loaded-taper design to allow step-wise subsidence 
without excessive metal and debris at cement-stem interface. 
In ‘Composite-beam’ fixation the stem needs to be well bound to cement as 
subsidence or impairment to the SC interface may damage the cement with polymethyl 
methacrylate (PMMA) and/or metal debris and ultimately implant failure. Roughened stem 
finish is preferred for composite-beam designs with the intention of increasing cement-stem 
bonding.  
Cementless (Press-fit) femoral systems 
Cementless or press-fit stemmed femoral prosthesis rely on the principle of 
osseointegration, which is the attachment of lamellar bone to implants without intervening 
fibrous tissue (Albrektsson, Branemark et al. 1981) in order to effectively transfer load from 
the femoral head prosthesis to the native femur.  
Khanuja et al. 2011 (Khanuja, Vakil et al. 2011) described six categories of 
cementless femoral stems including; type 1 (‘Single wedge’), type 2 (‘double-wedge’), type 3 
 10 
 
(tapered round (3A), spline/cone (3B), tapered rectangle (3C)), type 4 (cylindrical fully 
coated), type 5 (modular) and type 6 (anatomic).  
Complications of hip arthroplasty 
Requirement for revision arthroplasty is a significant complication following hip 
arthroplasty, with fracture being in the top three reasons for revision based on Australian 
registry data. Where fracture ranks depends on the indication and category and subtype of 
index procedure e.g. bipolar vs unipolar modular HA for fractured neck of femur, and THA 















Top 3 most common reasons for revision arthroplasty 
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Peri-prosthetic femoral fracture (PFF) around hip arthroplasty 
Post-operative PFFs usually occur during minor trauma with epidemiological studies 
revealing a lifetime incidence anywhere between 0.4% to 3.5% for primary THA and around 
4% following revision THA (Kavanagh 1992, Berry 1999, Lindahl, Garellick et al. 2006, 
Abdel, Houdek et al. 2016) being more common in uncemented femoral systems. With regard 
to HA, incidence of PFF has been estimated between 2 to 4 percent for cementless implants 
and 0.5 to 1 percent for cemented implants (McGraw, Spence et al. 2013, Phillips, Moran  
et al. 2013). Alarmingly, PFF rates have been projected in a recent analysis of multiple joint 
registries to increase by 4.6% every decade over the next 30 years (Pivec, Issa et al. 2015). 
Intra-operative PFFs usually occur during femoral stem implantation and are classified 
differently to post-operative PFFs and are therefore not dealt with in our study (Greidanus, 
Mitchell et al. 2003).  
Risk factors for PFF include patient gender, increasing age, osteoporosis, and type of 
implant; with cementless femoral components having a higher incidence of post-operative 
PFF (Berend, Smith et al. 2006, Lindahl 2007). Stress risers in femoral cortical bone may 
occur during broaching intra-operatively, however, they may not fracture until an enticing 
event such as a simple low energy fall post-operatively. It is important to note intra-operative 
PFF may go un-noticed, which is a limitation of investigating PPFs. 
PFF burden  
Mortality risk for PFF varies in the literature. Young and colleagues and 
Bhattacharyya and colleagues (Bhattacharyya, Chang et al. 2007, Young, Walker et al. 2008) 
reported an overall 11% increase in risk of death within 12 months of experiencing the 
complication. Furthermore, Shields et al. 2014 (Shields, Behrend et al. 2014) revealed a  
1 year mortality of 18%, with 80% of deaths occurring within the first 3 months. If the 
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patients do survive, even with surgical treatment, they are four times more likely to require 
re-admission post-operatively due to complications and are often left with a functional 
limitation (Carli, Negus et al. 2017).  
Economic analysis of PFF management around hip arthroplasties raises an additional 
challenge for all stakeholders, with an average cost estimate of £23,469 per patient reported 
in the United Kingdom setting between 1999-2009 (Phillips, Boulton et al. 2011). 
Furthermore, Shields et al. 2014 (Shields, Behrend et al. 2014) reported an economic analysis 
on treatment costs for PFF being around $50,000 USD for revision arthroplasty and $25,000 
USD for ORIF. 
A multi-disciplinary approach is required for management of such fractures with both 
orthopaedic traumatologists and arthroplasty surgeons fundamental in the planning and 
execution of surgical intervention. The Vancouver classification system, devised by Brady  
et al. 1999 (Brady, Garbuz et al. 1999), is the most commonly utilised system for classifying 
peri-prosthetic fractures around hip arthroplasties. This classification system has been shown 
to be both reliable and valid (Brady, Garbuz et al. 1999, Brady, Garbuz et al. 2000). The 
system considers the site of fracture, stability of implant and quality of surrounding bone 
stock, which are collective pillars for management decision-making. Type A fractures are 
confined to the greater or lesser trochanter. Type B fractures are diaphyseal, around the 
prosthesis or immediately distal to it and are further classified into type; B1, B2 and B3, 
characterised by: a well-fixed stem, an unstable stem with sufficient bone stock and an 




Vancouver B2 PFF Management  
Broadly, goals of PFF are facilitating early weight bearing without compromising 
fracture healing and return to pain free functional status. The Swedish National Hip 
Arthroplasty Registry data spanning from 1979-2000 identified 1,049 PFFs, with over half 
being Vancouver type B2 (52%) (Lindahl, Garellick et al. 2006). Vancouver type B2 fracture 
management recommendations are currently that of long femoral stem revision arthroplasty, 
with or without internal fixation, with the aim of re-establishing implant stability and 
facilitating a fracture healing (Masri, Meek et al. 2004, Abdel, Cottino et al. 2015). In most 
cases, revision femoral arthroplasty involves open surgical dislocation of the hip, removal of 
the loose femoral implant and exchange for an uncemented long stem prosthesis which 
bypasses the fracture site (Abdel, Cottino et al. 2015).  
Open reduction and internal fixation (ORIF) for Vancouver B2 fractures has not 
traditionally been recommended due to the non-union rates, prolonged immobilisation 
periods and risk of further revision surgery being required for an unstable femoral implant 
(Lindahl, Garellick et al. 2006, Solomon, Hussenbocus et al. 2015).  
In contrast to revision, ORIF strategies generally attract a shorter operative time and 
involve surgical dissection to directly visualise the fracture site, anatomical reduction and 
subsequent internal fixation with plates, screws which are temporised with clamping tools 
and subsequently internally fixed with plate(s), screws or allografts or a combination. 
Common fixation strategies include locking plates, compression plates, or cables with or 
without cortical strut allografts (Dehghan, McKee et al. 2014).  
Context of the systematic review 
At the time of systematic review protocol registration, a modest amount of literature 
existed assessing the outcomes of Vancouver type B2 fracture management by way of ORIF 
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and femoral revision with or without internal fixation. Our scoping search revealed 
approximately 1000 published cases of Vancouver type B2 fracture management in the 
literature, including case studies, case series and cohort studies.  
 Although revision arthroplasty is currently recommended for management of 
Vancouver Type B2 PFFs, open reduction internal fixation (ORIF) has been shown in some 
small studies to yield similar outcomes when compared to revision (Solomon, Hussenbocus 
et al. 2015, Joestl, Hofbauer et al. 2016). If selected Vancouver type B2 fractures were shown 
to be amenable to ORIF alone rather than revision, it would be beneficial given that much 
intra-operative risk would be mitigated by way of shorter operative times; there is a reduction 
in skill set demands upon the surgeon, reduced implant costs, and allowance for subsequent 
revision in arthroplasty in younger individuals. 
On the 4th of August 2016, we searched the JBI Database of Systematic Reviews and 
Implementation Reports, Cochrane Database of Systematic Reviews and PubMed and found 
no recent systematic review specifically on Vancouver B2 PFF management. Our systematic 
review protocol was published in February 2017.  
Upon writing this thesis the search was repeated including the aforementioned 
databases on 18th of March 2018 and yielded one result of a systematic review investigating 
Vancouver B2 and B3 PFF management (Khan, Grindlay et al. 2017). Key differences 
between our systematic review and that of Khan’s are shown in Table 3.  
We feel the body of evidence captured by our systematic review and meta-analysis is 
more expansive than that of Khan’s with over 2.5 times a greater number of Vancouver B2 
PFF cases included, and captures a larger window of patient care by not excluding papers 
based on a minimum mean duration of follow-up. Furthermore, our study provides additional 







Table 3 Main differences between the systematic reviews.  
 (Khan, Grindlay et al. 2017) Ianunzio 
PROSPERO registration 
 
Registration 5/2/2016, completion 7/3/2017 Registration 20/2/2017 and publication protocol 
Feb 2017 (Ianunzio, Munn et al. 2017) 
Databases Ovid MEDLINE, Embase, and the Cochrane 
Central Register of Controlled Trials and 
Database of Systematic Reviews 
PubMed Medline, EMBASE, CINAHL, The 
Cochrane Central Register of Controlled Trials 
(CENTRAL) and Web of Science. 
And grey literature databases were searched, 
including; ClinicalTrials.gov and Proquest 
Theses and Dissertations. 
Inclusion criteria Conducted search on both B2 and/or B3 
fractures, studies with 10 or more case 
Inclusion criteria and analysis on B2 fractures 
only, studies with 5 or more B2 PFF 
Exclusion criteria Excluded studies with less than 2-year mean 
follow-up, no exclusion based on publication 
date 
Did not exclude studies based on follow-up 
duration, excluded papers published prior to 
1990 
Number of studies included Khan included 14 studies including 
14 case series 
37 studies including 27 retrospective case series 
and 10 retrospective cohort studies 
Number of Vancouver B2 PFF 





Evidence synthesis  
Given the increasing amount of evidence being generated in orthopaedic research 
over the past few decades, it has become difficult for clinicians to summarise and assess the 
quality of the evidence in order to translate research findings into clinical practice (Oxman, 
Cook et al. 1994, Swingler, Volmink et al. 2003). For this reason, systematic reviews are a 
powerful tool to facilitate evidence-based healthcare (EBHC) by advising clinical decision 
making (Murad and Montori 2013). In addition, systematic reviews present several 
advantages over traditional literature reviews, also known as critical reviews. This is related 
to the principles of systematic reviews, including rigour, transparency and replication, which 
may in turn improve the quality of traditional literature reviews in a number of ways. By 
carrying out systematic searches across multiple databases, systematic reviews may help 
reduce researcher bias, as it forces the reviewers to look for studies beyond their pre-existing 
knowledge of the literature on the topic. In addition, systematic reviews may generate a more 
objective answer to the research question itself, given they mandate specific information on 
the population of interest, intervention/exposure, group of comparison and outcome, 
generating a broad yet focused body of evidence. 
Justification of Review approach 
A systematic review and meta-analysis was chosen to answer our research objective 
on the effectiveness of management strategies for Vancouver B2 PFF due to a number of 
reasons. First, this approach allowed us to collate and summarise the best available evidence 
around our research question to date by adopting a rigorous and transparent search, quality 
assessment and data synthesis. Second, orthopaedic research is often limited to observational 
studies, given the ethical and practical barriers to undertaking randomised controlled trials 
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(RCTs). Specifically, in relation to our objective, randomising exposure allocation would 
require unanimous support of surgeons within a unit, as well as flexible skill sets, which 
would enable them to perform either intervention in a reproducible way. In addition, the cost 
and time burden associated with running such an RCT would not be feasible without 
significant funding from government and health industry, which has ethical implications. 
Finally, even if a large, high-quality RCT was conducted, it may still not be enough to guide 
clinical practice. In light of this, a systematic review and meta-analysis (where heterogeneity 
allows) is seen as an effective research tool which can be conducted in a timely fashion and 
generate good quality evidence, which can be rapidly translated into clinical practice. 
 There are a number of factors that characterise a rigorous systematic review. Firstly, 
the systematic review should explicitly declare the review questions as well as the eligibility 
criteria before the search across databases. Globally, the process should follow the guidelines 
from Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) 
(Moher, Liberati et al. 2009) and be published in the form of a protocol in reliable databases, 
such as PROSPERO. Furthermore, the search strategy should be tailored to the clinical 
question and cover multiple databases, ideally including the grey literature, and be subject to 
dual critical appraisal using an approved checklist, such as the tool provided by the Joanna 
Briggs Institute. Where heterogeneity allows, meta-analyses should be performed, and forest-
plots generated to summarise pooled estimates from single group and comparative studies. 
Finally, the Grading of Recommendations Assessment, Development and Evaluation 
(GRADE) approach should be employed to generate a Summary of Findings Table where 
appropriate.  
Objectives, inclusion criteria and methods were specified in advance and published in 




Assumptions and limitations of approach 
Although systematic reviews and meta-analysis provide a good level of evidence, the 
quality of the review is associated with the methodological quality of the included studies 
themselves. Therefore, the quality of the systematic review cannot be superior to that of the 
included studies. Unfortunately, orthopaedic research is often of low quality and this limits 








Inclusion and exclusion criteria 
Types of participants 
The review considered studies including individuals with a total hip arthroplasty or hip 
hemi-arthroplasty, primary or revision, who sustained a Vancouver type B2, or 
equivalent, PFF. Those who sustained intra-operative fractures were excluded, given the 
classification system is different. Additionally, studies utilising alternative methods of 
classification other than Vancouver or equivalent were excluded. 
Types of interventions 
This review considered studies that evaluate the following: 
• ORIF by any method including but not limited to, cable plate, compression plate, 
locking plates, screws, cerclage wires, cortical strut allografts or a combination of 
methods; and/or 
• Any form of femoral revision arthroplasty, with or without internal fixation. 
The review compared the aforementioned interventions with each other. Studies that have 
evaluated two or more interventions and studies that have investigated only a single 
intervention were considered for inclusion. If any of the interventions were compared 
with a different approach, including non-operative management, these were considered 





Types of outcomes 
The types of outcomes, their definition, and their example measures are included in Table 4. 
 
Table 4 Outcomes included in the systematic review. 
Outcome Definition 
Re-operation Defined as return to theatre for any surgical intervention required to manage the Vancouver B2 fracture OR 
complication following initial management strategy 
Implant breakage/ 
migration of screws 
Fracture through any hardware component or migration of screws 
Femoral loosening As defined using Harris’ criteria (Harris, McCarthy et al. 1982) or other criteria as used by study authors. 
Femoral osteolysis greater than 3mm sized non-linear demarcated lesion (Solomon, Hussenbocus et al. 2015) 
Stem subsidence/migration  
 
‘Stem subsidence (is) measured using the width of radio-lucent lines present at the s-c interface in Gruen zone 
1 parallel to the stem long axis’ (Solomon, Hussenbocus et al. 2015) 
For CCPT femoral stems, <6mm subsidence expected and acceptable (Solomon, Hussenbocus et al. 2015) 
For other femoral stem systems thresholds for acceptable subsidence were based on relevant literature/expert 
opinion/product manufacturer guide 
Union Defined clinically as absence of pain at fracture site upon weight-bearing and radiographically as cortical 
bridging of fracture on three or more sides viewed on antero-posterior and lateral radiograph (Solomon, 
Hussenbocus et al. 2015, Joestl, Hofbauer et al. 2016) 
Delayed union – Defined as healing taking greater than 3 months from time of surgery (Joestl, Hofbauer et al. 2016) 
Non-union Defined as a lack of progressive signs of healing beyond 6 months post-operatively (Joestl, Hofbauer et al. 
2016) 
Malunion Defined as deviation of more than 5 degrees from anatomical norms in the mediolateral or antero-posterior 




Table 4 (cont.) Outcomes included in the systematic review. 
Outcome Definition 
Re-fracture Defined as any new peri-prosthetic fracture or re-fracture through previous fracture site. 
Loss of reduction Defined as any change in fracture alignment (Joestl, Hofbauer et al. 2016) 
Dislocation of prosthesis Loss of anatomical reduction at hip articulation 
Neurovascular injury Defined as any neurological or vascular deficit, permanent or temporary, attributed directly to management 
intervention as documented by surgical team (excluding effects of regional anesthesia) 
Prosthetic joint infection 
defined as 
Sinus tract to prosthesis; OR 
Culture pathogen from 2+ samples; OR 
4 out of 6 of the following; 
• Elevated erythrocyte sedimentation rate (Mustafa, Santesso et al.) and serum C-reactive protein 
(CRP) concentration; 
• Elevated synovial leukocyte count; 
• Elevated synovial neutrophil percentage; 
• Purulence in affected joint; 
• Isolation of organism in one culture of peri-prosthetic tissue or fluid 
• More than 5 neutrophils per 5 high powered fields on analysis of peri-prosthetic tissue at x400 
magnification 
Functional outcomes including 
but not limited to 
• Harris hip score; (Harris 1969) OR 
• Oxford hip score; (Dawson, Fitzpatrick et al. 1996) OR 
• University of California, Los Angeles (UCLA) activity score; (Zahiri, Schmalzried et al. 1998) OR 
• Parker mobility score. (Parker and Palmer 1993) 
Operative risks • Total operating room time 
• Skin-to-skin surgical time 
• Peri-operative blood transfusion requirement 
Length of stay in hospital Self-explanatory  
Mortality Self-explanatory 
Note: patients excluded from cohorts due to death were included in the analysis for mortality 
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Types of studies 
This review considered both experimental and observational study designs 
including; randomised controlled trials, non-randomised controlled trials, quasi-
experimental, before and after studies, prospective and retrospective cohort studies, case 
studies, case control studies and analytical cross-sectional studies for inclusion.  
Studies with mixed cohorts (B2/3/1, C, Ag or AL) were only included if:  
1) There was a proportion of 80% or greater of Vancouver type B2 PFF; or  
2) Outcomes were reported specifically for Vancouver type B2 PFF (or authors could 
provide access to the raw data). 
In addition, studies with mixed cohorts including a proportion of 80% or greater B2 
population that have mixed intervention methods (ORIF, Revision with or without 
internal fixation, or Non-op) with pooled data were excluded, unless authors could 
provide access to the raw data or specific data was available in the publication. 
Studies with mixed intervention methods (ORIF, Revision with or without internal 
fixation, or Non-op) with pooled outcome data were only to be included if all of the 
cohort is B2 and 80% or greater proportion of Revision or ORIF predominates. This was 
the case unless authors could provide access to the raw data or specific data in the 
publication was available. 
Search strategy 
The search strategy aimed to find both published and unpublished studies. A 
three-step search strategy was utilised in this review. An initial limited search of PubMed 
MEDLINE was undertaken using key words such as femoral fracture, peri-prosthetic and 
arthroplasty followed by analysis of the text words contained in the title and abstract, and 
of the index terms used to describe the article. A second search using all identified 
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keywords and index terms was then undertaken across all included databases. Thirdly, the 
reference list of all identified reports and articles was then searched for additional studies. 
Studies published in English were considered for inclusion in this review. Articles 
published prior to 1990 were excluded to ensure management strategies reflect current 
clinical practice. Additionally, we contacted known experts in the field and prominent 
authors to enquire about their knowledge of any completed published or unpublished 
studies relevant to our objective.  
The databases we searched include: 
PubMed Medline, EMBASE, CINAHL, The Cochrane Central Register of Controlled 
Trials (CENTRAL) and Web of Science.  
Additionally, the following grey literature databases were searched; ClinicalTrials.gov 
and Proquest Theses and Dissertations. 
The PubMed Medline search strategy was: 
Femoral fractures[mh] OR Femoral fracture*[tw] OR femur fracture*[tw] 
AND 
Periprosthetic[tw] OR peri-prosthetic[tw] OR peri-prosthetic[tw] 
AND 
Arthroplasty, replacement, hip[mh] OR hemiarthroplasty[mh] OR hip arthroplasty[tw] 
OR  
hip replacement[tw] OR hip hemiarthroplasty[tw] 
Assessment of methodological quality  
The quality assessment of the papers was performed by two independent 
reviewers (Jamie Ianunzio and Megan Cain), using standardised critical appraisal 
instruments according to the study design from the Joanna Briggs Institute (Appendix I). 
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The instruments consist of 9 or 10 ‘yes/no/unclear’ questions, depending on the study 
design, regarding different aspects of the included papers aiming to assess the quality of 
the papers. Both the reviewers were properly trained by attending a course to apply the 
above-mentioned instrument. The critical appraisal was compared and in case of 
disagreement a third reviewer’s opinion was sought for further discussion. All articles 
were included in the systematic review regardless of their methodological quality. 
Data extraction 
Data was extracted from papers included in the review using the standardised data 
extraction tool from JBI-System for the Unified Management, Assessment and Review of 
Information (SUMARI) (Appendix II). The data extracted included specific details about 
the interventions, populations, study methods and outcomes of significance to the review 
objective and specific objectives. In the event of data of interest being absent in the 
published article(s), raw data was requested via direct contact with corresponding 
author(s) and we allowed them 4 weeks to respond. We sought raw data in 37 studies and 
obtained a response from 10 studies, with only three providing raw data. Table 5 presents 




Table 5 Description of data extraction.  
Study characteristics Collected when available 
First author/year of 
publication 
Self-explanatory 
Cohort characteristics  Study design, data source 
Participants’ 
characteristics 
Participants, sampling method, recruitment, index 
procedure indication, implant details, mechanism of 
injury, fracture diagnosis method, setting, inclusion 
criteria, exclusion criteria 
Exposure Intervention category and technique, sex, age, time-frame 
from index to fracture, exposure allocation, surgeon 
experiential level, weight bearing status, venous 
thromboembolism prophylaxis and surgical antibiotic 
prophylaxis 
Outcome General characteristics, time-frame of assessment 
Statistical Analysis Test used 
Results Proportions/ means with respective Cis for each 
intervention arm 
Limitations and 









Data was synthesised in meta-analyses and presented in forest plots where 
possible. We performed both single group and comparative meta-analyses. Where 
synthesis in the meta-analysis was not possible, due to significant clinical or 
methodological heterogeneity, we provided a narrative description of the results including 
tables and figures to aid in data presentation where appropriate.  
Open Meta Analyst was adopted for single group analyses of continuous variables 
using means, whereas Medcalc was adopted for single group analyses of dichotomous 
variables using a Freeman-Tukey transformation. For comparative group analyses we 
used RevMan and adopted Mantel-Haenszel as the statistical method of choice for 
dichotomous outcomes. The inverse variance was used when the Mantel-Haenzel method 
was not possible for dichotomous outcomes, and it was also employed for all continuous 
outcomes. 
As we intended to generalise the results beyond the included studies, the random 
effects model meta-analysis was chosen as the default model as this is a more appropriate 
approach than the fixed model for this purpose (Tufanaru, Munn et al. 2015). The fixed 
effect meta-analysis model was used only if it was not appropriate to use the random 
effects model (for example, if less than five studies were included in the meta-analysis) 
(Tufanaru, Munn et al. 2015).  
We intended on using Odds Ratio, however, for ease of interpretation effect sizes 
were expressed as risk difference and relative risk (for categorical data) and weighted 
mean differences (for continuous data) and their respective 95% confidence intervals 
were calculated for analysis. In the case of zero event rates it was not possible to conduct 
meta-analysis for Risk Ratios, therefore, we adopted the Peto Odds Ratio (this only 
applies to 3 comparative meta-analyses). Studies were not included in meta-analyses if 
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authors did not provide the Standard Deviation (SD) and/or range, or raw data could not 
facilitate its calculation. We adopted the method of Hozo to calculate the SD from the 
range where required. Heterogeneity was assessed statistically using the standard Chi-
square and I2 and also explored using sub-group analyses. For I2 values of up to 25%, 
25% to 75%, and more than 75%, heterogeneity was defined as low, moderate and high, 
respectively (Higgins, Thompson et al. 2003). Although sub-group analyses for age, sex, 
co-morbidities, smoking status, surgical expertise and intervention technique were 
planned, only sub-group analysis for intervention technique was possible. 
A 'Summary of Findings' Table was created with the GRADEPro GDT software. 
We adopted the GRADE approach for grading the quality of evidence (Schunemann, 
Brozek et al.) The 'Summary of Findings' Table presents the following information where 
appropriate: absolute risks for the treatment and control, estimates of relative risk, and a 
ranking of the quality of the evidence based on the risk of bias, directness, heterogeneity, 
precision and risk of publication bias of the review results (Higgins and Green 2013). 
Outcomes were ranked accordingly in decreasing order of importance as follows: 
mortality/ attainment of pre-fracture mobility status (Critical score 9), surgical time/ re-
operation/ union/ dislocation (Critical score 8), and transfusion (Important score 6). 
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Figure 1 shows a flowchart of the study selection. From the electronic searches, 
1805 potential articles were found, of which 860 duplicates were removed. In the first 
screening, 213 studies were selected for full text reading. The reference lists of these 
articles revealed another 45 articles, and a total of 258 studies were selected for full-text 
reading. After the evaluation, 37 studies were finally included in the systematic review. 
The main reasons for exclusion were inclusion of mixed exposures and pooled outcomes 
(n=39), none (n=33) or less than 5 B2 PPF (n=33), and studies not written in English 





















































Adapted from: (Moher, Liberati et al. 2009) 
 
Figure 1 PRISMA flow diagram of search and study selection process.  
Number of records identified through a 
systematic search (N=1805) 
Number of additional records identified 
through other sources (N=0) 




Number of records 
excluded (N=860) 
 
Number of full-text 
articles assessed for 
eligibility (N=213) 
Number of articles 
excluded on reading 
full-text (N=179) 
Number of articles 
assessed for quality 
(N=37) (Note: reference 
list screening yielded 3 
additional articles) 
 




























Description of the included studies 
Appendix IV presents the characteristics of the included studies. There were 27 
retrospective case series and 10 retrospective cohort studies, which together evaluated 
outcomes of 926 Vancouver B2 fracture cases. The majority of the studies were 
conducted in tertiary hospitals in high-income countries, with over 70% located in 
Europe. Around two thirds of the articles were published in 2010 or later, and 15 studies 
presented data collected over a period of 10 years or more. Over half of the included 
studies had a minimum follow-up period of 12 months and included individuals over  
70 years old, with females being over-represented in most investigations. With regards to 
the intervention, 24 studies evaluated revision with or without cables, cerclage or wires, 
while three studies investigated revision plus ORIF with plate. There were 13 studies that 
analysed revision without specifying the technique or by adopting multiple methods. Ten 
articles assessed ORIF with plate, whereas another four studies assessed ORIF without 
specifying the plating method or utilised an alternative fixation method (e.g. cerclage 
wires). Finally, one study evaluated a non-operative intervention. Among the 37 included 
studies, six papers evaluated two interventions of interest, five articles included three 
interventions, while two studies evaluated four interventions. In order to simplify the 
understanding of our references we attributed a number for each of the included studies 
according to their alphabetic order (first author). In addition, when more than one 
intervention was investigated in the same study, we employed a letter to indicate the 
different interventions. For example, the study by Bhattacharyya and colleagues 
(Bhattacharyya, Chang et al. 2007) was the study number 2. As this study evaluated more 
than one intervention of interest, the referencing system was 2A for Revision +/- wires, 
cables or cerclages and 2B for ORIF with plate. Details on the referencing system 
adopted are presented on Table 6. A large variety of outcomes were investigated by the 
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included studies and the associations between interventions and outcomes were expressed 
in multiple ways, including means with standard errors or standard deviations, odds 




Table 6 Description of studies and referencing system adopted. 
Intervention arm Studies  
Revision with or without 
wires, cables, cerclage 
2A (Bhattacharyya, Chang et al. 2007) 
4 (Canbora, Kose et al. 2013) 
6 (Da Assunção, Pollard et al. 2015) 
7 (Eingartner, Volkmann et al. 2006) 
8 (Fink 2014) 
9 (Garcia-Rey, Garcia-Cimbrelo et al. 2013) 
10 (Grammatopoulos, Pandit et al. 2011) 
13A (Holley, Zelken et al. 2007) 
14A (Inngul and Enocson 2015) 
15A(Joestl, Hofbauer et al. 2016) 
15B(Joestl, Hofbauer et al. 2016) 
16 (Ko, Lam et al. 2003) 
17 (Konan, Rayan et al. 2011) 
18A (Korbel, Sponer et al. 2013) 
20A (Lindahl, Garellick et al. 2006) 
22 (Marx, Beier et al. 2012) 
24A (Mukka, Mellner et al. 2016) 
25A (Mukundan, Rayan et al. 2010) 
25C (Mukundan, Rayan et al. 2010) 
26 (Munro, Garbuz et al. 2014) 
27A (Niikura, Lee et al. 2014) 
28A (Pavlou, Panteliadis et al. 2011) 
29 (Pogliacomi, Corsini et al. 2014) 
31 (Sexton, Stossel et al. 2006) 
33B (Solomon, Hussenbocus et al. 2015) 
36 (Young, Pandit et al. 2007) 
37A (Zuurmond, van Wijhe et al. 2010) 
21B (Lunebourg, Mouhsine et al. 2015) 
24B (Mukka, Mellner et al. 2016) 
25B (Mukundan, Rayan et al. 2010) 
Revision strut allograft 
13C (Holley, Zelken et al. 2007) 
32 (Sledge and Abiri 2002) 
35 (Wu, Yan et al. 2009) 
Revision mixed 
methods/unspecified 
1 (Amenabar, Rahman et al. 2015) 
3 (Briant-Evans, Veeramootoo et al. 2009) 
5 (Corten, Macdonald et al. 2012) 
12 (Holder, Papp et al. 2014) 
13B (Holley, Zelken et al. 2007) 
19 (Levine, Della Valle et al. 2008) 
20B (Niikura, Lee et al. 2014) 
23 (Moreta, Aguirre et al. 2015) 
28B (Pavlou, Panteliadis et al. 2011) 
30 (Rayan, Konan et al. 2010) 
37B (Zuurmond, van Wijhe et al. 2010) 
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Table 6 (cont.) Description of studies and referencing system adopted. 
Intervention arm Studies 
ORIF with plate 
2B (Bhattacharyya, Chang et al. 2007) 
11 (Haidar and Goodwin 2005) 
13D (Holley, Zelken et al. 2007) 
15C (Joestl, Hofbauer et al. 2016) 
18B (Korbel, Sponer et al. 2013) 
21A (Lunebourg, Mouhsine et al. 2015) 
27B (Niikura, Lee et al. 2014) 
28C (Pavlou, Panteliadis et al. 2011) 
28D (Pavlou, Panteliadis et al. 2011) 
33A (Solomon, Hussenbocus et al. 2015) 
34A (Spina, Rocca et al. 2014) 
ORIF with wires, cables, 
cerclage 
24C (Mukka, Mellner et al. 2016) 
34B (Spina, Rocca et al. 2014) 
ORIF mixed methods or 
unspecified 
14B (Inngul and Enocson 2015) 
20C (Niikura, Lee et al. 2014) 
37C (Zuurmond, van Wijhe et al. 2010) 




Assessment of methodological quality 
Most studies obtained a score of over 70% on the methodological quality assessment 
(Appendix V). Regarding cohort studies (n=10) the most common methodological 
inadequacies identified were around addressing confounding factors in the analysis, with 
no studies addressing confounding factors. Additionally, only one out of seven studies 
were assessed to have measured outcomes in a valid and reliable way. Regarding case 
series (n=27), the most common methodological flaws were around inadequate 




Findings of the review 
  Findings are presented according to 1) type of study (comparative and single 
group studies), 2) surgical technique employed (Revision with or without 
wires/cerclage/cables, ORIF with plate, Revision and ORIF with plate, ORIF with plate, 
Revision any method, ORIF any method) and 3) outcomes evaluated.  
Comparative studies 
This section presents results on comparative studies which assessed one or more 
interventions of interest. The section is structured according to the pair of interventions 
under study and outcomes. 
Revision with or without wires/cerclage/cables vs ORIF with plate 
There were six studies (four retrospective cohort studies and two retrospective case 
series) which investigated various outcomes for the interventions of Revision with or 
without wires/cerclage/cables and ORIF with plate.  
Surgical time 
Two meta-analyses were performed as the Revision with or without 
wires/cerclage/cable exposures 15A and 15B could not be combined without duplicating 






Surgical time (analysis 1) 
 
Figure 2 Surgical time (minutes) for Revision with or without wires/cerclage/cables vs 
ORIF with plate. 
Figure 2 shows the surgical time of the exposure in the three studies that reported 
surgical time for 46 patients. Mean surgical time is in minutes. None of the studies 
explicitly defined surgical time and refer to the outcome as either ‘surgical 
duration’(Joestl, Hofbauer et al. 2016), ‘operation time’ (Niikura, Lee et al. 2014) or 
‘skin-to-skin surgical time’ (Solomon, Hussenbocus et al. 2015), all of which were 
accepted to mean surgical time for the purposes of this meta-analysis.  
Overall, there was a statistically significant difference in the surgical time between 
patients treated with Revision with or without wires/cerclage/cables compared with ORIF 
with plate (p=0.0004). The weighted mean difference in surgical time in the Revision 
with or without wires/cerclage/cables group was 50.3 minutes (95%CI 22.7 to 77.9) 
longer than the ORIF with plate group. There was no significant heterogeneity (p=0.16), 




Surgical time (analysis 2) 
 
Figure 3 Surgical time (minutes) for Revision with or without wires/cerclage/cables vs 
ORIF with plate. 
Figure 3 shows the surgical time of the three studies that reported surgical time for 46 
patients. Mean surgical time is in minutes.  
Overall, there was a statistically significant difference in the surgical time between 
patients treated with Revision with or without wires/cerclage/cables compared with ORIF 
with plate (p=0.0002). The weighted mean difference in surgical time in the Revision 
with or without wires/cerclage/cables group was 49.9 minutes (95%CI 23.4 to 76.5) 
longer than the ORIF with plate group. There was no significant heterogeneity (p=0.16), 
and I2 indicates there is a moderate degree of heterogeneity between the studies (45%). 
Blood loss intra-operatively 
One study compared intra-operative blood loss for Revision with or without 
wires/cerclage/cables, exposure 27A (n=2) and ORIF with plate, exposure 27B (n=3), 
with a mean intra-operative blood loss of 1502 mL (SD 1368) and 390 mL (SD 233), 




Transfusion packed red blood cell (PRBC) requirement (units) 
 
Figure 4 Transfusion PRBC (units) for Revision with or without 
wires/cerclage/cables vs ORIF with plate.
 
shows the transfusion PRBC requirement in the two studies that reported transfusion 
PRBC requirement for 24 patients. Study authors refer to the outcome as either ‘intra-
operative transfusion’ (27A) (Niikura, Lee et al. 2014) or ‘peri-operative transfusion’ 
(33B) (Solomon, Hussenbocus et al. 2015), both of which were accepted as transfusion 
PRBC requirement. Mean transfusion PRBC requirement is in units.  
Overall, there was a statistically significant difference in the transfusion PRBC 
requirement in patients treated with Revision with or without wires/cerclage/cables 
compared with ORIF with plate (p=0.0005). The weighted mean difference in transfusion 
PRBC requirement in the Revision with or without wires/cerclage/cables group was 2.6 
units (95%CI 1.2 to 4.1) more than the ORIF with plate group. There was no significant 





Two studies compared subsidence for Revision with or without 
wires/cerclage/cables and ORIF with plate, exposure 15A+B (n=28) with no events 
observed vs 15C (n=8) (Joestl, Hofbauer et al. 2016) with no events observed and 
exposure 33B with a prevalence of 14.3% (1/7) vs 33A (n=9) (Solomon, Hussenbocus  
et al. 2015) with no events observed, respectively. No meta-analysis was possible due to 
only 33B having an event rate other than zero. Only Solomon and colleagues provided a 
definition and explicit method for calculating subsidence (Solomon, Hussenbocus et al. 
2015).  
Union overall (combined analysis 1 and 2) 
 
 
Figure 5 Union (overall) for Revision with or without wires/cerclage/cables vs ORIF with 
plate. 
Figure 5 shows union in the four studies that reported union for 70 patients. Half 
of the studies (2/4) explicitly defined union and this was generally defined as the presence 
of a bridging callus across the main fracture site on a minimum two or three sides viewed 
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in two views on plain film radiographs, however, Pavlou and colleagues additionally 
considered clinical union (Pavlou, Panteliadis et al. 2011) (Table 7). Only one quarter 
(1/4) of the studies provided a time to union (Table 7).  
The risk difference for union in the Revision with or without wires/cerclage/cables 
group was 0.14 (95%CI -0.07 to 0.34) more than the ORIF with plate group. There was 
no significant heterogeneity (p=0.21), and I2 indicates there is a moderate degree of 
heterogeneity between the studies (35%).  
The risk ratio for union in the Revision with or without wires/cerclage/cables 
group was 1.17 (95%CI 0.90 to 1.53) more than the ORIF with plate group. There was no 
significant heterogeneity (p=0.26), and I2 indicates there is a moderate degree of 
heterogeneity between the studies (26%). 
Overall, there was no statistically significant difference in the prevalence of union 
in patients treated with Revision with or without wires/cerclage/cables compared with 
ORIF with plate for both risk difference and risk ratio.  
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Table 7 Definition of union, method of measurement and time to union among the included studies.  
Study Definition Method of 
measurement 
Time to union 
13A (Holley, 





N/S (Note: Time-frame of outcome 
assessment mean 34 months (Range 12-100, 
No SD reported) 
13D (Holley, 





N/S (Note: Time-frame of outcome 
assessment Mean 69.5 months (Range 57-
82, No SD reported) 
27A (Niikura, Lee 





N/S (Note: time-frame for outcomes 
assessment: Pooled follow-up mean 18.4 
months (SD 14.2, range NS)) 
27B (Niikura, Lee 





N/S (Note: time-frame for outcomes 
assessment: Pooled follow-up mean 18.4 
months (SD 14.2, range NS)) 
28A (Pavlou, 
Panteliadis et al. 
2011) 
Union, 
Radiographic union defined as: ‘…cortical continuity on 
both lateral and AP (antero-posterior) radiographs.’  
Clinical union defined as: ‘…as pain-free weight bearing 
with or without aid.’ 
Clinical and plain 
film radiographs 
Mean 5 months (SD 2.2, Range NS) 
28C/D (Pavlou, 
Panteliadis et al. 
2011) 
Union, 
Radiographic union defined as: ‘…cortical continuity on 
both lateral and AP (antero-posterior) radiographs.’  
Clinical union defined as: ‘…as pain-free weight bearing 
with or without aid.’ 
Clinical and plain 
film radiographs 
Mean 
C: 8.8 (SD 4.0, Range NS) 
D: 4.4 (SD 0.51, Range NS) 
 
33B (Solomon, 
Hussenbocus et al. 
2015) 
Union, 
Radiographic healing: ‘no visible fracture line on all Xray 
views available (AP, lateral and oblique).’ 
Plain film 
radiographs 
N/S (Note: Time-frame of outcomes 
assessment: Median 59 months (16-137) – 
excludes 2 deaths <3 months)) 
33A (Solomon, 
Hussenbocus et al. 
2015) 
Union, 
Radiographic healing: ‘no visible fracture line on all Xray 




(Note: Time-frame of outcomes assessment: 
Median 67 months (13-82) – excludes 3 
deaths <3 months 
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Sub-group analysis was performed by separating exposure 28C (ORIF with plate 
without bone graft) and 28D (ORIF with plate with bone graft) to assess for any 
appreciable change in the meta-analysis result for union (Pavlou, Panteliadis et al. 2011). 
Union (analysis 1 – excluding 28D)  
 
Figure 6 Union (overall) for Revision with or without wires/cerclage/cables vs ORIF with 
plate. 
Figure 6 shows union in the four studies that reported union for 66 patients. 
Overall, there was no statistically significant difference in the prevalence of union in 
patients treated with Revision with or without wires/cerclage/cables compared with ORIF 
with plate for both risk difference and risk ratio.  
The risk difference for union in the Revision with or without wires/cerclage/cables 
group was 0.14 (95%CI 0.08 to 0.36) more than the ORIF with plate group. There was no 
significant heterogeneity (p=0.19), and I2 indicates there is a moderate degree of 
heterogeneity between the studies (38%). 
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The risk ratio for union in the Revision with or without wires/cerclage/cables 
group was 1.17 (95%CI 0.87 to 1.58) more than the ORIF with plate group. There was no 
significant heterogeneity (p=0.24), and I2 indicates there is a moderate degree of 
heterogeneity between the studies (29%). 
Union (analysis 2 – excluding 28C) 
 
 
Figure 7 Union (overall) for Revision with or without wires/cerclage/cables vs ORIF with 
plate. 
Figure 7 shows union in the four studies that reported union for 60 patients. 
Overall, there was no statistically significant difference in the prevalence of union in 
patients treated with Revision with or without wires/cerclage/cables compared with ORIF 
with plate for both risk difference and risk ratio.  
The risk difference for union in the Revision with or without wires/cerclage/cables 
group was 0.02 (95%CI 0.23 to 0.27) more than the ORIF with plate group. There was no 
significant heterogeneity (p=0.65), and I2 indicates there is no important heterogeneity 
between the studies (0%). 
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The risk ratio for union in the Revision with or without wires/cerclage/cables 
group was 1.02 (95%CI 0.76 to 1.37) more than the ORIF with plate group. There was no 
significant heterogeneity (p=0.71), and I2 indicates there is no important heterogeneity 
between the studies (0%). 
Time to union 
One study compared time to union for Revision with or without 
wires/cerclage/cables and ORIF with plate. Pavlou and colleagues defined union both 
radiographically ‘… cortical continuity on both lateral and AP (antero-posterior) 
radiographs’ and clinically; clinical union ‘…pain-free weight bearing with or without 
aid’ (Pavlou, Panteliadis et al. 2011). Exposure 28A (n=25) (Pavlou, Panteliadis et al. 
2011) with a mean time to union of 4.3 months (SD 1.9) vs 28C (no graft) (n=10) with a 
mean time to union of 8.8 months (SD 4) (n=10), p-value 0.218 (ANOVA). Exposure 
28A (n=25) (Pavlou, Panteliadis et al. 2011) with a mean time to union of 4.3 months (SD 
1.9) vs 28D (with graft) (n=4) with a mean time to union of 4.4 months (SD 0.5) (n=4),  
p-value 0.736 (ANOVA). This comparative analysis would suggest that ORIF with plate 
and bone graft may neutralise any time advantage revision imparts upon attaining union.  
Non-union 
One study compared non-union for Revision with or without wires/cerclage/cables 
and ORIF with plate, exposure 28A (Pavlou, Panteliadis et al. 2011) with a prevalence of 
8% (2/25) vs exposure 28C+D with prevalence of 36% (5/14). Pavlou and colleagues 
defined non-union as ‘failure of a fracture to unite 12 months following fixation…’. 
Furthermore, the study analysed using Odds Ratio (OR); Exposure 28A (n=25) vs 28C 
(no graft) (n=10) with an OR of 7.7 (95%CI 1.12 to 52.3), p-value 0.038*. Exposure 28A 
(n=25) vs 28D (with graft) (n=4) with an OR of 3.83 (95%CI 0.26 to 56.2), p-value 0.327 
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(Pavlou, Panteliadis et al. 2011). This comparative analysis would suggest that ORIF with 
plate and bone graft may neutralise any advantage Revision imparts upon attaining union.  
Femoral osteolysis 
One study compared femoral osteolysis for Revision with or without 
wires/cerclage/cables and ORIF with plate, exposure 33B (n=7) and 33A (n=9), with no 
events observed in either exposure arm. Femoral osteolysis was defined as a greater than 
3mm diameter nonlinear demarcated lesion (recorded for each Gruen zone) (33B), 
however, no time-frame was stipulated (Solomon, Hussenbocus et al. 2015). 
Loss of reduction (fracture) 
One study compared loss of reduction (fracture) for Revision with or without 
wires/cerclage/cables and ORIF with plate, exposure 27A (n=2) and exposure 27B (n=3), 
with no events observed in either exposure arm (Niikura, Lee et al. 2014). No explicit 
definition of loss of reduction was reported. 
Malunion 
One study compared malunion for Revision with or without wires/cerclage/cables 
and ORIF with plate, exposure 27A (n=2) and 27B (n=3), with no events observed. 
Malunion was defined by authors as any angular deformity greater than 5° (Niikura, Lee 
et al. 2014). 
Length of stay 
One study compared hospital length of stay for Revision with or without 
wires/cerclage/cables and ORIF with plate, exposure 15A (n=14) with a mean 26 days 
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(SD 14) and exposure 15B (n=14) with a mean 29 days (SD 16) vs exposure 15C (n=8) 
with a mean 26 days (SD 13) (Joestl, Hofbauer et al. 2016).  
Mortality (overall) 
Two studies compared mortality for Revision with or without 
wires/cerclage/cables and ORIF with plate, exposure 15A+B (n=28) vs 15C (n=8), with 
no events observed (Joestl, Hofbauer et al. 2016); and exposure 33B vs 33A with a 
prevalence of 56% (5/9) and 25% (3/12), respectively (Solomon, Hussenbocus et al. 
2015). No meta-analysis was possible due to only 33B and 33A having event rates other 
than zero.  
Deep surgical site infection (DSSI) 
 
Figure 8 Deep surgical site infection (DSSI) for Revision with or without 
wires/cerclage/cables vs ORIF with plate. 
Figure 8 shows DSSI in the four studies that reported DSSI for 84 patients. No 
authors provided a definition for DSSI; only one study (Joestl, Hofbauer et al. 2016) 
implies aspiration hip joint was performed for diagnosis. The explicit time-frame of 
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outcome measurement was not reported in any study. Overall, there was no statistically 
significant difference in the prevalence of DSSI in patients treated with Revision with or 
without wires/cerclage/cables compared with ORIF with plate for both risk difference 
(p=0.66) and OR (p=0.43).  
The risk difference for DSSI in the Revision with or without wires/cerclage/cables 
group was 0.03 (95%CI 0.10 to 0.16) more than the ORIF with plate group. There was no 
significant heterogeneity (p=0.98), and I2 indicates there is no important heterogeneity 
between the studies (0%). 
The Peto Odds Ratio for DSSI in the Revision with or without 
wires/cerclage/cables group was 3.71 (95%CI 0.14 to 97.08) more than the ORIF with 
plate group. There was no significant heterogeneity (p=0.99), and I2 indicates there is no 
important heterogeneity between the studies (0%). 
Superficial surgical site infection (SSSI) 
Three studies compared SSSI for Revision with or without wires/cerclage/cables 
and ORIF with plate, exposure 15A+B vs 15A with a prevalence of 3.6% (1/28) and no 
events observed (0/8) (Joestl, Hofbauer et al. 2016), respectively, exposures 27A (n=2) vs 
27B (n=3) (Niikura, Lee et al. 2014), with no events observed and exposures 33B (n=7) 
vs 33A (n=12) (Solomon, Hussenbocus et al. 2015), with no events observed. No meta-
analysis was possible due to only 15A+B having an event rates other than zero (Joestl, 




Dislocation overall (Combined analysis 1 and 2) 
 
Figure 9 Dislocation for Revision with or without wires/cerclage/cables vs ORIF with 
plate. 
Figure 9 shows dislocation in the four studies that reported for 118 patients. Only 
one study (Solomon, Hussenbocus et al. 2015) reported a time period within which 
dislocation occurred, which was less than 3 months post-operatively. Overall, there was 
no statistically significant difference in the prevalence of dislocation in patients treated 
with Revision with or without wires/cerclage/cables compared with ORIF with plate for 
both risk difference and risk ratio.  
The risk difference for dislocation in the Revision with or without 
wires/cerclage/cables group was 0.05 (95%CI 0.09 to 0.19) more than the ORIF with 
plate group. There was no significant heterogeneity (p=0.47), and I2 indicates there is no 
important heterogeneity between the studies (0%). 
The risk ratio for dislocation in the Revision with or without wires/cerclage/cables 
group was 1.26 (95%CI 0.47 to 3.39) more than the ORIF with plate group. There was no 
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significant heterogeneity (p=0.54), and I2 indicates there is no important heterogeneity 
between the studies (0%). Sub-group analysis was performed by separating exposure 28C 
(ORIF with plate without bone graft) and 28D (ORIF with plate with bone graft) to assess 
for any appreciable change in the meta-analysis result for dislocation (Pavlou, Panteliadis 
et al. 2011).  
Dislocation Analysis 1 (excluding 28D (with graft)) 
 
Figure 10 Dislocation for Revision with or without wires/cerclage/cables vs ORIF with 
plate. 
 Figure 10 shows dislocation in the four studies that reported for 114 patients. 
Overall, there was a statistically significant difference in the prevalence of dislocation in 
patients treated with Revision with or without wires/cerclage/cables compared with ORIF 
with plate for risk difference, however, not for risk ratio.  
The risk difference for dislocation in the Revision with or without 
wires/cerclage/cables group was 0.13 (95%CI 0.01 to 0.26) more than the ORIF with 
56 
 
plate group. There was no significant heterogeneity (p=0.97), and I2 indicates there is no 
important heterogeneity between the studies (0%). 
The risk ratio for dislocation in the Revision with or without wires/cerclage/cables 
group was 2.59 (95%CI 0.68 to 9.89) more than the ORIF with plate group. There was no 
significant heterogeneity (p=0.99), and I2 indicates there is no important heterogeneity 
between the studies (0%). 
Dislocation Analysis 2 (excluding 28C due to no graft (Pavlou, Panteliadis et al. 2011)) 
 
Figure 11 Dislocation for Revision with or without wires/cerclage/cables vs ORIF with 
plate. 
Figure 11 shows dislocation in the four studies that reported for 108 patients. 
Overall, there was no statistically significant difference in the prevalence of dislocation in 
patients treated with Revision with or without wires/cerclage/cables compared with ORIF 
with plate for both risk difference and risk ratio.  
The risk difference for dislocation in the Revision with or without 
wires/cerclage/cables group was -0.01 (95%CI 0.16 to 0.15) less than the ORIF with plate 
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group. There was significant heterogeneity (p=0.01), and I2 indicates there is a moderate 
degree of heterogeneity between the studies (73%). 
The risk ratio for dislocation in the Revision with or without wires/cerclage/cables 
group was 0.86 (95%CI 0.37 to 2.01) less than the ORIF with plate group. There was 
significant heterogeneity (p=0.02), and I2 indicates a moderate degree of heterogeneity 
between the studies (69%). 
Re-operation 
One study compared re-operation for Revision with or without 
wires/cerclage/cables and ORIF with plate, exposure 13A vs 13D, with a prevalence of 
38% (3/8) and 50% (1/2), respectively (Holley, Zelken et al. 2007). Authors did not 
provide an explicit definition nor time-frame for re-operation, however, 13A and 13D had 
a minimum 12 months assessment time-frame (Holley, Zelken et al. 2007).  
Parker mobility scores pre and post-operatively 
 
Figure 12 Revision with or without wires/cerclage/cables vs ORIF with plate. 
Figure 12 shows pre and post-operative Parker mobility scores in the two studies 
that reported pre and post-operative Parker mobility scores for 41 patients. The time point 
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pre and post-operatively at which the Parker mobility score was calculated was not 
explicitly reported in either study.  
Overall, there was no statistically significant mean difference in the scores 
between patients treated with Revision with or without wires/cerclage/cables compared 
with ORIF with plate (p=0.86). The weighted mean difference in the Parker mobility 
score pre and post-operatively in the Revision with or without wires/cerclage/cables sub-
group was 0.49 (95%CI 0.40 to 1.38) points (lower post-operatively) compared with 0.33 
(95%CI 1.18 to1.84) points (lower post-operatively) in the ORIF with plate sub-group. 
There was no significant heterogeneity (p=0.99), and I2 indicates there is no important 
heterogeneity between the studies (0%). 
Harris hip score (HHS) (post-operative) 
One study compared post-operative HHS for Revision with or without 
wires/cerclage/cables and ORIF with plate, exposure 33B (n=4) vs 33A (n=5), with mean 
scores of 72 (SD 11.3) and 59 (SD 22.96), respectively. The time point post-operatively at 
which HHS was calculated was not explicitly reported by study authors (Solomon, 
Hussenbocus et al. 2015). 
Harris hip pain score (post-operative) 
One study compared post-operative Harris hip pain score for Revision with or 
without wires/cerclage/cables vs ORIF with plate, exposure 33B (n=7) vs 33A (n=8), with 
mean scores of 31.1 (SD 15.18) and 41 (SD 8.4), respectively. The time point post-
operatively at which Harris hip pain score was calculated, was not explicitly reported by 




Attainment of pre-fracture mobility status 
 
Figure 13 Attainment of pre-fracture mobility status for Revision with or without 
wires/cerclage/cables vs ORIF with plate. 
 Figure 13 shows attainment of pre-fracture mobility status in the three studies that 
reported attainment of pre-fracture mobility status for 56 patients. There was no explicit 
reporting by authors of how, or at which time point, post-operatively this assessment was 
made (e.g. clinical or self-reported).  
Overall, there was no statistically significant difference in the prevalence of 
attainment of pre-fracture mobility status in patients treated with Revision with or without 
wires/cerclage/cables compared with ORIF with plate for both risk difference and risk 
ratio.  
The risk difference for attainment of pre-fracture mobility status in the Revision 
with or without wires/cerclage/cables group was 0.06 (95%CI 0.21 to 0.34) more than the 
ORIF with plate group. There was no significant heterogeneity (p=0.37), and I2 indicates 
there is no important heterogeneity between the studies (0%). 
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The risk ratio for attainment of pre-fracture mobility status in the Revision with or 
without wires/cerclage/cables group was 1.10 (95%CI 0.71 to 1.72) more than the ORIF 
with plate group. There was no significant heterogeneity (p=0.40), and I2 indicates there 
is no important heterogeneity between the studies (0%). 
Revision with or without wires/cerclage/cables vs Revision and ORIF with plate 
There were two studies (one prospective cohort study and one retrospective cohort study) 
which investigated outcomes for the interventions of Revision with or without 
wires/cerclage/cables vs Revision and ORIF with plate (Mukundan, Rayan et al. 2010, 
Mukka, Mellner et al. 2016).  
Union 
There were two studies which compared union for Revision with or without 
wires/cerclage/cables vs Revision and ORIF with plate, exposure 24A with an event rate 
of 8/8 (100%) vs 24B (Mukka, Mellner et al. 2016) with an event rate of 8/8 (100%) and 
exposure 25A with an event rate of 19/19 (100%) vs 25B with an event rate of 8/8 
(100%) (Mukundan, Rayan et al. 2010).  
Revision and ORIF with plate vs ORIF with plate 
There was one study (retrospective case series) which investigated outcomes for the 
interventions of Revision and ORIF with plate vs ORIF with plate (Lunebourg, Mouhsine 
et al. 2015).  
Surgical time 
One study compared surgical time for Revision and ORIF with plate and ORIF 
with plate, exposure 21B (n=7) vs exposure 21A (n=16), with a mean surgical time of 209 
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minutes (SD 41) and 122 minutes (SD 26), respectively (Lunebourg, Mouhsine et al. 
2015). Authors referred to the outcome as operative time (accepted as surgical time) and 
this was defined as the time from the incision to the dressing of the surgical wound, as 
documented on the anaesthetic chart.  
Malunion  
One study compared malunion for Revision and ORIF with plate and ORIF with 
plate, exposure 21B (n=7) vs ORIF with plate, exposure 21A (n=16), with no events 
observed in either exposure group (Lunebourg, Mouhsine et al. 2015).  
Revision any method vs ORIF any method 
There were eleven studies (six retrospective cohort studies, one prospective cohort study 
and four case series) which investigated various outcomes for the intervention of Revision 
any method vs ORIF any method.  
Surgical Time 
Two meta-analyses were performed as the Revision with or without 
wires/cerclage/cable exposures 15A and 15B could not be combined without duplicating 
exposure 15C’s data (Joestl, Hofbauer et al. 2016) Both analyses generate a similar result 




Surgical time (analysis 1) 
 
Figure 14 Surgical time (minutes) for Revision any vs ORIF any. 
Figure 14 shows the surgical time of the exposure in the four studies that reported 
surgical time for 71 patients. Mean surgical time is in minutes. None of the studies 
explicitly defined surgical time and they referred to the outcome as either ‘surgical 
duration’, ‘operative time’, ‘operation time’ or ‘skin-to-skin surgical time’, all of which 
were accepted to mean surgical time for the purposes of this meta-analysis. In this 
context, the most meaningful reporting for surgical time would be ‘skin-to-skin’ surgical 
time as it represents the operative time from incision to the dressing of the surgical 
wound, which most accurately reflects time spent performing each surgical management 
strategy.  
Overall, there was a statistically significant difference in the surgical time between 
patients treated with Revision any compared with ORIF any. The weighted mean 
difference in surgical time in the Revision any group was 64.4 minutes (95%CI 43.9 to 
84.9) longer than the ORIF any. There was no significant heterogeneity (p=0.10), and I2 
indicates there is a moderate degree of heterogeneity between the studies (52%). 
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Surgical time (analysis 2) 
 
Figure 15 Surgical time (minutes) for Revision any vs ORIF any. 
Figure 15 shows the surgical time of the exposure in the four studies that reported 
surgical time for 71 patients. Mean surgical time is in minutes.  
Overall, there was a statistically significant difference in the surgical time between 
patients treated with Revision any compared with ORIF any. The weighted mean 
difference in surgical time in the Revision any group was 63.6 minutes (95%CI 43.5 to 
83.6) longer than the ORIF any. There was no significant heterogeneity (p=0.10), and I2 





Figure 16 Union (overall) for Revision any vs ORIF any. 
Figure 16 shows union in the five studies that reported union for 103 patients. 
Less than half of the studies (2/5) explicitly defined union and it was assessed 
radiographically alone in the majority (4/5) of studies. Only 20% (1/5) of the studies 
provided a time to union (Table 8).  
Overall, there was no statistically significant difference in the prevalence of union 
in patients treated with Revision any with ORIF any, for both risk difference and risk 
ratio.  
The risk difference for union in the Revision any group was 0.05 (95%CI 0.12 to 
0.22) more than the ORIF with plate group. There was no significant heterogeneity 




The risk ratio for union in the Revision any group was 1.04 (95%CI 0.85 to 1.28) 
more than the ORIF with plate group. There was no significant heterogeneity (p=0.26), 




Table 8 Definition of union, method of measurement and time to union among the included studies.  
Study Definition Method of 
measurement 
Time to union 
13A (Holley, Zelken 





N/S (Note: Time-frame of outcome assessment mean 
34 months (Range 12-100, No SD reported) 
13D (Holley, Zelken 





N/S (Note: Time-frame of outcome assessment Mean 
69.5 months (Range 57-82, No SD reported) 
21A (Lunebourg, 





N/S (Note: worst case by 4 months) 
Pooled mean observation 42 months (SD 20, 16-90) 
21B (Lunebourg, 
Mouhsine et al. 2015) 
Union, 
N/S 
Radiographs N/S (Note: worst case by 4 months) 
Pooled mean observation 42 months (SD 20, 16-90) 






N/S (Note: time-frame for outcomes assessment: 
Pooled follow-up mean 18.4 months (SD 14.2, range 
NS)) 






N/S (Note: time-frame for outcomes assessment: 
Pooled follow-up mean 18.4 months (SD 14.2, range 
NS)) 
28A (Pavlou, 
Panteliadis et al. 
2011) 
Union, 
Radiographic union defined as: ‘…cortical 
continuity on both lateral and AP (antero-
posterior) radiographs.’  
Clinical union defined as: ‘…as pain-free 
weight bearing with or without aid.’ 
Clinical and plain 
film radiographs 
Mean 5 months (SD 2.2, Range NS) 
28C/D (Pavlou, 
Panteliadis et al. 
2011) 
Union, 
Radiographic union defined as: ‘…cortical 
continuity on both lateral and AP (antero-
posterior) radiographs.’  
Clinical union defined as: ‘…as pain-free 
weight bearing with or without aid.’ 
Clinical and plain 
film radiographs 
Mean 
C: 8.8 (SD 4.0, Range NS) 




Table 8 (cont.) Definition of union, method of measurement and time to union among the included studies. 
Study Definition Method of 
measurement 
Time to union 
33B (Solomon, 
Hussenbocus et al. 
2015) 
Union, 
Radiographic healing: ‘no visible fracture line 





(Note: Time-frame of outcomes assessment: Median 
59 months (16-137) – excludes 2 deaths <3 months)) 
33A (Solomon, 
Hussenbocus et al. 
2015) 
Union, 
Radiographic healing: ‘no visible fracture line 





(Note: Time-frame of outcomes assessment: Median 
67 months (13-82) – excludes 3 deaths <3 months 
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Mortality (overall at final follow-up)
 
 
Figure 17 Mortality (overall at final follow-up) for Revision any vs ORIF any. 
Figure 17 shows mortality in the three studies that reported mortality for 83 
patients. Overall, the time-frame for assessment of outcome was similar across all three 
studies, and up to around ten years. 
Overall, there was no statistically significant difference in the prevalence of 
mortality in patients treated with Revision any compared with ORIF any, for both risk 
difference and risk ratio.  
The risk difference for mortality in the Revision any group was 0.12 (95%CI 0.06 
to 0.30) more than the ORIF any, group. There was no significant heterogeneity (p=0.21), 




The risk ratio for mortality in the Revision any group was 1.95 (95%CI 0.72 to 
5.27) more than the ORIF any group. There was no significant heterogeneity (p=0.73), 
and I2 indicates there is no important heterogeneity between the studies (0%). 
Deep surgical site infection 
 
 
Figure 18 Deep surgical site infection (DSSI) for Revision any vs ORIF any. 
 Figure 18 shows DSSI in the four studies that reported DSSI for 84 patients. No 
authors provided a definition for DSSI, however, one study (Joestl, Hofbauer et al. 2016) 
implies aspiration hip joint was performed for diagnosis. The explicit time-frame of 
outcome measurement was not reported in any study.  
Overall, there was no statistically significant difference in the prevalence of DSSI 
in patients treated with Revision any compared with ORIF any, for both risk difference 
and OR.  
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The risk difference for DSSI in the Revision any group was 0.04 (95%CI 0.07 to 
0.15) more than the ORIF any group. There was no significant heterogeneity (p=0.91), 
and I2 indicates there is no important heterogeneity between the studies (0%). 
The Peto Odds Ratio for DSSI in the Revision any group was 3.81 (95%CI 0.36 to 
40.60) more than the ORIF any group. There was no significant heterogeneity (p=1.00), 
and I2 indicates there is no important heterogeneity between the studies (0%). 
Superficial surgical site infection 
 
Figure 19 Superficial surgical site infection (SSSI) for Revision any vs ORIF any. 
 Figure 19 shows SSSI in the four studies that reported SSSI for 78 patients. No 
authors provided a definition for SSSI. The explicit time-frame of outcome measurement 
was not reported in any study.  
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Overall, there was no statistically significant difference in the prevalence of SSSI 
in patients treated with Revision any compared with ORIF any for both risk difference 
and OR.  
The risk difference for SSSI in the Revision any group was 0.02 (95%CI 0.13 to 
0.18) more than the ORIF any group. There was no significant heterogeneity (p=0.99), 
and I2 indicates there is no important heterogeneity between the studies (0%). 
The Peto Odds Ratio for SSSI in the Revision any group was 3.41 (95%CI 0.08 to 
146.7) more than the ORIF any group. There was no significant heterogeneity (p=0.97), 
and I2 indicates there is no important heterogeneity between the studies (0%). 
Re-operation 
 
Figure 20 Re-operation for Revision any vs ORIF any. 
Figure 20 shows Re-operation in the four studies that reported re-operation for 
218 patients. No authors provided an explicit definition nor a time-frame for re-operation. 
The overall assessment period was similar across studies and up to around 12 years. 
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Overall, there was no statistically significant difference in the incidence of re-
operation in patients treated with Revision any compared with ORIF any for both risk 
difference and risk ratio. 
The risk difference for re-operation in the Revision any group was -0.12 (95%CI 
0.28 to 0.04) less than the ORIF any group. There was no significant heterogeneity 
(p=0.97), and I2 indicates there is no important heterogeneity between the studies (0%). 
The risk ratio for union in the Revision any group was 0.61 (95%CI 0.34 to 1.09) 
less than the ORIF any group. There was no significant heterogeneity (p=0.84), and I2 
indicates there is no important heterogeneity between the studies (0%). 
There was a trend towards Revision being protective against re-operation but this was not 





This section presents results for outcomes for individual interventions under study. It is 
structured according to the intervention and outcomes.  
Revision with or without wires/cerclage/cables 
There were 24 studies (15 case series, 8 retrospective cohort studies and one prospective 
cohort study) which investigated outcomes associated with Revision with or without 
wires/cerclage/cables. 
Surgical time  
 
Figure 21 Surgical time (minutes) for Revision with or without wires/cerclage/cables. 
Figure 21 shows the meta-analysis for the four studies (n=70) that reported 
surgical time for the exposure of interest. None of the studies explicitly defined surgical 
time and refer to the outcome as either ‘surgical time’ (Da Assunção, Pollard et al. 2015), 
‘surgical duration’ (Joestl, Hofbauer et al. 2016), ‘operation time’ (Niikura, Sakurai et al. 
2014) or ‘skin-to-skin surgical time’ (Solomon, Hussenbocus et al. 2015). In this context, 
the most meaningful reporting for surgical time would be ‘skin-to-skin’ surgical time as it 
represents the operative time from incision to the dressing of the surgical wound, which 
most accurately reflects time spent performing each surgical management strategy (i.e. 
Revision with or without wires/cerclage/cables).  
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Overall, the mean surgical time was 177.5 minutes (95%CI 157.0 to 198.0). There 
was a high degree of heterogeneity between the studies (I2 = 84.8%). 
Blood loss (intra-operative)  
One study reported intra-operative blood loss for Revision with or without 
wires/cerclage/cables, exposure 27A (n=2) (Niikura, Sakurai et al. 2014) with a mean 
intra-operative blood loss of 1502 mL (535.0 to 2470.0). 
Transfusion packed red blood cell (PRBC) requirement (units) 
  
Figure 22 Transfusion packed red blood cell (PRBC) requirement for Revision with or 
without wires/cerclage/cables.  
Figure 22 shows the meta-analysis for the outcome transfusion packed red blood 
cell (TPRBC), which was assessed by 2 studies including a total of 11 patients (Niikura, 
Sakurai et al. 2014, Solomon, Hussenbocus et al. 2015). The studies refer to the outcome 
as either ‘intra-operative transfusion’ (Niikura, Sakurai et al. 2014) or ‘peri-operative 
transfusion’ (Solomon, Hussenbocus et al. 2015), both of which were accepted as peri-
operative transfusion PRBC requirement. Overall, the mean transfusion requirement was 
3.1 units (95%CI 1.9 to 4.2). There was no important heterogeneity between the studies 
(I2 = 0%). 
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Studies not included in the meta-analysis: Da Assunção and colleagues reported 
on transfusion packed red blood cell (PRBC) requirement, however, unfortunately did not 
include the standard deviation or range, and hence was excluded from this meta-analysis 
(Da Assunção, Pollard et al. 2015). 
Transfusion PRBC (1 or more units required within 48 hours of surgery) 
One study reported Transfusion PRBC requirement within 48 hours of surgery for 
Revision with or without wires/cerclage/cables, exposure 15A+B with a prevalence of 







Figure 23 Subsidence (any) for Revision with or without wires/cerclage/cables. 
Meta-analysis
0.0 0.2 0.4 0.6 0.8
Proportion
Canbora 4 2013










Figure 23 shows the meta-analysis for the eight studies (n=161) that reported 
subsidence for the exposure of interest. The terms stem subsidence (7/8 studies) and stem 
migration (1/8 studies) were accepted as subsidence for the purposes of this meta-
analysis. Definition of subsidence was provided in almost all studies (7/8 studies), 
however, only just over half (5/8 studies) explicitly reported their method for measuring 
subsidence (Table 9). 
Overall, the prevalence of subsidence was 14.5% (95%CI 4.4 to 28.9). There was 




Table 9 Definition of outcomes. 
Study Definition Method of measurement TimeframeTime-frame 
of outcome assessment 




"‘Stem measured from shoulder 
prostheses to most medial point of 
lesser troch, where LT not present or 
visible used tip of GT or cerclage 
wire as marker"’ 
Mean 39 months (Range 
15-90, SD not reported) 
6 (Da Assunção, 
Pollard et al. 2015) 
Union, 
‘Radiological subsidence was assessed on a 
digital Patient Archiving and Communication 
system, after calibrating the radiographic scale 
using the known diameter of the prosthetic 
femoral head.’ ‘The amount of subsidence was 
agreed by consensus between two experienced 
observers (AT and REdA) and was considered 
significant if > 5 mm.’ 
Plain film radiographs At final follow-up 
(Note: time-frame of 
outcome assessment 
between 4 and 66 months) 
9 (Garcia-Rey, 
Garcia-Cimbrelo et 
al. 2013)  
Subsidence,  
>9mm 
‘… measuring the vertical subsidence 
of the femoral stem according to the 
Callaghan et al. method (1985)’ 
Pooled mean - 99.6 
months (SD 42#, 36-204) 
15A/15B (Joestl, 




No distance specified 
N/S ‘…clinical and radiographic 
assessment’ 
15A: Range 10-103 
months (SD not reported) 
15B: Range 9-27 months 
(SD not reported) 
16 (Ko, Lam et al. 
2003)  
Stem subsidence,  
 >5mm  
N/S ‘Weekly radiographic 
assessment’ 




Table 9 (cont.) Definition of outcomes. 
Study Definition Method of measurement Time-frame of 
outcome assessment 
25C (Mukundan, 
Rayan et al. 2010) 
Stem subsidence, 
requiring revision surgery  
N/S ‘…radiographic assessment’ Minimum 2 years (no 
maximum reported) 
26 (Munro, Garbuz 
et al. 2014) 
Subsidence,  
Distance sub-categorisation not specified for 5/6 
B2s) 
1/6 >10mm subsidence needing revision 
‘…measured as movement relative to 
anatomic landmarks and checked against 













Manual measurements: ‘Stem subsidence 
(is) measured using the width of radio-
lucent lines present at the stem cement 
(sc) interface in Gruen zone 1 parallel to 
the stem long axis on plain film 
radiographs’  
and  
Computer based method of Ein-Bild-
Roentegn-Analyse (EBRA)  
Overall: median 59 
months (16-137) – 




Subsidence (>5mm or requiring revision) 
 
 
Figure 24 Subsidence (>5mm OR requiring revision) for Revision with or without 
wires/cerclage/cables. 
Meta-analysis
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Figure 24 shows the meta-analysis for the seven studies (n=131) that reported 
subsidence for the exposure of interest.  
Overall, the prevalence of subsidence >5mm or requiring Revision was 10.7% 
(95%CI 1.4 to 27.0). There was a high degree of heterogeneity between the studies  
(I2 = 83.3%). 
Studies not included in the meta-analysis: Munro and colleagues reported on 
subsidence, however, unfortunately did not include the distance of subsidence amongst 
the B2 PFF patient group, and hence was excluded from this meta-analysis (Munro, 














Figure 25 Union (overall) for Revision with or without wires/cerclage/cables. 
Meta-analysis
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Figure 25 shows the meta-analysis for the seventeen studies (n=278) that reported 
union (overall) for revision with or without wires/cerclage/cables. Just over half of the 
studies (10/18) explicitly defined union and it was generally defined as the presence of a 
bridging callus across the main fracture site on a minimum of two or three sides viewed in 
two views on plain film radiographs. Some studies (3/18) additionally considered clinical 
union, for example, the patient being able to fully weight bear without pain, and lacked 
pain on clinical stressing of fracture site (Garcia-Rey, Garcia-Cimbrelo et al. 2013). The 
time to union was reported in half of the studies (9/18) (Table 9). Overall, the prevalence 
of union was 97.0% (95%CI 94.5 to 98.7). There was a low degree of heterogeneity 
between the studies (I2 = 10.4%).  
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Table 9 Definition of union, method of measurement and time to union among the included studies. 
Study Definition Method of 
measurement 
Time to union 
4 (Canbora, Kose et 
al. 2013) 
Union,  
‘union defined as bony bridging across osteotomy 
site or no migration of fracture fragment.’ 
Plain film 
radiographs 
N/S (Note: time-frame of outcome assessment 
mean 39 months (Range 15-90, SD not reported)) 
6 (Da Assunção, 
Pollard et al. 2015) 
Union, 
‘Radiological union … presence of bridging callus 
across main fracture site in two orthogonal planes 




(Note: time-frame of outcome assessment 
between 4 and 66 months) 
7 (Eingartner, 
Volkmann et al. 
2006)  
Union, 
‘…complete osseous consolidation of fracture’ 
Plain film 
radiographs 
Mean 5.6 months (SD 2#, 3-11) 






Mean 3.6 months (SD 1.3, No range given) 
9 (Garcia-Rey, 
Garcia-Cimbrelo et 
al. 2013)  
Union,  
‘patient was bearing full weight without pain, 
lacked pain on clinical stressing of fracture site and 
radiographic evidence of callus bridging the 
fracture’ (on two views in this paper) 
Clinical and plain 
film radiographs 
Mean 5 months (Range 3-8, No SD reported) 
13A (Holley, Zelken 





N/S (Note: Time-frame of outcome assessment 
mean 34 months (Range 12-100, No SD reported) 
16 (Ko, Lam et al. 
2003)  
Union, 
 ‘Fracture healing was judged by full pain-free 
weight-bearing ability, lack of pain on clinical 
stressing at the fracture site, and radiographic 
evidence of callus bridging the fractures’  
Plain film 
radiographs 




Table 9 (cont,) Definition of union, method of measurement and time to union among the included studies. 
Study Definition Method of 
measurement 
Time to union 
17A (Konan, Rayan 
et al. 2011) 
Union, 
N/S 
N/S ‘… patients 
were followed up 
clinically and 
radiologically.’ 
Mean 5.2 months (Range 3-6, No SD reported) 







(Note: Time-frame of outcomes assessment: 
Mean 74 months (No SD or range reported)) 
24 (Mukka, Mellner 






Follow up mean in months: 24 (Range 20-1823 
days, No SD stated) 
25A/25C 
(Mukundan, Rayan 
et al. 2010) 
Union, 
‘Fractures were considered to be united clinically 
when the patient could fully weight bear with no 
pain’ and absence of non-union on plain film 
radiographs  
Clinical and plain 
film radiographs 
N/S 
(Note: time-frame of outcomes assessment: 
Minimum 2 years (no maximum reported)) 
26 (Munro, Garbuz 
et al. 2014) 
Union,  
‘Femoral union was defined as bone bridging 




(Note: time-frame for outcomes assessment: 
Pooled mean observation 54 months (29.8#, 24-
143)) 







(Note: time-frame for outcomes assessment: 





Table 9 (cont,) Definition of union, method of measurement and time to union among the included studies. 
Study Definition Method of 
measurement 
Time to union 
28A (Pavlou, 
Panteliadis et al. 
2011) 
Union, 
Radiographic union defined as: ‘…cortical 
continuity on both lateral and AP (antero-
posterior) radiographs.’  
Clinical union defined as: ‘…as pain-free weight 
bearing with or without aid.’ 
Clinical and plain 
film radiographs 
Mean 5 months (SD 2.2, Range NS) 
29 (Pogliacomi, 





N/S specific to B2s 
Note: Pooled mean 4.5 months (Range 3-8 
months (SD N/S) 
33B (Solomon, 
Hussenbocus et al. 
2015) 
Union, 
Radiographic healing: ‘no visible fracture line on 





(Note: Time-frame of outcomes assessment: 
Median 59 months (16-137) – excludes 2 deaths 
<3 months)) 
36 Young (Young, 











Figure 26 Non-union (overall) for Revision with or without wires/cerclage/cables. 
Figure 26 shows the meta-analysis for the three studies (n=57) that reported non-
union for Revision with or without wires/cerclage/cables. Non-union was defined by two 
Meta-analysis








studies (Sexton, Stossel et al. 2006, Pavlou, Panteliadis et al. 2011) as failure to unite by 
12 months post-operatively, it was not explicitly defined in the third study, however, it 
was interpreted as failure to unite (Pavlou, Panteliadis et al. 2011). Overall, the 
prevalence of non-union was 8.7% (95%CI 2.9 to 17.0). There was no important 
heterogeneity between the studies (I2 = 0%). 
Osseointegration (ingrowth fixation stem) 
Three studies reported osseointegration for Revision with or without 
wires/cerclage/cables, exposure 9, 16 and 29, with a prevalence of 100% (20/20), 100% 
(12/12) and 100% (36/36), respectively.  Importantly, only one study (Garcia-Rey, 
Garcia-Cimbrelo et al. 2013) provided an explicit definition; ‘…Femoral component 
fixation radiographic ingrowth, fibrous stable, or unstable according to criteria for porous 
prosthesis as described by (Engh, Glassman et al. 1990). 
Femoral osteolysis  
One study reported femoral osteolysis for Revision with or without 
wires/cerclage/cables, exposure 33B, with a prevalence of 0% (0/7). Femoral osteolysis 
was defined as a greater than 3mm diameter nonlinear demarcated lesion (recorded for 
each Gruen zone), however, no time-frame was stipulated (Solomon, Hussenbocus et al. 
2015). 
Malrotation 
One study reported malrotation for Revision with or without 
wires/cerclage/cables, exposure 16 (Ko, Lam et al. 2003), with a prevalence of 0% (0/12). 
No explicit definition of malrotation was reported. 
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Loss of reduction (fracture) 
One study reported loss of reduction (fracture) for Revision with or without 
wires/cerclage/cables, exposure 27A (Niikura, Sakurai et al. 2014), with a prevalence of 
0% (0/2). No explicit definition of loss of reduction was reported. 
Heterotopic ossification 
Two studies reported heterotopic ossification for Revision with or without 
wires/cerclage/cables, exposure 16 (Ko, Lam et al. 2003) and 36 (Spina, Rocca et al. 
2014), with a prevalence of 0% (0/12) and 10% (1/10), respectively. No explicit 
definition or time-frame for heterotopic ossification was reported. 
Malunion 
Two studies reported malunion for Revision with or without 
wires/cerclage/cables, exposure 27A (Niikura, Sakurai et al. 2014) and 31 (Sexton, 
Stossel et al. 2006), with event rates of 0/2 (0%) and 0/25 (0%), respectively. Malunion 
was defined radiologically by Niikura and colleagues ‘…as angular deformity greater 




Mortality (overall at final follow-up) 
 
  
Figure 27 Mortality (overall at final follow-up) for Revision with or without 
wires/cerclage/cables. 
Meta-analysis
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Figure 27 shows the meta-analysis for the eight studies (n=155) that reported 
mortality (overall) for the exposure of interest. Around 90% (7/8) of the studies provided 
a time period for mortality, which was similar across studies, and up to around 5 years. 
Overall, the prevalence of mortality was 21.6% (95%CI 9.0 to 38.0) and results from the 
meta-analysis indicated a high degree of heterogeneity between the studies (I2 = 79.9%). 
In studies where patients were excluded based on mortality, either directly, e.g. mortality 
within three months post-operatively OR in-directly, e.g. where minimum follow-up 
periods were applied to exclusion criteria, and the reason for not reaching this time period 
was mortality, the patients were included in the meta-analysis. Note: raw data was 
requested and used for Ko and colleagues, Mukka and colleagues and Solomon and 
colleagues for this outcome (Ko, Lam et al. 2003, Solomon, Hussenbocus et al. 2015, 
Mukka, Mellner et al. 2016). 
Intra-operative mortality 
One study reported intra-operative mortality for Revision with or without 
wires/cerclage/cables, exposure 27A (n=2) (Niikura, Sakurai et al. 2014) with no events 
observed.  
Multi-organ failure 
One study reported multi-organ failure for Revision with or without 
wires/cerclage/cables, exposure 6 (Da Assunção, Pollard et al. 2015), with a prevalence of 
2.7% (1/37). No explicit definition of multi-organ failure was reported. 
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Pressure ulcer (heel) 
One study reported pressure ulcer for Revision with or without 
wires/cerclage/cables, exposure 6 (Da Assunção, Pollard et al. 2015), with a prevalence of 






Aseptic loosening femur 
 
 
Figure 28 Aseptic loosening for Revision with or without wires/cerclage/cables. 
Meta-analysis








Figure 28 shows the meta-analysis for the three studies (n=47) that reported 
aseptic loosening femur for the exposure of interest. Solomon and colleagues (Solomon, 
Hussenbocus et al. 2015) defined loosening using Harris’ criteria (Harris, McCarthy et al. 
1982), the remaining two studies did not provide any definition (Young, Pandit et al. 
2007, Munro, Garbuz et al. 2014). Munro and colleagues, Solomon and colleagues and 
Young and colleagues observed patients for a minimum 24 months (no maximum 
reported specifically for B2 cohort), 3 months (maximum 12 years), 12 months 
(maximum 72 months) (Young, Pandit et al. 2007, Munro, Garbuz et al. 2014, Solomon, 
Hussenbocus et al. 2015). Overall, the prevalence of aseptic femoral loosening was 6.0% 
(95%CI 1.2 to 16.5). There was no important heterogeneity between the studies (I2 = 0%). 





Peri-prosthetic femoral fracture post-operatively 
 
  
Figure 29 Peri-prosthetic femoral fracture (post-operatively) for Revision with or without 
wires/cerclage/cables. 
Meta-analysis
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Figure 29 shows the meta-analysis for the 5 studies (n=105) that reported post-
operative PFF for the exposure of interest. Studies used plain film radiographs to assess 
for any new post-operative fracture. The time-frame of outcome measurement was 
reported in 80% (4/5) of the studies and was similar across studies (up to around 6 years). 
Overall, the prevalence of post-operative PFF was 4.8% (95%CI 1.6 to 9.6). There 
was no important heterogeneity between the studies (I2 = 0%). 
Peri-prosthetic femoral fracture intra-operatively 
One study reported intra-operative PFF for Revision with or without 





Deep surgical site infection (DSSI) 
 
  
Figure 30 Deep surgical site infection (DSSI) for Revision with or without 
wires/cerclage/cables. 
Meta-analysis
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Figure 30 shows the meta-analysis for the eight studies (n=152) that reported 
DSSI for the exposure of interest. No authors provided a definition for DSSI, only one 
study (Joestl, Hofbauer et al. 2016) implies aspiration hip joint was performed for 
diagnosis. The explicit time-frame of outcome measurement was not reported in any 
study, however, the overall assessment period across studies was similar, and up to 
around 10 years. 
Overall, the prevalence of DSSI was 5.7% (95%CI 2.1 to 10.8). There was a 
moderate degree of heterogeneity between the studies (I2 = 26.1%). Note raw data from 




Superficial surgical site infection (SSSI) 
 
  
Figure 31 Superficial surgical site infection (SSSI) for Revision with or without 
wires/cerclage/cables. 
Meta-analysis
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Figure 31 shows the meta-analysis for the six studies (n=89) that reported SSSI 
for the exposure of interest. No authors provided a definition for SSSI, however, one 
(Canbora, Kose et al. 2013) implies wound swab was performed for diagnosis. The 
explicit time-frame of the outcome measurement was not reported in any study, however, 
the overall assessment period across studies was similar, and up to around 10 years. 
Overall, the prevalence of SSSI was 4.5% (95%CI 1.1 to 10.2). There was no 
important heterogeneity between the studies (I2 = 10.8%). Note: raw data from Mukka 








Figure 32 Dislocation (any) for Revision with or without wires/cerclage/cables. 
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Figure 32 shows the meta-analysis for the eleven studies (n=211) that reported 
dislocation for the exposure of interest. No authors provided a definition for dislocation. 
Only one study (Solomon, Hussenbocus et al. 2015) reported a time period within which 
dislocation occurred, which was less than 3 months post-operatively. The overall 
assessment period was similar across studies, and up to around ten years. Out of studies 
where events occurred, only 11% (1/9) reported a direction of dislocation.   
Overall, the prevalence of dislocation was 10.4% (95%CI 5.8 to16.2). There was a 








Figure 33 Re-operation for Revision with or without wires/cerclage/cables. 
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Figure 33 shows the meta-analysis for the seven studies (n=138) that reported re-
operation for the exposure of interest. No authors provided an explicit definition or a 
time-frame for re-operation. The overall assessment period was similar across studies, 
and up to around twelve years. 
Overall, the prevalence of re-operation was 15.9% (95%CI 9.3 to 23.7). There was 





Deep vein thrombosis (DVT) 
 
 
Figure 34 Deep vein thrombosis for Revision with or without wires/cerclage/cables. 
Figure 34 shows the meta-analysis for the three studies (n=77) that reported DVT 
for the exposure of interest. No authors provided an explicit definition for DVT. Ko and 
colleagues reported Doppler ultrasound was used for diagnosis of DVT. The time-frame 
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of detection was reported by Ko and colleagues only, 3 weeks post-operatively (Ko, Lam 
et al. 2003). The overall assessment period was similar across studies, and up to around 
nine years. 
Overall, the prevalence of DVT was 3.3% (95%CI 0.6 to 10.0). There was a low 
degree of heterogeneity between the studies (I2 = 12.2%). 
 
Pulmonary embolism (PE) 
One study reported PE for Revision with or without wires/cerclage/cables, 
exposure 15A+B (n=28), with no events observed. No explicit definition of PE was 




Leg length discrepancy (LLD) (any) 
 
 
Figure 35 Leg length discrepancy for Revision with or without wires/cerclage/cables. 
Figure 35 shows the meta-analysis for the two studies (n=50) that reported LLD 
for the exposure of interest. No authors provided an explicit definition, diagnostic method 
or a time-frame for identifying LLD, however, Ko and colleagues reported LLD was 
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significant if there was a 2cm or greater discrepancy (Ko, Lam et al. 2003). The overall 
assessment period was similar across studies, and up to around five years. 
Overall, the prevalence of LLD was 5.3% (95%CI 1.0 to 15.2). There was no 
important heterogeneity between the studies (I2 = 0%). 
Thigh pain 
Two studies reported thigh pain for Revision with or without 
wires/cerclage/cables, exposure 6 (Da Assunção, Pollard et al. 2015) and 16 (Ko, Lam  
et al. 2003) with event rates of 1/38 (2.6%) and 0/12 (0%), respectively. Authors did not 
provide a clear definition for this outcome. 
Neurovascular injury 
Two studies reported neurovascular injury for Revision with or without 
wires/cerclage/cables, exposure 15A+B (Joestl, Hofbauer et al. 2016) and 18A (Korbel, 
Sponer et al. 2013), with event rates of 0/28 (0%) and 2/18 (11%) (both of which were 
femoral nerve palsies which resolved by 3 months post-operatively), respectively. 
Revision femoral component  
Two studies reported a Revision femoral component for Revision with or without 
wires/cerclage/cables, exposure 16 (n=12) (Ko, Lam et al. 2003) and 36 (Young, Pandit  
et al. 2007) (n=10), with no events observed in either study.  
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Femoral stem breakage 
One study reported femoral stem breakage for Revision with or without 
wires/cerclage/cables, exposure 18A (Korbel, Sponer et al. 2013), with an event rate of 
1/18 (0%). 
SF-12 mental score post-operatively 
One study reported post-operative SF-12 mental score for Revision with or 
without wires/cerclage/cables, exposure 26 (n=16) (Munro, Garbuz et al. 2014) with a 
mean score of 53 (SD NS, range NS). No explicit time-frame was specified for this 
outcome, however, the overall assessment period was 24 to 143 months. 
SF-12 physical score post-operatively 
One study reported post-operative SF-12 physical score for Revision with or 
without wires/cerclage/cables, exposure 26 (n=16) (Munro, Garbuz et al. 2014) with a 
mean score of 41 (SD NS, range NS). No explicit time-frame was specified for this 
outcome, however, the overall assessment period was 24 to 143 months. 
Harris hip score (post-operative) 
 




Figure 36 shows the meta-analysis for the five studies (n=41) that reported post-
operative HHS for the exposure of interest. The time point post-operatively at which HHS 
was calculated was not explicitly reported in any study, however, Canbora and colleagues 
state this was conducted at final follow-up, mean 5 months (15-90, no SD reported) 
(Canbora, Kose et al. 2013). The overall assessment period across studies ranged from  
15 to 137 months. 
Overall, the mean HHS was 80.7 (95%CI 77.4 to 83.9). There was a moderate degree of 
heterogeneity between the studies (I2 = 74.1%). 
Studies not included in the meta-analysis: Young and colleagues reported HHS post-
operatively and found a mean of 69.1, however, unfortunately, did not include the 
standard deviation or range, hence the study was excluded from this meta-analysis 
(Young, Pandit et al. 2007). 
Harris hip pain score (post-operative) 
One study reported post-operative Harris hip pain score for Revision with or 
without wires/cerclage/cables, exposure 33B* (n=7), with a mean score of 31.1 (SD 
15.18) (Solomon, Hussenbocus et al. 2015). 
Barthel ADLs index (post-operative) 
One study reported post-operative Barthel ADLs index for Revision with or 
without wires/cerclage/cables, exposure 4 (n=8) (Canbora, Kose et al. 2013), with a mean 




Beals and Towers’ criteria: Scoring an excellent outcome 
 
  
Figure 37 Beals and Towers’ criteria excellent outcome for Revision with or without 
wires/cerclage/cables. 
Meta-analysis








Figure 37 shows the meta-analysis for the three studies (n=35) that reported an 
excellent score on the Beals and Towers’ criteria for Revision with or without 
wires/cerclage/cables. The time point post-operatively at which the Beals and Towers’ 
criteria were assessed was not explicitly reported in any study, however, Canbora and 
colleagues state this was conducted at final follow-up, mean 5 months (15-90, no SD 
reported) (Canbora, Kose et al. 2013). The overall assessment period across studies was 
similar, and up to around seven years. 
Overall, the prevalence of Beals and Towers’ criteria excellent outcome was 
78.6% (95%CI 62.2 to 90.2). There was a high degree of heterogeneity between the 






Beals and Towers’ criteria good outcome 
 
 
Figure 38 Beals and Towers’ criteria good outcome for Revision with or without 
wires/cerclage/cables. 
Meta-analysis








Figure 38 shows the meta-analysis for the three studies (n=35) that reported Beals 
and Towers’ criteria for the exposure of interest. The time point post-operatively at which 
the Beals and Towers’ criteria were assessed was not explicitly reported in any study, 
however, Canbora and colleagues state this was conducted at final follow-up, mean 5 
months (15-90, no SD reported) (Canbora, Kose et al. 2013). The overall assessment 
period across studies was similar, and up to around seven years. 
Overall, the prevalence of Beals and Towers’ criteria good outcome was 13.1% 
(95%CI 4.4 to 28.0). There was a moderate degree of heterogeneity between the studies 





Beals and Towers’ criteria poor outcome 
 
  
Figure 39 Beals and Towers’ criteria poor outcome for Revision with or without 
wires/cerclage/cables. 
Meta-analysis








Figure 39 shows the meta-analysis for the three studies (n=35) that reported Beals 
and Towers’ criteria for the exposure of interest. The time point post-operatively at which 
the Beals and Towers’ criteria were assessed was not explicitly reported in any study, 
however, Canbora and colleagues state this was conducted at final follow-up, mean 5 
months (15-90, no SD reported) (Canbora, Kose et al. 2013). The overall assessment 
period across studies was similar, and up to around seven years. 
Overall, the prevalence of Beals and Towers’ criteria poor outcome was 11.1% 
(95%CI 3.2 to 25.5). There was a moderate degree of heterogeneity between the studies 
(I2 = 62.0%). 
 
Parker mobility score (post-operative) 
Three studies reported post-operative Parker mobility score for Revision with or 
without wires/cerclage/cables, exposure 15A (n=14), 15B (n=14) (Joestl, Hofbauer et al. 
2016) and 27A (n=2) (Niikura, Lee et al. 2014) with mean scores of 6.5 (SD 2, Range 
NS), 6.4 (SD 2, Range NS) and 6 (SD 4.2, Range NS), respectively. Note, for reference, 
mean pre-operative Parker mobility score for exposure 15A (n=14), 15B (n=14) (Joestl, 
Hofbauer et al. 2016) and 27A (n=2) were 6.8 (SD 1.7, Range NS), 6.99 (SD 1, Range 
NS) and 6 (SD 4.2, Range NS), respectively. 
Modified Charnley-D’Aubigne score excellent, good and poor outcome 
One study reported post-operative Modified Charnley-D’Aubigne score excellent 
outcome for Revision with or without wires/cerclage/cables, exposure 25A+C, with a 
prevalence of 59% (20/34) (Mukundan, Rayan et al. 2010). The time point post-
operatively at which the Modified Charnley-D’Aubigne score was assessed was not 
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explicitly reported. One study reported post-operative Modified Charnley-D’Aubigne 
score good outcome for Revision with or without wires/cerclage/cables, exposure 25A+C, 
with a prevalence of 24% (8/34) (Mukka, Mellner et al. 2016). The time point post-
operatively at which the Modified Charnley-D’Aubigne score was assessed was not 
explicitly reported. One study reported post-operative Modified Charnley-D’Aubigne 
score poor outcome for Revision with or without wires/cerclage/cables, exposure 25A+C, 
with prevalence of 18% (6/34) (Mukundan, Rayan et al. 2010). The time point post-
operatively at which the Modified Charnley-D’Aubigne score was assessed was not 
explicitly reported (Mukundan, Rayan et al. 2010). 
Oxford hip score (post-operative) 
Four studies reported on Oxford hip score assessed post-operatively (Young, 
Pandit et al. 2007, Zuurmond, van Wijhe et al. 2010, Munro, Garbuz et al. 2014, Da 
Assunção, Pollard et al. 2015). However, the scores were inversely proportional and 
measured in different scales, hence meta-analysis was not possible. Da Assunção and 
colleagues found a mean Oxford hip score of 35.0 (95%CI 31.4; 38.4), where the 
assessment scale was from 0 to 48, with higher scores indicating better function  
(Da Assunção, Pollard et al. 2015). On the other hand, Zuurmond et al., found a mean of 
28.0 (95%CI 23.0; 33.0), with higher scores indicating impaired function (Zuurmond, van 
Wijhe et al. 2010). The scale range was not reported.  
Munro and colleagues (Munro, Garbuz et al. 2014) and Young and colleagues 
(Young, Pandit et al. 2007) both reported OHS post-operatively (with mean scores of 74 
(n=16) and 32 (n=7), respectively), however, unfortunately did not include the standard 
deviation or range, hence meta-analysis was not possible. 
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WOMAC global score (post-operative) 
One study reported post-operative WOMAC global score for Revision with or 
without wires/cerclage/cables, exposure 26 (n=16) (Munro, Garbuz et al. 2014), with a 
mean score of 76 (SD NS, range NS). The time point post-operatively at which the 
WOMAC global score was assessed was not reported by study authors.  
WOMAC pain score (post-operative) 
One study reported post-operative WOMAC pain score for Revision with or 
without wires/cerclage/cables, exposure 26 (n=16) (Munro, Garbuz et al. 2014), with a 
mean score of 80 (SD NS, range NS). The time point post-operatively at which the 
WOMAC pain score was assessed was not reported by study authors. 
WOMAC function score (post-operative) 
One study reported post-operative WOMAC function score for Revision with or 
without wires/cerclage/cables, exposure 26 (n=16) (Munro, Garbuz et al. 2014), with a 
mean score of 75 (SD NS, range NS). The time point post-operatively at which the 
WOMAC function score was assessed was not reported by study authors. 
WOMAC stiffness score (post-operative) 
One study reported post-operative WOMAC stiffness score for Revision with or 
without wires/cerclage/cables, exposure 26 (n=16) (Munro, Garbuz et al. 2014), with a 
mean score of 70 (SD NS, range NS). The time point post-operatively at which the 
WOMAC stiffness score was assessed was not reported by study authors. 
UCLA activity score (post-operative) 
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One study reported post-operative UCLA activity score for Revision with or 
without wires/cerclage/cables, exposure 26 (n=16) (Munro, Garbuz et al. 2014), with a 
mean score of 4 (SD NS, range NS). The time point post-operatively at which the UCLA 
activity score was assessed was not reported by study authors. 
Satisfaction score overall (self-reported, scale 0 (completely unsatisfied) –100 
(completely satisfied). 
One study reported post-operative Satisfaction score overall for Revision with or 
without wires/cerclage/cables, exposure 26 (n=16) (Munro, Garbuz et al. 2014), with a 
mean score of 96 (SD NS, range NS). The time point post-operatively at which the 
Satisfaction score (overall) was assessed was not reported by study authors. 
Satisfaction score pain (self-reported, scale 0-100) 
One study reported post-operative Satisfaction score pain for Revision with or 
without wires/cerclage/cables, exposure 26 (n=16) (Munro, Garbuz et al. 2014), with a 
mean score of 98 (SD NS, range NS). The time point post-operatively at which the 
Satisfaction score for pain (self-reported) was assessed was not reported by study authors. 
Satisfaction score function (self-reported, scale 0-100) 
One study reported post-operative Satisfaction score function for Revision with or 
without wires/cerclage/cables, exposure 26 (n=16) (Munro, Garbuz et al. 2014), with a 
mean score of 90 (SD NS, range NS). The time point post-operatively at which the 




Satisfaction score recreation (self-reported, scale 0-100) 
One study reported post-operative Satisfaction score recreation for Revision with 
or without wires/cerclage/cables, exposure 26 (n=16) (Munro, Garbuz et al. 2014), with a 
mean score of 86 (SD NS, range NS). The time point post-operatively at which the 
Satisfaction score for recreation (self-reported) was assessed was not reported by study 
authors. 
Ambulatory status (post-operatively) 
One study reported post-operative ambulatory status for Revision with or without 
wires/cerclage/cables, exposure 27A (Niikura, Lee et al. 2014), with 1/2 (50%) mobilising 
with walker and 1/2 (50%) mobilising without aids. This assessment was made at final 




Attainment of pre-fracture mobility status 
 
  
Figure 40 Attainment of pre-fracture mobility status for Revision with or without 
wires/cerclage/cables. 
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Figure 40 shows the meta-analysis for the six studies (n=86) that reported 
attainment of pre-fracture mobility status for the exposure of interest. The time point post-
operatively at which mobility status was assessed was only reported by Sexton and 
colleagues, which was 18 months post-operatively (Sexton, Stossel et al. 2006). There 
was no explicit reporting of how this assessment was made by authors (e.g. clinical or 
self-reported). The overall assessment period across studies was similar, and up to around 
nine years. 
Overall, the prevalence of attainment pre-fracture mobility status was 88.8% 
(95%CI 66.6 to 99.6). There was a high degree of heterogeneity between the studies  
(I2 = 84.2%). 
Attainment of pre-fracture social status 
One study reported attainment of pre-fracture social status for Revision with or 
without wires/cerclage/cables, exposure 27A (Niikura, Lee et al. 2014), with an event rate 
of 2/2 (100%) both patients living independently at home. The time point post-operatively 





Revision and ORIF with plate 
There were five studies (two retrospective cohort studies, two case series and one 
prospective cohort study) which investigated outcomes associated with the intervention of 
Revision and ORIF with plate.  
Surgical time 
One study reported surgical time for Revision and ORIF with plate, exposure 21B 
(n=7) with a mean surgical time of 209 minutes (SD 41) (Lunebourg, Mouhsine et al. 
2015). The operative time was defined as the time from the incision to the dressing of the 
surgical wound, as documented on the anaesthetic chart.  
Union (overall) 
Three studies reported union for Revision and ORIF with plate, exposure 21B 
(Lunebourg, Mouhsine et al. 2015), 24B (Mukka, Mellner et al. 2016) and 25B 
(Mukundan, Rayan et al. 2010), with prevalence rates of 100% (7/7), 100% (8/8) and 
100% (8/8), respectively. Only Mukundan and colleagues explicitly defined union, and no 
studies reported a time-frame required to achieve union (Mukundan, Rayan et al. 2010). 
The overall assessment period across studies ranged from 2 months to 6 years.  
Malunion 
One study reported malunion for Revision and ORIF with plate, exposure 21B 
(Mukundan, Rayan et al. 2010), with no events observed. Authors defined malunion was 
‘…as fracture union with > 5 degree angle in any plane.’ No explicit time-frame was 
reported for this outcome. The overall assessment period of the study ranged from 16 to 
90 months.  
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Length of stay 
 
Figure 41 Length of stay for Revision and ORIF with plate. 
Figure 41 shows the meta-analysis for the three studies (n=59) that reported length 
of stay for the exposure of interest. Joestl and colleagues specified ‘hospital’ length of 
stay, however, Da Assunção and colleagues did not provide an explicit definition of 
length of stay (e.g. primary hospital where surgery was performed, or combined with 
step-down or transitional care facility) (Da Assunção, Pollard et al. 2015, Joestl, Hofbauer 
et al. 2016).  
Overall, the mean length of stay was 24 days (95%CI 21 to 28). There was no 
important heterogeneity between the studies (I2 = 0%). 
Mortality (at one year) 
One study reported mortality for Revision and ORIF with plate, exposure 24B 
(Mukka, Mellner et al. 2016), with prevalence at one year of 25% (2/8).  
Aseptic loosening femur 
One study reported aseptic loosening femur for Revision and ORIF with plate, 
exposure 21B (n=7) (Lunebourg, Mouhsine et al. 2015), with no events observed. 
Although no explicit definition was provided by the authors, they do state radiographs 
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were performed at 6 weeks, 3 months, 1 year then as clinically indicated to assess for 
aseptic loosening.  
Deep surgical site infection (DSSI) 
One study reported DSSI for Revision and ORIF with plate, exposure 24B 
(Mukka, Mellner et al. 2016), with a prevalence of 25% (2/8). Authors did not provide a 
definition for DSSI. 
Superficial surgical site infection (SSSI) 
One study reported SSSI for Revision and ORIF with plate, exposure 24B (n=8) 
(Mukka, Mellner et al. 2016), with no events observed. Authors did not provide a 
definition for SSSI. 
Re-operation 
One study reported Re-operation for Revision and ORIF with plate, exposure 24B 
(Mukka, Mellner et al. 2016), with a prevalence of 25% (2/8). Authors did not provide an 
explicit definition nor a time-frame for re-operation. 
Studies not included in the meta-analysis: (Lunebourg, Mouhsine et al. 2015). 
Reported on re-operation (by way of Revision) for Vancouver B2 PFF in their cohorts, 
however, unfortunately, only explicitly specified the exposure (either 21A ORIF with 
plate or 21B Revision + ORIF with plate) in one out of two revision cases and hence 
could not be included in our meta-analysis without introducing some uncertainty.  
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Modified Charnley-D’Aubigne score excellent outcome 
One study reported post-operative Modified Charnley-D’Aubigne score excellent 
outcome for Revision and ORIF with plate, exposure 25B (Mukundan, Rayan et al. 
2010), with a prevalence of 63% (5/8). The time point post-operatively at which the 
Modified Charnley-D’Aubigne score was assessed was not explicitly reported. 
 
Modified Charnley-D’Aubigne score good outcome 
One study reported post-operative Modified Charnley-D’Aubigne score good 
outcome for Revision and ORIF with plate, exposure 25B (Mukundan, Rayan et al. 
2010), with a prevalence of 38 (3/8). The time point post-operatively at which the 




Revision and cortical strut allograft(s) 
There were three studies (all case series) which reported on outcomes for the intervention 
of Revision and cortical strut allograft(s). 
Surgical time 
One study reported surgical time (referred to as ‘procedure time’ by authors) for 
Revision and cortical strut allograft, exposure 32 (n=7) (Sledge and Abiri 2002), with a 
mean surgical time of 215 minutes (SD and Range NS). No definition of outcome was 
provided by the authors.  
Transfusion packed red blood cell (PRBC) requirement (units) 
One study reported transfusion PRBC for Revision and cortical strut allograft, 
exposure 32 (n=7) (Sledge and Abiri 2002), with a mean transfusion PRBC of 2 units  
(no SD reported). 
Subsidence (any) 
One study reported subsidence (any) for Revision and cortical strut allograft, 
exposure 32 (Sledge and Abiri 2002), with a prevalence of 64% (2/7) (2mm and 5mm 
subsidence). Authors did not provide a definition, method of measuring, nor a time-frame 
of assessment for subsidence.  
Subsidence (>5mm or requiring revision) 
One study reported subsidence (>5mm or requiring revision) for Revision and 
cortical strut allograft, exposure 32 (n=7) (Sledge and Abiri 2002), with no events 
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observed. Authors did not provide a definition, method of measuring nor a time-frame of 
assessment for subsidence. 
Union (fracture) 
Two studies reported union for Revision and cortical strut allograft(s), exposure 
13C (Holley, Zelken et al. 2007) and 35 (Wu, Yan et al. 2009), with a prevalence of 86% 
(6/7) and 100% (5/5), respectively. Wu and colleagues reported a mean time to union of 
5.6 months (Range 3-9, SD NS), however, Holley and colleagues did not specify a time-
frame (Holley, Zelken et al. 2007, Wu, Yan et al. 2009).  
Length of stay (LOS) 
One study reported hospital LOS for Revision and cortical strut allograft, 
exposure 32 (n=7) (Sledge and Abiri 2002), with a mean LOS time of 6 days (SD and 
Range NS). 
Cortical strut ingrowth 
Two studies reported cortical strut ingrowth for Revision and cortical strut 
allograft(s), exposure 32 (Sledge and Abiri 2002) and 35 (Wu, Yan et al. 2009), with a 
prevalence of 100% (7/7) and 100% (5/5), respectively. Sledge and colleagues refers to 
this as spot welding at strut host junction on plain film radiograph and Wu and colleagues 
as ‘trabecular bridging between any part of the graft and host bone’ (on radiograph). Wu 
and colleagues report a mean time to achieve cortical strut ingrowth of 11.5 months  
(SD: 2.4, range: 7;18) (Wu, Yan et al. 2009). 
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Aseptic loosening femur 
One study reported aseptic loosening femur for Revision and cortical strut 
allograft, exposure 32 (n=7) (Sledge and Abiri 2002), with no events observed. No 
explicit definition or a time-frame of assessment of aseptic loosening femur was reported 
by authors. 
Peri-prosthetic fracture (post-operatively) 
One study reported PFF post-operatively for Revision and cortical strut allograft, 
exposure 32 (n=7) (Sledge and Abiri 2002), with no events observed. Authors imply the 
use of plain film radiographs to identify PFF post-operatively, however, the timing of this 
assessment is not clear.  
Pulmonary embolism (PE) 
One study reported PE for Revision and cortical strut allograft, exposure 13C 
(Holley, Zelken et al. 2007), with an event prevalence of 14% (1/7). Authors refer to the 
PE as ‘non-fatal’, however, do not provide the method of diagnosis nor a time-frame of 
assessment. The overall assessment period for the study was a mean 65.9 months (Range 
24-111, No SD reported). 
Harris hip score (post-operative) 
Two studies reported post-operative Harris hip score for Revision and cortical 
strut allograft, exposure 32 (n=7) (Sledge and Abiri 2002) and 35 (n=5) (Wu, Yan et al. 
2009), with mean scores of 83 (SD NS, range NS) and 70 (SD 9.3), respectively. The 
time point post-operatively at which HHS was calculated was reportedly at final follow-
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up in Wu and colleagues, however, not specified by Sledge and colleagues. The overall 
assessment period across studies was similar and up to around seven years. 
Satisfaction score (post-operative) (self-reported visual analogue scale 0 (no pain) – 100 
(intolerable pain) 
One study reported post-operative satisfaction score for Revision and cortical strut 
allograft, exposure 35 (n=5) (Wu, Yan et al. 2009), with a mean score of 18.4 (Range 11-
25, SD NS). Authors do not specify a time-frame of assessment.  
Attainment of pre-fracture mobility status 
One study reported attainment pre-fracture mobility status for Revision and 
cortical strut allograft, exposure 32 (Sledge and Abiri 2002), with an event rate of 86% 
(6/7). Authors do not specify how this is concluded, nor a time-frame of assessment.  
Revision mixed methods/unspecified 
There were eleven studies (eight retrospective case series and three retrospective cohort 
studies) which investigated various outcomes for the intervention of Revision mixed 
methods/unspecified. 
Subsidence (any) 
Two studies reported subsidence for Revision mixed methods/unspecified, 
exposure 5 (Corten, Macdonald et al. 2012) and exposure 30 (Rayan, Konan et al. 2010), 
with a prevalence of 3.2% (1/31 – 5mm, stable at up to 4 years observation) and 0% 
(0/14), respectively. Neither studies explicitly defined subsidence.  
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Subsidence (>5mm or requiring revision) 
Two studies reported subsidence (>5mm or requiring revision) for Revision mixed 
methods/unspecified, exposure 5 (n=31) (Corten, Macdonald et al. 2012) and exposure 30 
(n=14) (Rayan, Konan et al. 2010), with no events observed in both studies. Neither 




Union (overall)  
 
  
Figure 42 Union (overall) for Revision mixed methods/unspecified. 
Meta-analysis












Figure 42 shows the meta-analysis for the seven studies (n=105) that reported 
union for exposure of interest. Just over half of the studies (4/7) explicitly defined union 
and the same proportion considered clinical as well as radiographic union. The time to 
union was only explicitly reported in around a quarter of studies (Table 10). Overall, the 
prevalence of union was 94.4% (95%CI 88.6 to 98.2). There was a low degree of 




Table 10 Definition of union, method of measurement and time to union among the included studies. 
Study Definition Method of 
measurement 
Time to union 
3 (Briant-Evans, 
Veeramootoo et al. 
2009) 
Union,  




Range 2-11 months 
5 (Corten, 
Macdonald et al. 
2012) 
Union, 
‘… clinical union in the presence of radiographic 
evidence of bone bridging in both AP and lateral XR’ 
Clinical and plain 
film radiographs 
Unclear. Range between 1 and 11 
years. 
 
12 (Holder, Papp et 





Unclear. Pooled range of 
observation for union outcome 2-64 
months 






N/S (Note: Time-frame of outcome 
assessment mean 68 months (Range 
26-139, No SD reported)) 
19 (Levine, Della 
Valle et al. 2008)  
Union, 
Defined clinically as no pain on weight bearing, 
palpation and stressing fracture site and; 
Radiographically by bridging callus 
Clinically and plain 
film radiographs 
Unclear.  Maximum time to union 
24 weeks.  
28B (Pavlou, 
Panteliadis et al. 
2011) 
Union, 
Radiographic union defined as: ‘…cortical continuity on 
both lateral and AP (antero-posterior) radiographs.’  
Clinical union defined as: ‘…as pain-free weight bearing 
with or without aid.’ 
Clinical and plain 
film radiographs 
Mean 4.26 months (SD 1.9, Range 
NS) 
30 (Rayan, Konan et 
al. 2010)  
Union, 
N/S 
Clinical and plain 
film radiographs 
Minimum 2 years radiographic 
follow-up (Note: Pooled range 3-6 




One study reported malunion for Revision mixed methods/unspecified, exposure 
30 (n=14) (Rayan, Konan et al. 2010), with no events observed. No definition of 
malunion was provided by the authors. 
Cortical strut ingrowth 
One study reported cortical strut ingrowth for Revision mixed 
methods/unspecified, exposure 5 (Corten, Macdonald et al. 2012), with a prevalence of 
100% (14/14). Method of assessment by authors; ‘Ingrowth of the cortical onlay struts 
was evaluated according to the criteria for incorporation described by Emerson et al. 
(1992)’. 
Union Extended trochanteric osteotomy (ETO) 
One study reported union ETO for Revision mixed methods/unspecified, exposure 
19 (Levine, Della Valle et al. 2008), with a prevalence of 100% (12/12) at mean 13.1 







Figure 43 Mortality (overall) for Revision mixed methods/unspecified. 
Meta-analysis










Figure 43 shows the meta-analysis for the five studies (n=144) that reported 
mortality (overall) for the exposure of interest. 80% (4/5) of the studies provided a time 
period for mortality, including mortality within 3 months (Holder, Papp et al. 2014),  
6 months (Corten, Macdonald et al. 2012), 2 years (Amenabar, Rahman et al. 2015) and 
‘at end of study’ (Briant-Evans, Veeramootoo et al. 2009), which could be between  
3 months up to 9 years.  
Overall, the prevalence of mortality was 17.3% (95%CI 9.6 to 26.8). There was a 
moderate degree of heterogeneity between the studies (I2 = 43.4%). In studies where 
patients were excluded based on mortality, either directly, e.g. mortality within three 
months post-operatively OR in-directly, e.g. where minimum follow-up periods were 
applied to exclusion criteria and reason for not reaching this time period was mortality, 
the patients were included in the meta-analysis.  
Failure (any complication requiring Revision surgery) 
One study reported failure for Revision mixed methods/unspecified, exposure 1, 
(Amenabar, Rahman et al. 2015) with a prevalence of 9.2% (7/76). Authors defined 
failure ‘…as those stems that required Revision surgery and replacement for any reason 
(including infection).’ They did not provide an explicit time-frame for these ‘failures’ 
between 1.5 and 29.8 months post-operatively.    
Aseptic loosening femur 
One study reported aseptic loosening femur for Revision mixed 
methods/unspecified, exposure 1 (Amenabar, Rahman et al. 2015), with a prevalence of 
6.6% (5/76). No definition of aseptic loosening femur was described by the authors. The 
time-frame for identification was reported between 1.5 and 29.8 months post-operatively.  
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Peri-prosthetic fracture (post-operatively) 
Two studies reported PFF post-operatively for Revision mixed 
methods/unspecified, exposure 1 (Amenabar, Rahman et al. 2015) and 5, with prevalence 
rates of 2.6% (2/76) and 3.2% (1/31), respectively. Authors imply the use of plain film 





Deep surgical site infection 
 
  
Figure 44 Deep surgical site infection (DSSI) for Revision mixed methods/unspecified.  
Meta-analysis








Figure 44 shows the meta-analysis for the three studies (n=131) that reported 
DSSI for the exposure of interest. No authors provided a definition for DSSI. The explicit 
time-frame of outcome measurement was not reported in any study.  
Overall, the prevalence of DSSI was 4.2% (95%CI 1.5 to 9.2). There was a mild 
degree of heterogeneity between the studies (I2 = 14.9%). 
Superficial surgical site infection 
One study reported SSSI for Revision mixed methods/unspecified, exposure 28B 
(n=27) (Pavlou, Panteliadis et al. 2011), with no events observed. Authors did not provide 
a definition, nor a time-frame of assessment for SSSI, however, patients were assessed 







Figure 45 Re-operation for Revision mixed methods/unspecified. 
Figure 45 shows the meta-analysis for the three studies (n=98) that reported re-
operation for the exposure of interest. No authors provided an explicit definition nor time- 
Meta-analysis








frame for re-operation. The overall assessment period across studies was similar, and up 
to around twelve years. 
Overall, the prevalence of re-operation was 25.1% (95%CI 17.0 to 34.7). There 
was no important heterogeneity between the studies (I2 = 0%). 
Neurovascular injury 
One study reported neurovascular injury for Revision mixed methods/unspecified, 
exposure 30 (Rayan, Konan et al. 2010), with a prevalence of 0.7% (1/14), a sciatic nerve 
palsy which completely recovered over an unspecified time period.  
SF-12 mental score post-operatively (at time of last follow-up) 
One study reported post-operative SF-12 mental score for Revision mixed 
methods/unspecified, exposure 1 (n=76) (Amenabar, Rahman et al. 2015) with a mean 
score of 55.1 (SD 8.1). Aside from stating score was assessed at final follow-up, explicit 
time-frame was specified for this outcome. The overall assessment period across studies 
was similar, and up to around 14 years. 
SF-12 physical score post-operatively 
One study reported post-operative SF-12 physical score for Revision mixed 
methods/unspecified, exposure 1 (n=76) (Amenabar, Rahman et al. 2015) with a mean 
score of 37.4 (SD 9.4). Aside from stating that the score was assessed at final follow-up, 
an explicit time-frame was specified for this outcome. The overall assessment period 
across studies was similar, and up to around 14 years. 
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Harris hip score (post-operative) 
Two studies reported post-operative Harris hip score for Revision mixed 
methods/unspecified, exposure 5 (n=31) (Corten, Macdonald et al. 2012) and 23 (n=6), 
with mean scores of 77.5 (SD NS, range NS) and 73 (SD 3.2), respectively. The time 
point post-operatively at which HHS was calculated was not explicitly reported in any 
study, however, the earliest assessment was performed 10 months and 1 year post-
operatively for Corten et al. (Corten, Macdonald et al. 2012) and Moreta et al. (Moreta, 
Aguirre et al. 2015), respectively. 
WOMAC pain score (post-operative) 
One study reported post-operative WOMAC pain score for Revision mixed 
methods/unspecified, exposure 5 (n is unclear) (Corten, Macdonald et al. 2012), with a 
mean score of 3 (SD NS, range NS). The time point post-operatively for the WOMAC 
pain score was at a minimum one year.  
WOMAC function score (post-operative) 
One study reported post-operative WOMAC function score for Revision mixed 
methods/unspecified, exposure 5 (n is unclear) (Corten, Macdonald et al. 2012), with a 
mean score of 13 (SD NS, range NS). The time point post-operatively for the WOMAC 
function score was at a minimum one year. 
WOMAC stiffness score (post-operative) 
One study reported post-operative WOMAC stiffness score for Revision mixed 
methods/unspecified, exposure 5 (n is unclear) (Corten, Macdonald et al. 2012), with a 
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mean score of 2 (SD NS, range NS). The time point post-operatively for the WOMAC 
function score was at a minimum one year. 
Attainment of pre-fracture mobility status 
Two studies reported attainment of pre-fracture mobility status for Revision mixed 
methods/unspecified, exposure 5 and 23, with a prevalence of 50% (8/16) and 42% 
(6/14), respectively. Corten and colleagues (Corten, Macdonald et al. 2012) did not 
explicitly report how this was measured or concluded; however, they imply functional 
assessments were made at the earliest 1 year post-operatively. Moreta and colleagues 
(Moreta, Aguirre et al. 2015), assessed this based on follow-up clinical review or phone 
interview using categories of mobility. It is unclear whether or not this pre and post-





There were thirty-five studies (twenty-five retrospective case series and ten cohort 
studies) which investigated various outcomes for the interventions of Revision any. 
Surgical time 
 
Figure 46 Surgical time (minutes) for Revision any. 
Figure 46 shows the meta-analysis for the six studies (n=77) that reported surgical 
time for the exposure of interest. Only Lunebourg et al. explicitly defined operative time; 
‘… as the time from the incision to the dressing of the surgical wound (as documented on 
the anaesthetic chart).’ (Lunebourg, Mouhsine et al. 2015). Studies refer to the outcome 
as either ‘surgical time’ (Da Assunção, Pollard et al. 2015), ‘surgical duration’ (Joestl, 
Hofbauer et al. 2016), ‘operative time’ (Lunebourg, Mouhsine et al. 2015) ‘operation 
time’ (Niikura, Lee et al. 2014) or ‘skin-to-skin surgical time’ (Solomon, Hussenbocus  
et al. 2015). In this context, the most meaningful reporting for surgical time would be 
‘skin-to-skin’ surgical time as it represents the operative time from incision to the 
dressing of the surgical wound, which most accurately reflects time spent performing 
each surgical management strategy (i.e. Revision any).  
146 
 
Overall, the mean surgical time was 182.2 minutes (95%CI 162.2 to 202.1). There 
was a high degree of heterogeneity between the studies (I2 = 84.7%). 
Studies not included in the meta-analysis: Sledge 32 and colleagues reported on 
surgical time (mean surgical time 215 minutes), however, unfortunately did not include 
the standard deviation or range, hence this was excluded from the meta-analysis (Sledge 







Figure 47 Subsidence (any) for Revision any. 
Meta-analysis
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Figure 47 shows the meta-analysis for the eleven studies (n=229) that reported 
subsidence for the exposure of interest. The terms stem subsidence (10/11 studies) and 
stem migration (1/11 studies) were accepted as subsidence for the purposes of this meta-
analysis. Definition of subsidence was provided in the majority of studies (7/11 studies), 
however, only just under half (5/11 studies) explicitly reported their method for 
measuring subsidence.  
Overall, the prevalence of subsidence was 13.3% (95%CI 5.2 to 24.5). There was 




Subsidence (>5mm or requiring revision) 
 
  
Figure 48 Subsidence (>5mm OR requiring revision) for Revision with or without 
wires/cerclage/cables. 
Meta-analysis
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Figure 48 shows the meta-analysis for the ten studies (n=183) that reported 
subsidence (>5mm or revision) for the exposure of interest. Overall, the prevalence of 
subsidence >5mm or requiring Revision was 7.3% (95%CI 1.3 to 17.6). There was a high 
degree of heterogeneity between the studies (I2 = 79.0%). 
Studies not included in the meta-analysis: Munro and colleagues reported on 
subsidence, however, unfortunately did not include the distance of subsidence amongst 
the B2 PFF patient group, hence this was excluded from the meta-analysis (Munro, 




Union (overall)  
Figure 49 Union (overall) for Revision any. 
Meta-analysis





























Figure 49 shows the meta-analysis for the twenty-four studies (n=418) that 
reported union (overall) for the exposure of interest. Half of the studies (12/24) explicitly 
defined union and these were generally defined as the presence of a bridging callus across 
the main fracture site on a minimum of two or three sides viewed in two views on plain 
film radiographs. Some studies (6/24) additionally considered clinical union, for example, 
i.e. the patient being able to fully weight bear without pain and lacked pain on clinical 
stressing of fracture site (Garcia-Rey, Garcia-Cimbrelo et al. 2013). Only one-third of 
studies reported a time to union. The overall assessment period across studies was similar, 
and up to around eleven years.  
Overall, the prevalence of union was 96.6% (95%CI 94.4 to 98.1). There was a 
mild degree of heterogeneity between the studies (I2 = 7.9%).  
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Table 10 Definition of union, method of measurement, and time to union among the included studies. 
Study Definition Method of 
measurement 
Time to union 
3 (Briant-Evans, 
Veeramootoo et al. 
2009) 
Union,  ‘…callus bridging (at) fracture in two 
radiographic views.’ 
Plain film radiographs Range 2-11 months 
4 (Canbora, Kose et 
al. 2013) 
Union,  ‘union defined as bony bridging across 
osteotomy site or no migration of fracture 
fragment.’ 
Plain film radiographs N/S (Note: time-frame of outcome 
assessment mean 39 months (Range 15-
90, SD not reported)) 
5 (Corten, 
Macdonald et al. 
2012) 
Union, ‘… clinical union in the presence of 
radiographic evidence of bone bridging in both 
AP and lateral XR’ 
Clinical and plain film 
radiographs 
Unclear. 
Range between 1 and 11 years. 
6 (Da Assunção, 
Pollard et al. 2015) 
Union, ‘Radiological union … presence of 
bridging callus across main fracture site in two 
orthogonal planes as judged by two experienced 
consultants’ 
Plain film radiographs N/S 
(Note: time-frame of outcome assessment 
between 4 and 66 months) 
7 (Eingartner, 
Volkmann et al. 
2006)  
Union, 
‘… complete osseous consolidation of fracture’ 
Plain film radiographs  
Mean 5.6 months (SD 2#, 3-11) 
8 (Fink, Urbansky 
et al. 2014) 
Union, 
N/S 




al. 2013)  
Union,  
‘patient was bearing full weight without pain, 
lacked pain on clinical stressing of fracture site 
and radiographic evidence of callus bridging the 
fracture’ (on two views in this paper) 
Clinical and plain film 
radiographs 





Table 10 (cont.) Definition of union, method of measurement and time to union among the included studies. 
Study Definition Method of 
measurement 
Time to union 
12 (Holder, Papp et 
al. 2014)  
Union, 
N/S 
Plain film radiographs Unclear. 
Pooled range of observation for union 
outcome 2-64 months 
13A (Holley, Zelken 
et al. 2007) 
13B (Holley, Zelken 
et al. 2007) 
13C (Holley, Zelken 




Plain film radiographs N/S 
Note: Time-frame of outcome assessment 
mean 34 months  
(Range 12-100, No SD reported) 
(Note: Time-frame of outcome assessment 
mean 68 months  
(Range 26-139, No SD reported)) 
Mean 65.9 months  
(Range 24-111, No SD reported) 
16 (Ko, Lam et al. 
2003)  
Union, 
 ‘Fracture healing was judged by full pain-free 
weight-bearing ability, lack of pain on clinical 
stressing at the fracture site, and radiographic 
evidence of callus bridging the fractures’  
Plain film radiographs Mean 14.5 weeks (Range 12-16, No SD 
reported) 
17A/B(Konan, 
Rayan et al. 2011) 
Union, 
N/S 
N/S ‘… patients were 
followed up clinically 
and radiologically.’ 
Mean 5.2 months (Range 3-6, No SD 
reported) 
19 (Levine, Della 
Valle et al. 2008)  
Union, 
Defined clinically as no pain on weight bearing, 
palpation and stressing fracture site and; 
Radiographically by bridging callus 
Clinically and plain 
film radiographs 
Unclear.  




Table 10 (cont.) Definition of union, method of measurement and time to union among the included studies. 
Study Definition Method of 
measurement 
Time to union 
21B (Lunebourg, 





(Note: worst case by 4 months) 
Pooled mean observation 42 months (SD 
20, 16-90) 







(Note: Time-frame of outcomes 
assessment: Mean 74 months (No SD or 
range reported)) 
24A (Mukka, 
Mellner et al. 2016)  
24B (Mukka, 




Plain film radiographs N/S 
Follow up mean in months: 24 (Range 20-
1823 days, No SD stated) 
29 (Range 104-2094 days), No SD stated) 
25A/25B/25C 
(Mukundan, Rayan 
et al. 2010) 
Union, ‘Fractures were considered to be united 
clinically when the patient could fully weight 
bear with no pain’ and absence of non-union on 
plain film radiographs  
Clinical and plain film 
radiographs 
N/S 
(Note: time-frame of outcomes 
assessment: Minimum 2 years (no 
maximum reported)) 
26 (Munro, Garbuz 
et al. 2014)  
Union,  
‘Femoral union was defined as bone bridging 
across the fracture site on three of four cortices.’ 
Plain film radiographs N/S 
(Note: time-frame for outcomes 
assessment: Pooled mean observation 54 
months (29.8#, 24-143)) 




Plain film radiographs N/S 
(Note: time-frame for outcomes 
assessment: Pooled follow-up mean 18.4 
months (SD 14.2, range NS)) 
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Table 10 (cont.) Definition of union, method of measurement and time to union among the included studies. 
Study Definition Method of 
measurement 
Time to union 
28A/B (Pavlou, 




Radiographic union defined as: ‘…cortical 
continuity on both lateral and AP (antero-
posterior) radiographs.’  
Clinical union defined as: ‘…as pain-free weight 
bearing with or without aid.’ 
Clinical and plain film 
radiographs 
A: Mean 5 months (SD 2.2, Range NS) 
 
B: Mean 4.26 months (SD 1.9, Range NS) 
29 (Pogliacomi, 
Corsini et al. 2014) 
Union, 
N/S 
Plain film radiographs N/S specific to B2s 
Note: Pooled mean 4.5 months (Range 3-8 
months (SD N/S) 
30 (Rayan, Konan 
et al. 2010)  
Union, 
N/S 
Clinical and plain film 
radiographs 
N/S 
Minimum 2 years radiographic follow-up 
(Note: Pooled range 3-6 months to union) 
33 (Solomon, 
Hussenbocus et al. 
2015) 
Union, 
Radiographic healing: ‘no visible fracture line 
on all Xray views available (AP, lateral and 
oblique).’ 
Plain film radiographs N/S 
(Note: Time-frame of outcomes 
assessment: Median 59 months (16-137) – 
excludes 2 deaths <3 months)) 




Plain film radiograph 5.6 months (Range 3-9, SD NS 
36 (Young, Pandit 
et al. 2007) 
Union, 
N/S 







Figure 50 Non-union (overall) for Revision any. 
Figure 50 shows the meta-analysis for the three studies (n=84) that reported non-
union (overall) for exposure of interest. Only Pavlou and colleagues explicitly defined 
Meta-analysis








non-union, being ‘Failure of a fracture to unite 12 months following fixation …’ (Pavlou, 
Panteliadis et al. 2011). Overall, the prevalence of non-union was 7.1% (95%CI 2.7 to 




Figure 51 Mortality (overall) for Revision any. 
Figure 51 shows the meta-analysis for the twelve studies (n=307) that reported 
mortality (overall) for the exposure of interest. 
Meta-analysis
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Overall, the prevalence of mortality was 19.0% (95%CI 11.4 to 28.1). There was a 
high degree of heterogeneity between the studies (I2 = 71.8%). In studies where patients 
were excluded based on mortality, either directly, e.g. mortality within three months post-
operatively OR in-directly, e.g. where minimum follow-up periods were applied to 
exclusion criteria and the reason for not reaching this time period was mortality, the 
patients were included in the meta-analysis. Note: raw data from Ko et al. was used for 





Aseptic loosening femur 
 
  
Figure 52 Aseptic loosening for Revision any. 
Meta-analysis











Figure 52 shows the meta-analysis for the six studies (n=137) that reported aseptic 
loosening femur for the exposure of interest. Solomon and colleagues (Solomon, 
Hussenbocus et al. 2015) defined loosening using Harris’ criteria (Harris, McCarthy et al. 
1982), the remaining studies did not provide any definition. The overall assessment 
period across studies was similar, and up to around twelve years. 
Overall, the prevalence of aseptic femoral loosening was 6.2% (95%CI 2.9 to 





Peri-prosthetic fracture post-operatively 
 
 
Figure 53 Peri-prosthetic femoral fracture (post-operatively) for Revision any. 
Figure 53 shows the meta-analysis for the 8 studies (n=219) that reported post-
operative PFF for the exposure of interest. Studies used plain film radiographs to assess 
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for any new post-operative fracture. The overall assessment period across studies ranged 
from 0 to 167 months.  
Overall, the prevalence of post-operative PFF was 4.2% (95%CI 2.0 to 7.1). There was no 




Deep surgical site infection  
 
 
Figure 54 Deep surgical site infection (DSSI) for Revision any. 
Meta-analysis
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Figure 54 shows the meta-analysis for the eleven studies (n=291) that reported 
DSSI for the exposure of interest. No authors provided a definition for DSSI, however, 
one study (Joestl, Hofbauer et al. 2016) implies an aspiration hip joint was performed for 
diagnosis. The explicit time-frame of outcome measurement was not reported in any 
study, however, the overall assessment period across studies ranged from 0 to 167 
months.  
Overall, the prevalence of DSSI was 5.4% (95%CI 2.6 to 9.2). There was a 




Superficial surgical site infection 
 
  
Figure 55 Superficial surgical site infection (SSSI) for Revision any. 
Meta-analysis
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Figure 55 shows the meta-analysis for the seven studies (n=124) that reported 
SSSI for the exposure of interest. No authors provided a definition for SSSI, however, 
one (Canbora, Kose et al. 2013) implies a wound swab was performed for diagnosis. The 
explicit time-frame of outcome measurement was not reported in any study, however, the 
overall assessment period across studies ranged from 3 months to 11 years.  
Overall, the prevalence of SSSI was 3.2% (95%CI 0.9 to 7.8). There was no 
important heterogeneity between the studies (I2 = 0%). Note: raw data from Mukka 





Figure 56 Dislocation for Revision any. 
Meta-analysis
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Figure 56 shows the meta-analysis for the twelve studies (n=298) that reported 
dislocation for the exposure of interest. No authors provided a definition for dislocation. 
Only one study, Solomon 33 et al., reported a time period within which dislocation 
occurred, which was less than 3 months post-operatively (Solomon, Hussenbocus et al. 
2015). The overall assessment period across studies was similar, and up to around 
fourteen years. Amongst studies where events occurred, only 10% (1/10) reported a 
direction of dislocation.   
Overall, the prevalence of dislocation was 9.1% (95%CI 5.4 to 13.6). There was a 








Figure 57 Re-operation for Revision any. 
Meta-analysis
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Figure 57 shows the meta-analysis for the seven studies (n=244) that reported re-
operation for the exposure of interest. No authors provided an explicit definition nor a 
time-frame for re-operation. The overall assessment period across studies was similar, 
and up to around twelve years. 
Overall, the prevalence of Re-operation was 19.4% (95%CI 13.0 to 26.7). There 




Harris hip score post-operatively 
 
Figure 58 Harris hip score (HHS) (post-operative) for Revision any. 
Figure 58 shows the meta-analysis for the seven studies (n=52) that reported post-
-operative HHS for the exposure of interest. The time point post-operatively at which 
HHS was calculated was not explicitly reported in any study, however, Canbora and 
colleagues and Wu and colleagues state this was conducted at final follow-up (Wu, Yan  
et al. 2009, Canbora, Kose et al. 2013). The overall assessment period across studies 
ranged from 15 to 137 months. 
Overall, the mean HHS was 77.6 (95%CI 73.6 to81.6). There was a high degree of 
heterogeneity between the studies (I2 = 88.3%). 
Studies not included in the meta-analysis: (Sledge and Abiri 2002, Young, Pandit 
et al. 2007, Corten, Macdonald et al. 2012). All these studies reported on post-operative 
HHS, however, unfortunately did not include the standard deviation or range, hence they 




Beals and Towers’ criteria excellent outcome 
 
 
Figure 59 Beals and Towers’ criteria excellent outcome for Revision any. 
Figure 59 shows the meta-analysis for the four studies (n=49) that reported Beals 
and Towers’ criteria for the exposure of interest. The time point post-operatively at which 
Meta-analysis









the Beals and Towers’ criteria were assessed was not explicitly reported in any study, 
however, Canbora and colleagues (Canbora, Kose et al. 2013) state this was conducted at 
final follow-up, mean 5 months (15-90, no SD reported) and Moreta and colleagues 
(Moreta, Aguirre et al. 2015) that it was conducted at a minimum 10 months post-
operatively. The overall assessment period across studies was similar, and up to around 
seven years. 
Overall, the prevalence of Beals and Towers’ criteria excellent outcome was 
63.3% (95%CI 49.3 o 76.4). There was a high degree of heterogeneity between the 




Beals and Towers’ criteria good outcome 
 
  
Figure 60 Beals and Towers’ criteria good outcome for Revision any. 
Figure 60 shows the meta-analysis for the four studies (n=49) that reported Beals 
and Towers’ criteria for the exposure of interest. The time point post-operatively at which 
Meta-analysis









the Beals and Towers’ criteria were assessed was not explicitly reported in any study, 
however, Canbora and colleagues (Canbora, Kose et al. 2013) states this was conducted at 
final follow-up, mean 5 months (15-90, no SD reported) and Moreta and colleagues 
(Moreta, Aguirre et al. 2015) that it was conducted at minimum 10 months post-
operatively. The overall assessment period across studies was similar, and up to around 
seven years. 
Overall, the prevalence of Beals and Towers’ criteria good outcome was 20.4% 
(95%CI 10.6 to 33.7). There was a moderate degree of heterogeneity between the studies 





Beals and Towers’ criteria poor outcome 
 
 
Figure 61 Beals and Towers’ criteria poor outcome for Revision any. 
Figure 61 shows the meta-analysis for the four studies (n=49) that reported Beals 
and Towers’ criteria for the exposure of interest. The time point post-operatively at which 
Meta-analysis









the Beals and Towers’ criteria were assessed was not explicitly reported in any study, 
however, Canbora and colleagues (Canbora, Kose et al. 2013) state this was conducted at 
final follow-up, mean 5 months (15-90, no SD reported) and Moreta and colleagues 
(Moreta, Aguirre et al. 2015) that it was conducted at minimum 10 months post-
operatively. The overall assessment period across studies was similar, and up to around 
seven years. 
Overall, the prevalence of Beals and Towers’ criteria poor outcome was 17.1% 
(95%CI 8.2 to 30.0). There was a moderate degree of heterogeneity between the studies 





Oxford hip score (post-operative) 
 
Figure 62 Oxford hip score (OHS) (post-operative) for any. 
Figure 62 shows the meta-analysis for the three studies (n=36) that reported post-
operative OHS for the exposure of interest. The time-frame post-operatively at which 
OHS was calculated was a mean of 26 months (SD NS, Range NS) and 64.9 months 
(Range 16–157, SD NS), for Da Assunção and Zuurmond, respectively (Zuurmond, van 
Wijhe et al. 2010, Da Assunção, Pollard et al. 2015).  
Overall, the mean OHS was 32.3 (95%CI 29.6 to 35.0). There was no important 
heterogeneity between the studies (I2 = 0%). 
Studies not included in the meta-analysis: (Young, Pandit et al. 2007, Munro, 
Garbuz et al. 2014). Both reported OHS post-operatively (with mean scores of 74 (n=16) 
and 32 (n=7), respectively, however, unfortunately did not include the standard deviation 
or range, hence were excluded from this meta-analysis. 
181 
 
Attainment of pre-fracture mobility status 
 
  
Figure 63 Attainment of pre-fracture mobility status for Revision with or without 
wires/cerclage/cables. 
Meta-analysis














Figure 63 shows the meta-analysis for the nine studies (n=123) that reported 
attainment of pre-fracture mobility status for the exposure of interest. The time point post-
operatively at which mobility status was assessed was only reported by Sexton and 
colleagues, which was 18 months post-operatively (Sexton, Stossel et al. 2006). There 
was no explicit reporting of how this assessment was made by authors (e.g. clinical or 
self-reported) except for Moreta and colleagues, who stated clinical appointment or phone 
interview was used for assessment (Moreta, Aguirre et al. 2015). The overall assessment 
period across studies was similar, and up to around eleven years. 
Overall, the prevalence of attainment pre-fracture mobility status was 79.9% 





ORIF with plate  
There were eleven studies (five retrospective cohort studies and six retrospective case 
series) which investigated various outcomes for the interventions of ORIF with plate. 
Surgical time 
 
Figure 64 Surgical time (minutes) for ORIF with plate. 
Figure 64 shows the meta-analysis for the four studies (n=39) that reported 
surgical time for the exposure of interest. Studies referred to the outcome as either 
‘surgical duration’ (Joestl, Hofbauer et al. 2016), ‘operative time’ (Lunebourg, Mouhsine 
et al. 2015) ‘operation time’ (Niikura, Lee et al. 2014) or ‘skin-to-skin surgical time’ 
(Solomon, Hussenbocus et al. 2015), all of which were accepted to mean surgical time for 
the purposes of this meta-analysis. Only Lunebourg and colleagues explicitly defined 
operative time as ‘…the time from the incision to the dressing of the surgical wound’ (as 
documented on the anaesthetic chart) (Lunebourg, Mouhsine et al. 2015).  
Overall, the mean surgical time was 126.0 minutes (95%CI 116.2 to 135.9). There 




Blood loss (intra-operative) 
 
Figure 65 Blood loss (intra-operative) for ORIF with plate.  
Figure 65 shows the meta-analysis for the two studies (n=19) that reported intra-
operative blood loss for the exposure of interest. Neither study explicitly defined blood 
loss, however, Lunebourg and colleagues state it was ‘… found on the anaesthetic report’ 
(Lunebourg, Mouhsine et al. 2015).  
Overall, the mean blood loss was 450mL (95%CI 376 to 525). There was no 





Transfusion packed red blood cell (PRBC) requirement (units) 
 
Figure 66 Transfusion packed red blood cell (PRBC) requirement for ORIF with plate. 
Figure 66 shows the meta-analysis for the three studies (n=50) that reported 
Transfusion PRBC for the exposure of interest. The studies refer to the outcome as either 
‘transfusion’ (6) ‘intra-operative transfusion’ (27B) or ‘peri-operative transfusion’ (33B), 
all of which were accepted as transfusion PRBC requirement. Overall, the mean 
transfusion requirement was 2.0 units (95%CI 1.5 to 2.5). There was no important 
heterogeneity between the studies (I2 = 0%). 
Transfusion PRBC (1 or more units required within 48 hours of surgery) 
One study reported Transfusion PRBC requirement within 48 hours of surgery for 
ORIF with plate, exposure 15C (Joestl, Hofbauer et al. 2016), with an event rate of 63% 
(5/8). 
Subsidence (any) 
Two studies reported subsidence for ORIF with plate, exposure 15C (n=8) (Joestl, 
Hofbauer et al. 2016) and exposure 33A (n=9), with no events observed in either study. 
While Joestl et al. did not define subsidence, Solomon and colleagues did (Solomon, 






Figure 67 Union (overall) for ORIF plate. 
Meta-analysis













Figure 67 shows the meta-analysis for the nine studies (n=64) that reported union 
(overall) for exposure of interest. 3/8 (37.5%) studies explicitly defined union (Table 11) 
and the same proportion additionally considered clinical union. One-quarter (2/8) of 
studies reported a time to union. The overall assessment period across studies was similar, 
and up to around eleven years. 
Overall, the prevalence of union was 87.4% (95%CI 73.8 to 96.6). There was a 




Table 11 Definition of union, method of measurement, and time to union among the included studies. 
Study Definition Method of 
measurement 
Time to union 







at mean 4.1 months (3-5 months) 
 
13D (Holley, 







N/S (Note: Time-frame of outcome assessment 
Mean 69.5 months (Range 57-82, No SD 
reported) 
15C (Joestl, 
Hofbauer et al. 
2016)  
Union, ‘Fracture union was defined clinically as the ability to 
bear weight without pain at the fracture site and 
radiographically as the presence of callus bridging in a 
minimum of three cortices on both the antero-posterior and 




N/S (Note: Time-frame of outcome assessment: 
Range 9-50 months) 
21A (Lunebourg, 







N/S (Note: worst case by 4 months) 
Pooled mean observation 42 months (SD 20, 16-
90) 
27B (Niikura, 





N/S (Note: time-frame for outcomes assessment: 
Pooled follow-up mean 18.4 months (SD 14.2, 
range NS)) 
28C/D (Pavlou, 
Panteliadis et al. 
2011)  
Union, Radiographic union defined as: ‘…cortical continuity 
on both lateral and AP (antero-posterior) radiographs.’ 
Clinical union defined as: ‘…as pain-free weight bearing with 





C: 8.8 (SD 4.0, Range NS) 
D: 4.4 (SD 0.51, Range NS) 
33A (Solomon, 
Hussenbocus et 
al. 2015)  
Union, 
Radiographic healing: ‘no visible fracture line on all Xray 
views available (AP, lateral and oblique).’ 
Plain film 
radiographs 
N/S (Note: Time-frame of outcomes assessment: 
Median 67 months (13-82) – excludes 3 deaths <3 
months 
34A (Spina, 







Note: Time-frame of outcomes assessment: 




One study reported non-union for ORIF with plate, exposure 28C and 28D, with a 
prevalence of 40% (4/10) and 25% (1/4), respectively. Pavlou and colleagues defined 
non-union as ‘Failure of a fracture to unite 12 months following fixation…’ (Pavlou, 
Panteliadis et al. 2011).  
Femoral osteolysis  
One study reported femoral osteolysis for ORIF with plate, exposure 33A (n=9) 
(Solomon, Hussenbocus et al. 2015), with no events observed.  Femoral osteolysis was 
defined as: a greater than 3mm diameter nonlinear demarcated lesion (recorded for each 
Gruen zone) (Solomon, Hussenbocus et al. 2015), however, no time-frame was stipulated. 
The overall assessment period across studies was similar, and up to around seven years. 
Loss of reduction (fracture) 
One study reported loss of reduction (fracture) for ORIF with plate, exposure 27B 
(n=3) (Niikura, Lee et al. 2014), with no events observed. No explicit definition of loss of 
reduction was reported. 
Malunion 
Two studies reported malunion for ORIF with plate, exposure 21A (Lunebourg, 
Mouhsine et al. 2015) and 27B (Niikura, Lee et al. 2014), with event rates of 0/16 (0%) and 
0/3 (0%), respectively. Malunion was defined by both authors as any angular deformity 




Length of stay 
One study reported length of stay for ORIF with plate, exposure 15C (n=8), 
(Joestl, Hofbauer et al. 2016) with a mean length of stay 26 days (SD 13). Joestl et al. 







Figure 68 Mortality (overall) for ORIF with plate. 
Figure 68 shows the meta-analysis for the four studies (n=31) that reported 
mortality (overall) for the exposure of interest. Bhattacharyya was the only study to 
specify a time-frame for mortality, reporting cumulative deaths at 4 years. Both deaths in 
Meta-analysis









the 33A Solomon study occurred within three months post-operatively (Solomon, 
Hussenbocus et al. 2015). The overall assessment period across the remaining studies was 
9-50 months (Joestl, Hofbauer et al. 2016) and 1-130 months (Spina, Rocca et al. 2014). 
Overall, the prevalence of mortality was 22.2% (95%CI 9.9 to 39.4). There was a 
moderate degree of heterogeneity between the studies (I2 = 59.0%). In studies where 
patients were excluded based on mortality, either directly, e.g. mortality within three 
months post-operatively OR in-directly, e.g. where minimum follow-up periods were 
applied to exclusion criteria and reason for not reaching this time period was mortality, 
the patients were included in the meta-analysis.  
Intra-operative mortality 
One study reported intra-operative mortality for ORIF with plate, exposure 27B 
(n=3) (Niikura, Lee et al. 2014), with no events observed.  
Aseptic loosening femur 
One study reported aseptic loosening femur for ORIF with plate, exposure 33A 
(n=9), with no events observed (Solomon, Hussenbocus et al. 2015). The term femoral 
loosening was used by Solomon and colleagues defined it using Harris’ criteria (Harris, 
McCarthy et al. 1982), however, no time-frame was stipulated (Solomon, Hussenbocus et 
al. 2015). The overall assessment period was up to around seven years (excluding deaths 
within 3 months). 
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Deep surgical site infection 
 
 
Figure 69 Deep surgical site infection (DSSI) for ORIF with plate.  
Meta-analysis











Figure 69 shows the meta-analysis for the six studies (n=45) that reported DSSI 
for the exposure of interest. No authors provided a definition for DSSI; only one study 
(Joestl, Hofbauer et al. 2016) implies an aspiration hip joint was performed for diagnosis. 
The explicit time-frame of the outcome measurement was not reported in any study.  
Overall, the prevalence of DSSI was 4.4% (95%CI 0.5 to 11.7). There was no 
important heterogeneity between the studies (I2 = 0%). 
Superficial surgical site infection 
Four studies reported SSSI for ORIF with plate, exposure 15C (n=8) (Joestl, 
Hofbauer et al. 2016), 27B (n=3) (Niikura, Lee et al. 2014), 28C (n=10) (Pavlou, 
Panteliadis et al. 2011) and 33A (n=12) (Solomon, Hussenbocus et al. 2015), with no 
events observed. No study explicitly defined SSSI. 
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Dislocation overall (combined analysis) 
 
  
Figure 70 Dislocation for ORIF with plate (combined)  
Figure 70 shows the meta-analysis for the four studies (n=37) that reported 
dislocation for the exposure of interest. No authors provided a definition or direction of 
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dislocation. Only one study (Solomon, Hussenbocus et al. 2015) reported a time period 
within which a dislocation occurred, which was less than 3 months post-operatively.  
Overall, the prevalence of dislocation was 11.8% (95%CI 3.8 to 25.7). There was 
a low degree of heterogeneity between the studies (I2 = 9.9%). 
Subgroup analysis (analysis 2) was performed by separating exposure 28C (ORIF 
with plate without bone graft) and 28D (ORIF with plate with bone graft) to assess for 
any appreciable change in the meta-analysis result for dislocation (Pavlou, Panteliadis  





Dislocation (analysis 2) 
 
  
Figure 71 Dislocation for ORIF with plate (Analysis 2)  
Meta-analysis
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Figure 71 shows the meta-analysis for the five studies (n=37) that reported 
dislocation for the exposure of interest. No authors provided a definition or direction of 
dislocation. Only one study (Solomon, Hussenbocus et al. 2015) reported a time period 
within which dislocation occurred, which was less than 3 months post-operatively.  
Overall, the prevalence of dislocation was 12.1% (95%CI 0.8 to 33.7). There was a 
moderate degree of heterogeneity between the studies (I2 = 66.2%). 
 
Delayed wound healing 
One study reported delayed wound healing for ORIF with plate, exposure 33A, 
with an event rate of 0/9 (0%) (Solomon, Hussenbocus et al. 2015). No explicit definition 







Figure 72 Re-operation for ORIF with plate. 
Figure 72 shows the meta-analysis for the three studies (n=14) that reported re-
operation for the exposure of interest. No authors provided an explicit definition nor a 
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time-frame for re-operation. The overall assessment period across studies was similar, 
and up to around eleven years. 
Overall, the prevalence of Re-operation was 38.0% (95%CI 16.2 to 64.2). There 
was no important heterogeneity between the studies (I2 = 0%). 
Studies not included in the meta-analysis: (Lunebourg, Mouhsine et al. 2015). 
Lunebourg and colleagues reported on re-operation (by way of Revision) for Vancouver 
B2 PFF in their cohorts, however, unfortunately, only explicitly specified the exposure 
(either 21A ORIF with plate OR 21B Revision + ORIF with plate) in one out of two 
Revision cases and hence could not be included in our meta-analysis without introducing 
some uncertainty (Lunebourg, Mouhsine et al. 2015).  
Deep vein thrombosis (DVT) 
Two studies reported DVT for ORIF with plate, exposure 11 (Haidar and 
Goodwin 2005) and 15C (n=8) (Joestl, Hofbauer et al. 2016), with a prevalence of 17% 
(1/6) and no observed events, respectively. No authors provided an explicit definition for 
DVT. 
Pulmonary embolism (PE) 
One study reported PE for ORIF with plate, exposure 15C (n=8) (Joestl, Hofbauer 
et al. 2016), with no events observed. No explicit definition of PE was provided.  
Leg length discrepancy (LLD) (2cm or more) 
One study reported LLD for ORIF with plate, exposure 11 (Haidar and Goodwin 
2005), with an incidence of 17% (1/6). Outcome was referred to as ‘limb shortening’ by 
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authors, however, no explicit definition, diagnostic method, nor a time-frame for 
identifying LLD was provided.  
Neurovascular injury 
One study reported Neurovascular injury for ORIF with plate, exposure 15C (n=8) 
(Joestl, Hofbauer et al. 2016), with no events observed. No explicit definition of 
neurovascular injury was provided. 
Plate breakage 
Two studies reported plate breakage for ORIF with plate, exposure 15C (n=8) 
(Joestl, Hofbauer et al. 2016) and 18B (n=6) (Korbel, Sponer et al. 2013), with no 
observed events and a prevalence of 3/6 (50%), respectively.   
Harris hip score post-operatively 
One study reported post-operative Harris hip score for ORIF with plate, exposure 
33A* (n=5) (Solomon, Hussenbocus et al. 2015), with a mean score of 59 (SD 22.96). 
The time point post-operatively at which HHS was calculated was not explicitly reported.  
Harris hip pain score (post-operative) 
One study reported post-operative Harris hip pain score for ORIF with plate, 
exposure 33A* (n=8) (Solomon, Hussenbocus et al. 2015), with a mean score of 41 (SD 
8.4). The time point post-operatively at which HHS was calculated was not explicitly 
reported. 
Beals and Towers’ criteria excellent outcome 
One study reported Beals and Towers’ criteria excellent outcome for ORIF with 
plate, exposure 34A, with a prevalence of 50% (3/6) (Spina, Rocca et al. 2014). The time 
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point post-operatively at which the Beals and Towers’ criteria were assessed was not 
explicitly reported. 
 
Beals and Towers’ criteria good outcome 
One study reported Beals and Towers’ criteria good outcome for ORIF with plate, 
exposure 34A (Spina, Rocca et al. 2014), with a prevalence of 16.7% (1.6). The time 
point post-operatively at which the Beals and Towers’ criteria were assessed was not 
explicitly reported. 
 
Beals and Towers’ criteria poor outcome 
One study reported Beals and Towers’ criteria excellent outcome for ORIF with 
plate, exposure 34A (Spina, Rocca et al. 2014), with a prevalence of 33% (2/6). The time 
point post-operatively at which the Beals and Towers’ criteria were assessed was not 
explicitly reported. 
 
Parker mobility score (post-operative) 
Two studies reported post-operative Parker mobility score for ORIF with plate, 
exposure 15C (n=8) (Joestl, Hofbauer et al. 2016) and 27B (n=3) (Niikura, Lee et al. 
2014) with mean scores of 6.6 (SD 2) and 2 (SD 2.7), respectively. Note, for reference, 
mean pre-operative Parker mobility score for exposure 15C (n=8) (Joestl, Hofbauer et al. 
2016) and 27B (n=3) were 7 (SD 1.2) and 2 (SD 2.7), respectively. 
Ambulatory status (post-operative) 
Two studies reported post-operative ambulatory status for ORIF with plate, 
exposure 27B (Niikura, Lee et al. 2014), with 66% (2/3) non-ambulatory and 33% (1/3) 
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mobilising with crutch, and exposure 34A with 40% (2/5) mobilising without aids (Spina, 




Attainment of pre-fracture mobility status  
 
 
Figure 73 Attainment pre-fracture mobility status for ORIF with plate. 
Figure 73 shows the meta-analysis for the three studies (n=19) that reported 
Attainment pre-fracture mobility status for the exposure of interest. There was no explicit 
reporting of how this assessment was made by authors (e.g. clinical or self-reported). The 
overall assessment period for Joestl et al. (Joestl, Hofbauer et al. 2016) and Solomon et al. 
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(Solomon, Hussenbocus et al. 2015) studies ranged from 9 to 82 months Niikura and 
colleagues (Niikura, Lee et al. 2014) study reported a pooled mean follow-up time of 18.4 
months (no range provided).  
Overall, the prevalence of Attainment pre-fracture mobility status was 59.5% 
(95%CI 36.7 to 79.6). There was a moderate degree of heterogeneity between the studies 
(I2 = 55.6%). 
Attainment of pre-fracture social status 
One study reported attainment of pre-fracture social status for ORIF with plate, 
exposure 27B (Niikura, Lee et al. 2014), with a prevalence of 100% (3/3), one patient 
returning home independently, one patient returning home with caregiver and one patient 
returning to nursing home. 
Pain free (self-assessment) 
One study reported pain free (self-assessment) status for ORIF with plate, 
exposure 32A, with an event rate of 4/6 (66%) (Sledge and Abiri 2002). The time point 
post-operatively at which the outcome was assessed was not reported by study authors. 
Quality of Life (self-assessment) post-operatively (1 (poor) – 10 (excellent)) 
One study reported perceived post-operative quality of life, exposure 34A (n=6) 
(Spina, Rocca et al. 2014), with a mean score of 6 (SD NS, range NS). Note: pre-
operative mean score was 8 (SD NS, range NS). The time point post-operatively at which 




ORIF with wires/cerclage/cables 
There were two cohort studies which investigated various outcomes for the interventions 
of ORIF with wires/cerclage/cables.  
Union 
Two studies reported union for ORIF with wires/cerclage/cables, exposure 24C 
(Mukka, Mellner et al. 2016) and 34B (Spina, Rocca et al. 2014), with a prevalence of 
100% (2/2) and no events observed, respectively. Neither study defined union, nor 
provided a time-frame for its observation.  
Mortality (overall) 
One study reported mortality for ORIF with wires/cerclage/cables, exposure 24C 
(Mukka, Mellner et al. 2016) (n=2) with no events observed. 
Deep surgical site infection 
One study reported DSSI for ORIF with wires/cerclage/cables, exposure 24C 
(Mukka, Mellner et al. 2016) (n=2) with no events observed. 
Re-operation 
Two studies reported re-operation for ORIF with wires/cerclage/cables, exposure 
24C (n=2) (Mukka, Mellner et al. 2016) and 34B (n=1) (Spina, Rocca et al. 2014), with 
no events observed in either study.   
Beals and Towers’ criteria excellent outcome 
One study reported Beals and Towers’ criteria excellent outcome for ORIF with 
wires/cerclage/cables, exposure 34B (Spina, Rocca et al. 2014), with a prevalence of 0% 
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(0/1). The time point post-operatively at which the Beals and Towers’ criteria were 
assessed was not explicitly reported. 
Beals and Towers’ criteria good outcome 
One study reported Beals and Towers’ criteria good outcome for ORIF with 
wires/cerclage/cables, exposure 34B (Spina, Rocca et al. 2014), with a prevalence of 0% 
(0/1). The time point post-operatively at which the Beals and Towers’ criteria were 
assessed was not explicitly reported. 
Beals and Towers’ criteria poor outcome 
One study reported Beals and Towers’ criteria excellent outcome for ORIF with 
wires/cerclage/cables, exposure 34B (Spina, Rocca et al. 2014), with a prevalence of 
100% (1/1). The time point post-operatively at which the Beals and Towers’ criteria were 
assessed was not explicitly reported. 
Ambulatory status (post-operative) 
One study reported post-operative ambulatory status for ORIF with 
wires/cerclage/cables, exposure 34B (Spina, Rocca et al. 2014) with a prevalence of 0% 
(0/1) mobilising without aids. The time point post-operatively at which the outcome was 
assessed was not reported by study authors. 
Pain free (self-assessment) 
One study reported pain free (self-assessment) status for ORIF with 
wires/cerclage/cables, exposure 32B (n=1), with no events observed (Sledge and Abiri 
2002). The time point post-operatively at which the outcome was assessed was not 
reported by study authors. 
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ORIF mixed methods/unspecified 
There were three studies (two cohort studies and one retrospective case series) which 





Figure 74 Re-operation for ORIF mixed methods/unspecified. 
Meta-analysis








Figure 74 shows the meta-analysis for the three studies (n=34) that reported re-
operation for the exposure of interest. No authors provided an explicit definition or a 
time-frame for re-operation. 
Overall, the prevalence of re-operation was 30.9% (95%CI 16.8 to 48.2). There 
was no important heterogeneity between the studies (I2 = 0%). 
Oxford hip score (post-operatively) 
One study reported mortality for ORIF mixed methods/unspecified, exposure 37C 
(n=6), with a mean of 23.8 (SD 7.9) (Zuurmond, van Wijhe et al. 2010). The overall 
assessment period across studies was similar, and up to around thirteen years. 
ORIF any 
There were thirteen studies (seven cohort studies and six retrospective case series) which 





Figure 75 Union (overall) for ORIF any). 
Meta-analysis














Figure 75 shows the meta-analysis for the nine studies (n=67) that reported union 
(overall) for exposure of interest. One third of the studies 3/9 explicitly defined union and 
22% (2/9) of studies reported a time to union. The overall assessment period across 
studies was similar, and up to around eleven years. 
Overall, the prevalence of union was 86.7% (95%CI 73.4 to 95.9). There was a 




Deep surgical site infection 
 
  
Figure 76 Deep surgical site infection (DSSI) for ORIF any.  
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Figure 76 shows the meta-analysis for the seven studies (n=47) that reported DSSI 
for the exposure of interest. No authors provided a definition for DSSI, only one study 
(Joestl, Hofbauer et al. 2016) implies an aspiration hip joint was performed for diagnosis. 
The explicit time-frame of outcome measurement was not reported in any study.  
Overall, the prevalence of DSSI was 4.6% (95%CI 0.7 to 11.8). There was no 
important heterogeneity between the studies (I2 = 0%). 
Superficial surgical site infection 
Five studies reported SSSI for ORIF with plate, exposure 15C (n=8) (Joestl, 
Hofbauer et al. 2016), 24C (n=2) (Mukka, Mellner et al. 2016), 27B (n=3) (Niikura, Lee 
et al. 2014), 28C (n=10) (Pavlou, Panteliadis et al. 2011) and 33A (n=12) (Solomon, 
Hussenbocus et al. 2015), with no events observed. No authors provided an explicit 







Figure 77 Re-operation for ORIF with plate. 
Figure 77 shows the meta-analysis for the seven studies (n=51) that reported re-
operation for the exposure of interest. No authors provided an explicit definition or a 
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time-frame for re-operation. The overall assessment period across studies was similar, 
and up to around eleven years. 
Overall, the prevalence of re-operation was 31.1% (95%CI 19.9 to 43.5). There 





Only one case series evaluated non-operative intervention. 
Union 
One study reported union for non-operative intervention, exposure 27C (Niikura, 
Lee et al. 2014), with a prevalence of 100% (1/1). Union was not defined nor a time-
frame of assessment given by authors.  
Ambulatory status (post-injury) 
One study reported post-operative ambulatory status for non-operative 
intervention, exposure 27C (Niikura, Lee et al. 2014), with 100% (1/1) mobilising with 
cane. The explicit time-frame of the outcome measurement was not reported in any study. 
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Summary of findings (Grade) 















Summary of findings 
 
Overall, no management strategies have been shown to be consistently superior 
for the outcomes included in this systematic review. Comparative meta-analysis revealed 
small differences between management strategies across different outcomes. While the 
surgical time was shorter and the transfusion requirement was less for ORIF with plate vs 
Revision +/- wires, cerclage and cables, pre and post-operative Parker mobility scores, 
subsidence, union, mortality, dislocation and infection rates were similar. Regarding 
Revision via any method vs ORIF any method, union, malunion and infection rates were 
similar, however, mortality rates were lower for ORIF and re-operation rates were lower 
for Revision. The section below presents a detailed discussion about the clinical 
significance of the main findings of this systematic review and meta-analysis according to 
outcomes. 
Mortality 
Single study meta-analysis performed for Revision with or without 
wires/cerclage/cables (studies=8 patients=155), Revision any method (studies=12 
patients=307), ORIF with plate (studies=4 patients=31) revealed a prevalence of mortality 
of 21.6% (95%CI 9.0 to 38.0), 19.0% (95%CI 11.4 to 28.1) and 22.2% (95%CI 9.9 to 
39.4), respectively. It should be noted that the observational time-frame ranged from 6 
months to 6 years, 3 months to 9 years and 0 months to 10 years, for Revision with or 
without wires/cerclage/cables, Revision any method and ORIF with plate, respectively.  
Comparative meta-analysis for three studies (Joestl, Hofbauer et al. 2016, 
Solomon, Hussenbocus et al. 2015, Zuurmond, van Wijhe et al. 2010) including 83 
patients revealed a 12% increase in the prevalence of mortality for Revision any method 
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compared with ORIF any method. These results were not statistically significant. It 
should be noted that the time-frame for mortality varied between studies and between the 
exposures within the same study, however, there was no significant trend observed (see 
Appendix IV for further details). 
Although mortality is a critically important outcome, in light of our findings it 
should not influence the decision-making when choosing between ORIF with plate and 
Revision any method.  
Re-operation 
Single study meta-analysis performed for Revision with or without 
wires/cerclage/cables (studies=7 patients=38), Revision any method (studies=7 
patients=244), ORIF with plate (studies=3 patients=14) and ORIF any method (studies=7, 
patients=51) revealed a prevalence of re-operation of 15.9% (95%CI 9.3 to 23.7), 19.4% 
(95%CI 13.0 to 27.2), 38.0% (95%CI 15.2 to 64.2) and 31.1% (95%CI 19.9 to 43.5), 
respectively. It should be noted that the observational time-frame ranged from 3 months 
to 12 years and 1 month to 11 years, Revision any method and ORIF any method, 
respectively. 
Comparative meta-analysis for four studies (Lindahl, Garellick et al. 2006, Holley, 
Zelken et al. 2007, Zuurmond, van Wijhe et al. 2010, Inngul and Enocson 2015) 
including 218 patients revealed a 12% lower prevalence for re-operation for Revision any 
method compared with ORIF any method. It should be noted that the time-frame for re-
operation assessment varied between studies and between the exposures within the same 




Although there was no statistically significant difference in the prevalence of re-
operation between the exposures, our findings suggest a trend towards Revision any 
method being protective against re-operation when compared to ORIF any method. A 
previous systematic review on this topic reported that there was no difference between 
ORIF any method and Revision any method (Khan, Grindlay et al. 2017). Nevertheless, 
our meta-analysis for re-operation only included two out of the four studies included by 
the previous systematic review. Interestingly, this review included the study by Solomon 
et al., in their meta-analysis for the outcome of re-operation and we did not (Solomon, 
Hussenbocus et al. 2015). Despite this, we could not identify reporting of re-operation in 
Solomon’s study publication, and also upon review of their de-identified raw data. 
Therefore, we are not able to confirm whether this outcome was assessed in the above-
mentioned study. Solomon did however report that closed reduction was performed to 
manage patients with post-operative hip dislocations, but no further details were provided 
regarding whether this was performed in the operating theatre or in the emergency 
department. In addition, the previous systematic review included the study by Lunebourg 
and colleagues for the re-operation meta-analysis, which was not included in our meta-
analysis. Lunebourg and colleagues reported two re-operations (referred to as Revision 
surgery by authors) for the Vancouver B2 PFF cohort (n=23), however, only one of these 
re-operations was explicitly stated to have undergone internal fixation (ORIF any 
equivalent) at the time of original management for PFF (Lunebourg, Mouhsine et al. 
2015). The remaining Vancouver B2 PFF case undergoing re-operation was not explicitly 
declared by authors to belong to either the ORIF with plate plus revision (Revision any 
method equivalent) or the ORIF with plate alone exposure group (ORIF any equivalent). 
As such, we could not justify the inclusion of this study in the meta-analysis for the 
outcome of re-operation. Finally, we included two studies which were not included by 
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Khan and colleagues (Lindahl, Garellick et al. 2006, Holley, Zelken et al. 2007). It is 
possible that these two studies did not meet the inclusion criteria of the previous 
systematic review. Nevertheless, the study by Lindahl et al., 2006 accounted alone for 
over half of the total weight in our meta-analysis for this outcome (Lindahl, Garellick  
et al. 2006). Despite the differences between the two meta-analyses, both of them showed 
similar results, with a non-statistically significant trend towards Revision any method 
being protective for re-operation compared to ORIF any method.     
Union 
Single study meta-analysis performed for Revision with or without 
wires/cerclage/cables (studies=17 patients=278), Revision any method (studies=24 
patients=418), ORIF with plate (studies=9 patients=64) and ORIF any method (studies=9, 
patients=67) revealed a prevalence of union of 97.0% (95%CI 94.5 to 98.7), 96.6% 
(95%CI 94.5 to 98.1), 87.4% (95%CI 73.8 to 96.6) and 86.7% (95%CI 73.4 to 95.9), 
respectively. 
Comparative meta-analysis for four studies (Holley, Zelken et al. 2007, Pavlou, 
Panteliadis et al. 2011, Niikura, Lee et al. 2014, Solomon, Hussenbocus et al. 2015) (13, 
27, 28, 33) including 70 patients revealed a 14% increase in the prevalence of union for 
Revision with or without wires/cerclage/cables compared with ORIF with plate. In 
addition, comparative meta-analysis including five studies (Holley, Zelken et al. 2007, 
Pavlou, Panteliadis et al. 2011, Niikura, Lee et al. 2014, Solomon, Hussenbocus et al. 
2015) on 103 patients comparing Revision any method vs ORIF any method revealed a 
3% increase in the prevalence of union reported for Revision any method. All of these 
results were not statistically significant.  
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Stratified analyses were conducted for the presence/absence of bone graft as an 
adjunct to ORIF with plate (28C/28D) (Pavlou, Panteliadis et al. 2011). The analyses 
yielded similar results, with no statistically significant difference between union rates, 
however, there was a modest trend toward higher union rates with Revision with or 
without wires/cerclage/cables. However, they suggested that the addition of bone graft to 
ORIF with plate intervention may neutralise this difference almost completely.  
Overall, less than half of the studies explicitly defined union, with radiographic 
assessment being the diagnostic method of choice in the majority of studies. Furthermore, 
less than a quarter of studies provided a time to union. This reflects a global deficiency in 
the quality of outcome definition and reporting, which reduces the overall methodological 
quality of the included studies. Within the limitations of this systematic review, our 
findings suggest that no surgical management strategy is superior with regards to 
promoting union. Therefore, this outcome should not influence the decision-making when 
choosing between ORIF and Revision or any of its subcategories. However, bone graft 
augmentation of ORIF with plate should be investigated further, as it has shown to 
slightly increase union rates in one comparative study.  
Dislocation 
Single study meta-analysis performed for Revision with or without 
wires/cerclage/cables (studies=11 patients=214), Revision any method (studies=12 
patients=298) and ORIF with plate (studies=4 patients=37) revealed a prevalence of 
dislocation of 10.4% (95%CI 5.8 to 16.2), 9.1% (95%CI 5.4 to 13.6) and 11.8% (95%CI 
3.8 to 25.7), respectively.  
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Comparative meta-analysis for four studies (Pavlou, Panteliadis et al. 2011, 
Korbel, Sponer et al. 2013, Solomon, Hussenbocus et al. 2015, Joestl, Hofbauer et al. 
2016) including 118 patients revealed that the prevalence of dislocation was 5% higher 
for Revision with or without wires/cerclage/cables, in comparison with ORIF with plate. 
Nevertheless, this result was not statistically significant. 
Stratified analyses were conducted for the presence/absence of bone graft as an 
adjunct to ORIF with plate (28C/28D) (Pavlou, Panteliadis et al. 2011) to assess for any 
appreciable change in meta-analysis results for dislocation. The analyses yielded similar 
results with no statistically significant difference in the prevalence of dislocation between 
the two surgical approaches. Nevertheless, only 4 out of 118 patients included in the 
meta-analysis received bone graft, and further research should be conducted in order to 
investigate the potential protective role of ORIF with plate and bone graft with regards to 
dislocation. 
In light of current results, similar to the outcome of union, our findings suggest 
that no surgical management strategy is superior with regards to preventing dislocation. 
Therefore, this outcome should not influence the decision-making when choosing 
between ORIF with plate and Revision with or without wires/cerclage/cables.  
Surgical time 
Single study meta-analysis performed for Revision with or without 
wires/cerclage/cables (studies=4 patients=70), Revision any method (studies=5 
patients=77) and ORIF with plate (studies=4 patients=39) revealed a mean surgical time 
of 177.5 (95%CI 157.0 to 198.0), 182.2 (95%CI 162.2 to 202.1) and 126.0 (95%CI 116.2 
to 135.9) minutes, respectively. 
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Comparative meta-analysis for three studies (Niikura, Lee et al. 2014, Solomon, 
Hussenbocus et al. 2015, Joestl, Hofbauer et al. 2016) including 46 patients revealed that 
surgical time was 50 minutes longer for Revision with or without wires/cerclage/cables, 
in comparison with ORIF with plate. In addition, comparative meta-analysis including 
four studies (Niikura, Lee et al. 2014, Lunebourg, Mouhsine et al. 2015, Solomon, 
Hussenbocus et al. 2015, Joestl, Hofbauer et al. 2016) on 71 patients comparing Revision 
any method vs ORIF any method revealed a mean difference of around one hour, with a 
longer duration reported for Revision any method. All of these results were statistically 
significant. None of the studies explicitly defined surgical time and refer to the outcome 
as either ‘surgical duration’ (Joestl, Hofbauer et al. 2016), ‘operation time’ (Niikura, Lee 
et al. 2014) or ‘skin-to-skin surgical time’ (Solomon, Hussenbocus et al. 2015), all of 
which were accepted to mean surgical time for the purposes of this meta-analysis. In this 
context, the most meaningful reporting for surgical time would be ‘skin-to-skin’ surgical 
time as it represents the operative time from incision to the dressing of the surgical 
wound, which most accurately reflects time spent performing each surgical management 
strategy (i.e. Revision with or without wires/cerclage/cables). The clinical and practical 
implications of an additional 50-minute surgical time are significant, with prolonged 
anaesthetic exposure for the patient and greater economic burden on the health system. 
Therefore, ORIF with plate represents a more efficient management strategy and may 
impart a harm and cost minimisation when compared to Revision with or without 





Single study meta-analysis performed for Revision with or without 
wires/cerclage/cables (studies=2 patients=11), ORIF with plate (studies=3 patients=50) 
revealed a mean of 3.1 (95%CI 1.9 to 4.2) and 2.0 (95%CI 1.5 to 2.5) units PRBC, 
respectively. 
Comparative meta-analysis for two studies (Niikura, Lee et al. 2014, Solomon, 
Hussenbocus et al. 2015) including 24 patients revealed greater transfusion requirement 
for Revision with or without wires/cerclage/cables of 2.6 units PRBC, in comparison with 
ORIF with plate. Although these results were statistically significant, the sample size was 
small, even after combining the two studies. Therefore, these results should be interpreted 
with caution, and further research is required to confirm these findings. Nevertheless, an 
additional two and a half units PRBC transfusion requirement per patient is of clinical 
importance, given the risks of transfusion to the patient and the cost involved with its 
provision. In this sense, ORIF with plate would represent a risk minimisation to the 
patient and would reduce the overall cost of the surgery. 
Attainment of pre-fracture mobility status 
Single study meta-analysis performed for Revision with or without 
wires/cerclage/cables (studies=6 patients=86), Revision any method (studies=9 
patients=123) and ORIF with plate (studies=3, patients=19), revealed a prevalence of 
attainment of pre-fracture mobility status of 88.8% (95%CI 66.6 to 99.6), 79.9% (95%CI 
59.4 to 94.4) and 59.5% (95%CI 36.7 to 79.6), respectively.  
Comparative meta-analysis for three studies (Niikura, Lee et al. 2014, Solomon, 
Hussenbocus et al. 2015, Joestl, Hofbauer et al. 2016) including 56 patients revealed a 6% 
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increase in the prevalence of attainment of pre-fracture mobility status for Revision with 
or without wires/cerclage/cables compared with ORIF with plate. This result was not 
statistically significant.  
It should be noted that there was no explicit reporting by authors of how or at 
which time point post-operatively this assessment was made (e.g. clinical or self-
reported). Future studies should include this and other patient-reported measures when 
evaluating surgical management strategies for Vancouver B2 PPF.   
Parker mobility scores pre and post-operatively  
Comparative meta-analysis for two studies (Niikura, Lee et al. 2014, Joestl, 
Hofbauer et al. 2016) including 41 patients revealed no statistically significant difference 
in the difference in Parker mobility score pre and post-operatively for Revision with or 
without wires/cerclage/cables compared with ORIF with plate. Both sub-groups revealed 
patients had modestly lower scores post-operatively with 0.49 (95%CI 0.40 to 1.38) 
points (lower post-operatively) for Revision with or without wires/cerclage/cables sub-
group compared with 0.33 (95%CI 1.18 to 1.84) points (lower post-operatively) in the 




Limitations of the systematic review 
Quality of the evidence  
Overall the methodological quality of the included studies was low and this is 
consistent with the field of orthopaedics research in general (Fayaz, Haas et al. 2013). In 
addition, the majority of studies lack the appropriate level of evidence, adequate sample 
sizes and often do not present a clear and systematic definition of exposures and 
outcomes. Furthermore, the studies lack sophisticated statistical techniques to handle 
confounding bias on most occasions. Despite these limitations, the current systematic 
review presents results based on the best available evidence on the effectiveness of 
surgical management strategies for Vancouver B2 PFF. The main methodological issues 
of the included studies in the current systematic review are reported below: 
Definition of the population and exposure 
 
Grouping patients into one single cohort based purely on their fracture 
classification as Vancouver B2 is useful to assess management strategies. However, there 
are variations within this type of fracture that may contribute to prognosis and response to 
treatment that should be considered in the evaluation of the surgical management 
strategy. These factors are related to the patients themselves, the implants used in the 
surgery, the performance of the surgical intervention itself and the after-care regime. 
Patient factors would include the indication for the index procedure (e.g. hip hemi-
arthroplasty for a fractured neck of the femur vs primary total hip replacement for hip 
osteoarthritis) and age. Index procedure details, including arthroplasty construct (THA vs 
HA), femoral stem geometry and fixation principle (e.g. cemented vs uncemented 
systems) are important considerations in planning for subsequent management in the 
event of a PFF. The experiential level of the surgeon performing the intervention may 
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affect the outcomes of the surgery, and some of the included studies had more 
experienced surgeons concentrated in one intervention arm. Similarly, the after-care 
regime may also have an impact on the outcomes of the surgery. These include for 
example the weight-bearing, surgical antibiotic prophylaxis, and the venous 
thromboembolism prophylaxis protocols employed by surgeons. Table 14 shows the 
proportion of studies included in the review which reported these factors. 
 
Table 14 Proportion of characteristics related to the exposure reported by the included 
studies. 
Population 
Indication of index procedure 19% (7/37) 
Age 84% (31/37) 
Index procedure details 
Index arthroplasty construct (THA/HA) 51% (19/37) 
Index femoral stem type 19% (7/37) 
Index femoral stem fixation 
(cemented/cementless) 68% (25/37) 
Exposure 
Experiential level of surgeon 24% (9/37) 
Allocation of exposure 62% (23/37) out of which 65% was surgeon preference 
After-care regime 
Weight-bearing regime 62% (23/37) 
Surgical antibiotic prophylaxis protocol 22% (8/37) 
Venous thromboembolism prophylaxis 
protocol 22% (8/37) 
 
It should be noted that our intention for sub-group analysis, including patient age and 
surgeon experiential level, was not able to be executed due to the lack of reported data on 




Definition of the outcomes 
 
 The explicit definition of outcome measures, their method and time-frame of 
measurement is important in orthopaedic research in order to effectively inform surgical 
decision-making and patient information on expected risks and benefits of proposed 
interventions (which may be non-operative or operative) along with their probable time-
frames. The absence of strict definitions or criterion for an outcome measure makes 
interpretation of intra-study comparisons challenging as there may be multiple patients 
within a cohort exhibiting a similar clinical picture whom are inconsistently allocated to 
an outcome because of disparities between the assessor’s (surgeon’s) definition and its 
application to the clinical scenario. This potential for intra-assessor variability is further 
complicated by the fact that commonly multiple surgeons will participate in providing 
orthopaedic care within a given unit and unanimous opinion is variably observed which 
will lead to inter-assessor variability.  
Furthermore, the method of measurement will impact on outcome assessment in 
terms of accuracy and precision of outcome detection. Additionally, the time-frame for its 
identification is vital in informing practice and counselling patients. Using an example 
from our study, the single study meta-analysis for Revision with or without 
wires/cerclage/cables for union outcome; 56% (10/18) studies provided a definition for 
union, however, although these definitions generally included radiographic assessment of 
cortical bridging usually 2 or 3 out of four times to satisfy a diagnosis of union, none of 
these definitions were exactly the same. 100% (18/18) reported a method of detection by 
way of a plain film radiograph with a further 17% (3/18) additionally considering clinical 
examination to support a diagnosis of union. Additionally, the time to union was only 
reported in half (9/18) of the studies.  
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In the case of complications, beyond the detection method and time-frame, the 
reporting of their management outcomes is also important to consider. In the case of 
prosthetic hip dislocation, it is relatively simple with a continuum between complete joint 
congruency, subluxation, where some articular contact is present, and dislocation, where 
no articular contact is observed. This may be identified clinically with a patient exhibiting 
a shortened and externally or internally rotated lower limb (depending on direction of 
dislocation) and inability to weight bear and can be further correlated with a plain film 
radiograph. In our single study meta-analysis of Revision with or without 
wires/cerclage/cables for dislocation outcome, 0% (0/11) study authors provided a 
definition or direction of dislocation. Dislocations are seldom left without treatment as the 
patient would be rendered unable to mobilise on that limb. In terms of the implication of a 
dislocation, if medical staff perform a reduction manoeuvre under sedation or anaesthesia 
to restore the normal joint enlocation this may or may not be considered as a re-operation 
depending on whether or not this was performed in the Emergency Department 
resuscitation room or in the operating theatre. As discussed above, Solomon et al. 
reported multiple dislocations and closed reductions being performed; however, none of 
these were reported as re-operations. If these dislocations were interpreted as re-
operations, this would read as a re-operation rate (for dislocation) of 11% (1/9) for 
exposure 33A ORIF with plate and 29% (2/7) for 33B Revision with or without 
wires/cerclage/cables (Niikura, Lee et al. 2014, Solomon, Hussenbocus et al. 2015). This 
may change our view on either intervention depending on its size of effect and clinical 
relevance. Regardless of whether or not the dislocation event results in reporting as ‘re-
operation’, an unstable joint articulation will impart much morbidity upon the patient with 
recurrent dislocations resulting in repeated hospital presentation and possible requirement 
for Revision surgery to improve arthroplasty construct to improve stability. It is clear that 
234 
 
depending on a studies definition of re-operation, important data may or may not be 
reported which would likely impact on the surgeon’s decision-making and provision of 
expected outcomes to patients.  
Beyond the detection method and time-frame, the concept of a threshold for an 
outcome being considered a reality is important to consider. Relevant to dislocation, 
subsidence of the femoral stem is a commonly reported outcome which may lead to 
altered stability of a hip arthroplasty construct by way of a stem migrating within the 
femoral canal and altering the dynamic at the prosthetic head and acetabular interface. 
The amount of subsidence which surgeons tolerate prior to labelling as such, varied 
amongst studies, however, generally 5mm or less was accepted to be within acceptable 
limits. For this reason we performed two single study meta-analyses for Subsidence for 
Revision with or without wires/cerclage/cables which included; Subsidence (any) where 
any subsidence was considered to represent its existence regardless of distance and 
Subsidence greater than 5mm or requiring Revision surgery, (with the latter thought to be 
somewhat more meaningful from a clinical perspective), for if 5mm or less subsidence is 
identified in a patient it would be unlikely to cause clinically detectable symptoms and 
ultimately, if any degree of subsidence is tolerated by the patient without causing 
symptoms or complications necessitating revision, it is likely to be clinically unimportant. 
For subsidence in any meta-analysis, a definition of subsidence was provided in 88% 
(7/8) studies, however, only 63% (5/8) explicitly reported their measurement method.   
This uncertainty impacts not only our single study meta-analyses but our 
comparative meta-analyses. An example is our meta-analyses of Re-operation for 
Revision any method vs ORIF any method where 0% (0/4) study authors provided an 
explicit definition for re-operation. Additionally, they did not provide an explicit time-
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frame within which re-operation was observed, with the only guidance being the overall 
time-frame for outcome assessment published by authors.  
Furthermore, when considering comparisons between studies such as our 
comparative analysis section, an important limitation is the variable time-frames of 
outcome assessment. Upon review of these time-frames for outcomes assessed, most 
study ranges did not vary considerably (see Appendix IV for further details). In addition, 
all studies reported outcomes for clinically relevant observational time periods. For 
example, for the outcome of union, the critical period of evaluation is within the first year 
post-surgery, as union is generally achieved within 9 to 12 months after surgery.  
Study protocols must establish strict definitions for outcome measures and their 
detection method and time-frame of assessment to ensure results are consistent and 
interpretable clinically. Beyond this, inter-study comparisons rely on these protocols in 
being explicit to ensure that outcomes observed are indeed comparable. Indeed, practice 
varies across units, health networks, states and nations. Herein lies a limitation to our 
meta-analyses.  
 
Potential confounding bias  
 
The included studies did not take age into account in their analysis, and this could 
be a potential source of confounding bias. Age is associated with both the assignment of 
surgical management strategy (older patients are more likely to receive ORIF with plate 
than Revision) and with the outcomes of transfusion, with older individuals being more 
likely to need transfusion; union, with older patients is less likely to progress to union due 
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to biological deficiencies; mortality, with older patients more likely to die, and re-
operation, where a surgeon’s inclination to offer re-operation after a Vancouver B2 PFF 
management strategy fails, may be less likely if the patient originally underwent ORIF as 
opposed to Revision.  
There is also a potential of bias associated with the review process, such as the 
inclusion of studies published in English only. In addition, the title and abstract screening 
was performed by one reviewer only. Therefore, it is possible that some studies were 




Strengths of the systematic review  
 
This systematic review was born out of the absence of high quality, randomised 
controlled studies in the published literature to advise management of Vancouver B2 
PFFs, which is an ever-more prevalent orthopaedic diagnosis. Regardless of the low 
quality of studies included, it represents the best available body of evidence to advise 
practice. It is the only systematic review on the topic which was guided by a published 
systematic review protocol (Ianunzio, Munn et al. 2017) and that included searching grey 
literature databases (in addition to published literature). Our systematic review’s rigour 
and comprehensiveness is highlighted by drawing comparisons with the recently 
published systematic review by Khan and colleagues, whereby our study encompasses 37 
studies including 926 patient fracture cases, representing over 250% greater content than 






Overall, no management strategies have been shown to be consistently superior for the 
outcomes included in this systematic review and meta-analyses. This best body of 
evidence does not provide support for one intervention method over another except to say 
that;  
• Revision with or without wires/cerclage/cables compared with ORIF with plate  
o ORIF with plate exposes patients to shorter surgical times and lower 
transfusion requirements 
o Outcomes of union, dislocation, attainment of pre-fracture mobility status 
and Parker mobility score should not be used to advise surgical 
management decision-making 
• ORIF any method compared with Revision any method 
o ORIF any method exposes patients to shorter surgical times  
o A non-statistically significant trend towards Revision any method being 
protective against re-operation exists and requires further investigation.  
• Outcomes of mortality and union should not be used to advise surgical 






Future studies require larger, prospective, preferably randomised studies with 
more precise reporting of population and exposure, outcome definitions and observational 
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Appendix I: Appraisal instruments 
 
JBI Critical Appraisal Checklist for Randomised Controlled Trials 
 
 
Yes No Unclear Not 
applicable 
 
1. Was true randomisation used for assignment of 
participants to treatment groups? 
 
    
2. Was allocation to treatment groups concealed?     
3. Were treatment groups similar at the baseline?     
4. Were participants blind to treatment assignment? 
 
    
5. Were those delivering treatment blind to 
treatment assignment?  
 
    
6. Were outcomes assessors blind to treatment 
assignment? 
    
7. Were treatments groups treated identically other 
than the intervention of interest? 
    
8. Was follow-up complete, and if not, were 
strategies to address incomplete follow-up 
utilised? 
    
 
9. Were participants analysed in the groups to which 
they were randomized? 
10. Were outcomes measured in the same way for 
treatment groups? 
11. Were outcomes measured in a reliable way? 
12. Was appropriate statistical analysis used? 
13. Was the trial design appropriate, and any 
deviations from the standard RCT design 
(individual randomisation, parallel groups) 
accounted for in the conduct and analysis of the 
trial?  




JBI Critical Appraisal Checklist for Quasi-Experimental 
 
 
Yes No Unclear Not 
applicable 
 
1. Is it clear in the study what is the ‘cause’ and 
what is the ‘effect’ (i.e. there is no confusion 
about which variable comes first)?  
 
    
2. Were the participants included in any 
comparisons similar?  
    
3. Were the participants included in any 
comparisons receiving similar treatment/care, 
other than the exposure or intervention of 
interest? 
    
4. Was there a control group?  
 
    
5. Were there multiple measurements of the 
outcome/conditions both pre and post the 
intervention/exposure?  
 
    
6. Was follow-up complete, and if not, was 
follow-up adequately reported and strategies to 
deal with loss to follow-up employed?  
 
    
7. Were the outcomes of participants included in 
any comparisons measured in the same way?  
    
 
8. Were outcomes measured in a reliable way? 
 
9. Was appropriate statistical analysis used? 





JBI Critical Appraisal Checklist for Cohort Studies  
 Yes No Unclear Not 
applicable 
1. Were the two groups similar and recruited 
from the same population? 
 
    
2. Were the exposures measured similarly to 
assign people to both exposed and unexposed 
groups? 
    
3. Was the exposure measured in a valid and 
reliable way? 
    
4. Were confounding factors identified? 
 
    
5. Were strategies to deal with confounding 
factors stated?  
 
    
6. Were the groups/participants free of the 
outcome at the start of the study (or at the 
moment of exposure)?  
 
    
7. Were the outcomes measured in a valid and 
reliable way?  
 
    
8. Was the follow-up time reported and sufficient 
to belong enough for outcomes to occur? 
    
9. Was follow-up complete, and if not, were the 
reasons to loss to follow-up described and 
explored? 
 
10. Were strategies to address incomplete follow-
up utilised? 
 
    






JBI Critical Appraisal Checklist for Case Control Studies  
 Yes No Unclear  Not applicable 
1. Were the groups comparable other than 
the presence of disease in cases or the 
absence of disease in controls? 
    
2. Were cases and controls matched 
appropriately? 
    
3. Were the same criteria used for 
identification of cases and controls? 
    
4. Was exposure measured in a standard, 
valid and reliable way? 
 
    
5. Was exposure measured in the same 
way for cases and controls? 
 
    
6. Were confounding factors identified?  
 
    
7. Were strategies to deal with 
confounding factors stated? 
 
    
8. Were outcomes assessed in a standard, 
valid and reliable way for cases? 
    
9. Was the exposure period of interest long 
enough to be meaningful? 
 
    






JBI Critical Appraisal Checklist for Analytical Cross Sectional Studies 
 Yes No Unclear Not 
applicable 
1. Were the criteria for inclusion in the sample 
clearly defined? 
    
2. Were the study subjects and the setting 
described in detail? 
    
3. Was the exposure measured in a valid and 
reliable way? 
    
4. Were objective, standard criteria used for 
measurement of the condition? 
 
    
5. Were confounding factors identified? 
 
    
6. Were strategies to deal with confounding 
factors stated? 
 
    
7. Were the outcomes measured in a valid and 
reliable way? 
    
 





JBI Critical Appraisal Checklist for Case Series   
 Yes No Unclear Not 
applicable 
1. Were there clear criteria for inclusion in the 
case series?  
  
    
2. Was the condition measured in a standard, 
reliable way for all participants included in the 
case series? 
 
    
3. Were valid methods used for identification of 
the condition for all participants included in 
the case series? 
 
4. Did the case series have consecutive inclusion 
of participants?  
 
 
5. Did the case series have complete inclusion of 
participants? 
 
    
6. Was there clear reporting of the demographics 
of the participants in the study? 
 
    
7. Was there clear reporting of clinical 
information of the participants? 
    
 
8. Were the outcomes or follow-up results of 
cases clearly reported?  
    
 
9. Was there clear reporting of the presenting 
site(s)/clinic(s) demographic information? 
 
    
10. Was statistical analysis appropriate?  
 




Appendix II: Data extraction instrument  
 
JBI Data Extraction Form for Experimental / Observational Studies 
 
Reviewer _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ Date _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
_ _ _ 
Author _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _  Year _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 
_  
Journal _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _  Record Number _ _ _ _ _ _ _ _ _ _ _ _ 
_ _  
Study Method 
RCT                     ☐ Quasi-RCT  ☐  Longitudinal  ☐ 













Outcome Intervention (    ) 
number/total number 







Outcome Intervention (    ) 
number/total number 










Appendix III: List of excluded studies after full-text reading. 
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Reason for exclusion: Study included mixed interventions (check number 3) (n=1) 
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Participants Mixed cohort 
of patients with PFF, n=43 
Vancouver B2  
Sampling: Unclear 
Recruitment: 2000-2005 
Indication index NS 
Index implant details NS  
Mechanism injure Minor 
trauma 103/106 (97.2%) 
Motor vehicle accident 
3/106 (2.8%) 
Fracture diagnosis method 
Radiographs and intra-
operative assessment 
Setting Multi-centre. Two 
tertiary trauma centres 
Boston, Massachusetts, 
USA 
Inclusion criteria Patients 
with a PFF treated 
operatively 
Exclusion criteria Nil 
Exposure A Revision +/- 
W/C/C (n=38) (Revision long 
stem, uncemented, posterior 
approach, implant NS, Zimmer) 
Exposure B ORIF with plate 
(n=5) 
(lateral locking plate, implant 
NS, company NS) 
Allocation of exposure 
Surgeon preference 
Surgeon experiential level NS 



















A: 6/38 (15.8%)  
B: 3/5 (60%)  




















exists i.e. it 









Revision or ORIF 
based on surgeon 
preference.  
For the association 
under study there 
was no attempt to 




patients more likely 
to receive ORIF and 




mortality and ORIF 
is potentially 
confounded by 
factors such as age 
and comorbidities, 














Participants Cohort of 




Indication index NS 
Index implant details THA 
(see later)  
Mechanism injury Low 
energy fall 
Exposure A Revision +/- 
W/C/C (n=14) (Revision 
uncemented distally fixed long 
stem and cables, anterolateral 
approach, Helios, Biomet) M:F 
3:11 Mean age in years: 81 
(SD 9) Index implant  
Cemented: Uncemented 1:13 
Exposure B   Revision +/- 



















mobility status A: 8/14 
(57.1%) B: 7/14 (50%) C: 
5/8 (62.5%) 
Dislocation A: 1/14 (7.1%) 
B: 2/14 (14.3%) C: 0/8 (0%) 
Infection (DSSI or SSSI) A: 
1/14 (7.1%) 











Patient allocation to 
Revision or ORIF 
was NS. 
For the associations 
under study there 
was no attempt to 






Fracture diagnosis method 
Trauma surgeon (author) 
Setting Single-centre 
Tertiary hospital Vienna, 
Austria 
Inclusion criteria Patients 
with a Vancouver B2 PFF 
around a THA   Exclusion 
criteria Pathological 
fractures 
Index procedure hip HA 
distally fixed long stem and 
cables, anterolateral approach 
Hyperion, Biomet)  
M:F 6:8 Mean age in years: 
80 (SD 9) 
Index implant Cemented/ 
uncemented 1:13 
Exposure C ORIF with plate 
(n=8) (Locking compression 
plate (4.5mm LCP, Synthes) 
M:F 1:7 Mean age in years: 
85 (SD 8) Index implant 
Cemented/ uncemented: 0:8 
Allocation of exposure: NS 
Surgeon experiential level NS 
Weight bearing status 
For Exposure A and B Early 
mobilization with two crutches 
or walker OR  Partial OR full 
weight bearing immediately 
post-operatively (no protocol 
specified) 
For Exposure C Partial weight 
bearing (20kg) with 2 crutches 
or walker for 6 weeks, then in 
absence or pain and XR 
supportive of healing upgraded 
to full weight bearing  
Venous thromboembolism 
prophylaxis Low molecular 
weight heparin until full weight 
bearing 
Surgical antibiotic 










(pre and post 
op)  
-Subsidence -





























A, B and 
C) 
 
Infection DSSI A: 1/14 
(7.1%) B: Not reported C: 
0/8 (0%) 
Infection SSSI A: Not 
reported B: 1/14 (7.1%) C: 
0/8 (0%) 
Length of stay (days) A: 26 
(SD 14, Range 11-55) B: 29 
(SD 16, Range 19-70) C: 26 
(SD 13, Range 11-49) p-
value=0.4748 
Mortality overall A: 0/14 
(0%) B: 0/14 (0%) C: 0/8 
(0%) 
Neurovascular injury A: 
0/14 (0%) B: 0/14 (0%) C: 
0/8 (0%) 
Parker mobility score post-
operatively A: 6.5 (SD 2, 
Range 4-9) B: 6.35 (SD 2, 
Range 4-9) C: 6.62 (SD 2, 
Range 4-9) p-value=0.2940 
*Note: Parker mobility 
score pre-operatively  A: 
6.8 (SD 1.7, Range 4-9) B: 
6.99 (SD 1, Range 5-9) C: 7 
(SD 1.2, Range 4-9) p-
value=0.6513 
Subsidence A: 0/14 (0%) B: 
0/14 (0%) C: 0/8 (0%) 
Surgical time (‘surgical 
duration’ mins) A: 190 (SD 
47, Range 135-355) 
B: 191 (SD 35, Range 130-
260) C: 151 (SD 48, Range 
90-205) p-value=0.1025 
Transfusion (1 or more 
units PRBC required 
within 48 hours surgery) A: 
12/14 (85.7%) B: 6/14 





C: 8/8 (100%) 






of the femoral 
shaft in order 
to ensure 
stem stability 
to the bone 






are more likely to 
receive ORIF and 
are more likely to 
die). 
The study did not 
present an analysis 
on anatomical 
fracture reduction to 
support their 
conclusions on this 
matter. In addition, 
the statistical 
approach to test the 
differences in binary 
outcomes e.g. 
transfusion was NS, 
although p-values 
were presented.  
Overall, the study 
reported that there 





lack of a statistically 
significant 
difference could be 







DVT A: 0/14 (0%) B: 0/14 
(0%) C: 0/8 (0%) 
PE A: 0/14 (0%) B: 0/14 




















Participants Mixed cohort 
of patients with PFF, n=158 
Vancouver B2  
Sampling NS 
Recruitment 1999-2000 
Indication index NS 




Mechanism injury Not 
explicit - minor trauma 70-
80% 
Fracture diagnosis method 
Radiographs (surgeon and 
radiologist) 
Setting Multi-centre 








Inclusion criteria Patients 
with a PFF around THA 
reported in national joint 
register 
Exclusion criteria Nil 
Exposure A Revision +/- 
W/C/C (n=49) (Majority 
cemented long stem, approach 
NS, no implant specified) 
Exposure B Revision mixed 
methods/unspecified (n=86) 
(Majority cemented long stem, 
ORIF technique NS, no implant 
specified) 
Exposure C ORIF mixed 
methods/unspecified (n=19) 
(Technique NS although 
authors state common practice 
single plate fixation, no implant 
specified) 
Allocation of exposure 
Surgeon preference 
Surgeon experiential level NS 





Note: Although no specific 
implant usage for Exposure 
groups, globally available 
exposure data advises 144/193 
(75%) of revision procedures 
were performed with a 
cemented long stem implant 
and  49/193 (25%) of revision 
procedures were performed 
with an uncemented long stem 
distally fixed implant. Only 2 

























A: 5/49 (10.2%) B: 20/86 












ORIF alone.  
The purpose of this 




results of treatment 
of periprosthetic 
fractures.  
For the association 
of type of treatment 
and re-operation, 
authors did not 
attempt to account 
for presence of 
confounding factors 
(e.g. older/frail are 
patients more likely 
to receive ORIF and 
may be at higher 
risk of developing 
complications 
resulting in the need 
for re-operation (e.g. 
malnutrition my lead 





utilised in Exposure 













Participants Mixed cohort 




Exposure A Revision (n=8) 
(Revision same length or longer 
stem, cemented or uncemented 












Union* A: 8/8 (100%) B: 8/8 
(100%) C: 2/2 (100%) 
Mortality overall* A: 4/8 







The purpose of this 
study was to 
compare the 
prevalence and 






Indication index NS 
Index implant details 
THA:HA 3:15 
Primary:Revision 18:0 
Stem All CPT (Cemented, 
polished tapered stems)  
Mechanism injury NS 
Fracture diagnosis method 
Radiographs (Senior 
revision hip surgeon) 
Setting Multi-centre 
Two tertiary centres  
Danderyd Hospital 
Stockholm and Sundsvall 
Hospital, Sweden 
Inclusion criteria Patients 
80 years and older 
sustaining a PFF within 24 
months of primary THA or 




M:F 3:5 Mean age in years: 
84.6 (Range 80.73-90.36, No 
SD) 
Time from index to fracture 
in years: 1.27 (9 days to 1748, 
No SD) 
Index implant  THA:HA 2:6 
Stem  All cemented CPT 
Follow up mean in months: 24 
(Range 20-1823 days, No SD 
stated) 
Exposure B 
Revision + ORIF plate (n=8)  
(Revision same length or longer 
stem, cemented and ORIF plate, 
direct lateral approach, no 
implant specified) M:F 3:5 
Mean age in years: 86.35 
(Range 80.97-92.63, No SD) 
Time from index to fracture 
in years: 1.05 (37 days to 1251, 
No SD) 
Index implant  THA:HA 1:7 
Stem  All cemented CPT 
Follow up mean in months: 
29 (Range 104-2094 days), No 
SD stated) 
Exposure C ORIF with 
W/C/C (n=2)  (ORIF with 
cerclage only, approach NS, no 
implant specified) M:F NS 
Mean age in years: 94.2 
(Range 94.1-94.3, No SD) 
Time from index to fracture 
in years: 2.3 (Range 762-926, 
No SD) 
Index implant  THA:HA 0:2 
Stem  All cemented CPT 
Follow up mean in months: 
14.6 (Range 158-732 days), No 
SD stated) 
Allocation of exposure NS 
Surgeon experiential level NS 











Mortality within 1 year* A: 
3/8 (37.5%) B: 2/8 (25%) C: 
0/2 (0%) 
Infection (DSSI or SSSI)* 
A: 3/8 (37.5%) B: 2/8 (25%) 
C: 0/2 (0%) 
Infection DSSI* A: 2/8 
(25%) B: 2/8 (25%) C: 0/2 
(0%) 
Infection SSSI* A: 1/8 
(12.5%) B: 0/8 (0%) C: 0/2 
(0%) 
Re-operation* A: 2/8 (25%) 
B: 2/8 (25%) 









PFFs in an 
octogenarian 
THA/HA cohort.  
The study indicates 
that there was no 
difference for 
between exposure 






however, given the 
small sample size 
and low incidence of 
these outcomes it is 


















Participants Mixed cohort 




Indication index NS 
Index implant details 
THA:HA 58:14 
Primary:Revision 56 (:15 
Cemented:Uncemented 55 
(40 primary THA, 15 
revision THA):17 (14 HA, 3 
primary THA)  
Stem  NS 
Mechanism injury All 
simple falls 




Tertiary hospital Leeds, 
United Kingdom 
Inclusion criteria Patients 
sustaining a PFF following 
THA or HA managed by a 
single surgeon at their 
institution 
Exclusion criteria NS 
Exposure A Revision +/- 
W/C/C (n=19) 
(Revision long stem, 
cemented/uncemented NS, 
approach NS, implant NS, 
company NS) 
Exposure B Revision + ORIF 
plate (n=8) 
(Revision long stem with ORIF 
Dynamic compression plate, 
cemented/uncemented NS, 
approach NS, implant NS, 
company NS) 
Exposure C Revision +/- 
W/C/C (n=15) (Revision with 
distally locked long stem, 
cemented/uncemented NS, 
approach NS, implant NS, 
company NS) 
Allocation of exposure Not 
explicit (Implies Vancouver 
algorithm used) 
Surgeon experiential level 
Consultant (single surgeon) 





























Subsidence A: Not reported 
B: Not reported C: 3/15 
(20%) 
Union A: 19/19 (100%) B: 
8/8 (100%) C: 14/15 (93.3%) 
Infection DSSI A: Not 
reported B: Not reported 
C: 2/15 (13.3%) 
Dislocation A: 0/19 (0%) B: 
0/8 (0%) C: 1/15 (6.7%) 
Modified Charnley-
D’Aubigne Postel score 
proportion of excellent 
outcome A: 14/19 (73.7%) 
B: 5/8 (62.5%) 
C: 6/15 (40%) 
Modified Charnley-
D’Aubigne Postel score 
proportion of poor outcome 
A: 0/19 (0%) B: 3/8 (37.5%) 

















The purpose of this 
study was to present 
a single surgeon’s 
series of PFF 
management.  
For the outcomes of 
subsidence and deep 
surgical site 
infection no 
conclusions can be 
drawn as authors 
only published 
outcome data for 
exposure group C.  
Regardless of 
exposure, the 




For the outcome of 
Modified Charnley 
D’Aubigne Postel 
score, Revision long 
stem (exposure A) 




when compared with 
Revision ORIF with 
plate (exposure B) 
and Revision with 
distally locked long 
stem (exposure C). 









Local records  
 
Participants Mixed cohort 
of patients with PFFs, n=52 
B2 
Sampling Unclear (appears 
consecutive) 
Recruitment 1995-2007 
Indication index NS 
Index implant details NS 
Exposure A Revision +/- 
W/C/C (n=25) (Revision stem 
only, approach NS, implant NS, 
company NS) 
Exposure B Revision mixed 
methods/unspecified (n=27) 
(Revision stem and cortical 
















Union overall A: 23/25 
(92%) B: 26/27 (96.2%) 
C: 6/10 (60%) D: 3/4 (75%) 
Time to union (months) 
A: 5 (SD 2.2, Range NS) B: 
4.26 (SD 1.9, Range NS) 
p-value=0.218 







rarely has a 
role as the 
The aim of this 
study was to 
evaluate treatment 
methods of PFF 





Mechanism injury NS 
Fracture diagnosis method 
Not explicit 
Setting Multi-centre 
Two arthroplasty centres, 
UK (note no explicit 
location specified) 
Inclusion criteria Patients 
with a PFF around a THA 
treated operatively 
Exclusion criteria Lost to 
follow-up or deceased for 
reasons not related to 
surgery (19/202 including; 
15/81 (18.5%) B2, 3/18 
(16.7%) B1, 1/107 (0.93%) 
B3) 
approach NS, implant NS, 
company NS) 
Exposure C ORIF with plate 
(without bone grafting) 
(n=10) Single or double plating, 
no implant specified, no 
company specified) 
Exposure D ORIF with plate 
(with bone grafting) (n=4) 
Single or double plating, with 
bone grafting, no implant 
specified, no company 
specified) 
Allocation of exposure NS 
(although implies Vancouver 
algorithm) 
Surgeon experiential level NS 





Note: Although no specific B2 
demographic data provided 
pooled data published Sex M:F 
76:145 Age at surgery (mean): 





































B, C, D) 
A: 4.3 (SD 1.9, Range NS) 
C: 8.8 (SD 4.0, Range NS) p-
value=0.038 
Time to union (months) A: 
4.3 (SD 1.9, Range NS) 
D:4.4 (SD 0.5, Range NS) p-
value=0.736 
Time to union (months) B: 
5 (SD 2.2, Range NS) C: 8.8 
(SD 4.0, Range NS) p-
value=0.067 
Time to union (months) 
B: 5 (SD 2.2, Range NS) D: 
4.4 (SD 0.5, Range NS) p-
value=0.298 
Time to union (months) 
C: 8.8 (SD 4.0, Range NS) 
D: 4.4 (SD 0.51, Range NS) 
p-value=0.043 
Non-union overall 
A: 2/25 (8%) B: 1/27 (3.7%) 
C: 4/10 (40%) 
D: 1/4 (25%) 
Non-union A vs B 
OR 2.26 (0.19-26.6 95%CI)  
p-value=0.517 
Non-union A vs C 
OR 7.7 (1.12-52.32 95% CI)  
p-value=0.038 
Non-union A vs D 
OR 3.83 (0.26-56.2, 95% CI)  
p-value=0.327 
Non-union B vs C 
OR 17.3 (1.63-184.4, 
95%CI)  p-value=0.018 
Non-union B vs D 
OR 8.7 (0.43-177.3, 95%CI)  
p-value=0.1 
Non-union D vs C 
OR 2 (0.15-26.7 95%CI)  
p-value=0.6 
Dislocation A: 3/25 (12%) 
B: Not reported C: 0/10 (0%) 





































Revision appears to 
be protective against 
non-union when 
compared to ORIF 





not controlled for by 
study authors.  
Although this study 
reports statistically 
significant 
differences in time 
to union (shorter), 
and non-union 
(lower incidence) 
for Revision stem 
(exposure group A) 
and ORIF plate 
without bone graft 
(exposure group C), 
and non-union 
(lower incidence) 
for Revision stem 
and cortical strut or 
impaction 
allografting 
(exposure group B) 
and ORIF plate 
without bone graft), 
there was no attempt 
to account for 
presence of 
confounding factors 
(e.g. older/frail are 
patients more likely 
to receive ORIF and 
are more likely to be 
exhibit poor healing 
potential and thus a 
higher propensity 
for non-union and 




Infection (DSSI or SSSI) A: 
2/25 (8%) B: 0/27 (0%) C: 
0/10 (0%) D: 1/4 (25%) 
Infection DSSI A: Not 
reported B: 0/27 (0%) C: 
0/10 (0%) D: Not reported 
Infection SSSI A: Not 
reported B: 0/27 (0%) C: 
0/10 (0%) D: Not reported 
of union, time to 
union and non-union 
difficult.  
Additionally, the 
influence of bone 
graft utilisation it 
self may confound 
comparisons 
between Revision 
and ORIF given the 
absence of a 
statistically 
significant between 
exposure groups B 
and D for outcome 
of non-union. Study 
authors did not state 
why 14 Vancouver 
type B2 PFFs 
underwent ORIF 
despite them 
implying usage of 
Vancouver 
algorithm, authors 
imply one indication 
for such ORIF is 




For the outcomes of 
Dislocation there 
appears to be higher 
rates in ORIF plate 
with bone graft 



























Local records  
 
Participants Cohort of 
patients with Vancouver B2 
PFF, n= 21 
Sampling Unclear 
Recruitment 2000-2010 
Indication index NS 
Index implant details See 
exposure 
Mechanism injury NS 
Fracture diagnosis method 
Radiographs, ERBA 
Setting Single-centre 
Tertiary hospital Adelaide, 
South Australia 
Inclusion criteria Patients 
with a Vancouver B2 PFF 
(assessed as loose at stem-
cement interface only 
(except for major fracture 
lines), with anatomical 
reduction deemed possible) 
around cemented, collarless 
polished tapered femoral 
stem treated operatively 
Exclusion criteria Death 
pre-operatively (1), 
concomitant acetabular 
revision for loosening (1) 
 
Exposure A ORIF with plate 
(n=12) (ORIF cable ready plate 
with non-locking screws, lateral 
approach to femur, Zimmer) 
M:F 7:5 Mean age in years: 
79 (Range 57-89, No SD 
reported) 
ASA 2:4/12 (33%), 3:5/12 
(42%), 4:3/12 (25%) 
Time from index to fracture 
in years median: 2.4 (Range 
0.08-16, No SD) 
Primary:Revision 12:0 
Cemented:Uncemented 12:0  
Stem  CPT: 6, Exeter: 6 
Lost to follow-up n=3 
Exposure group A (death prior 
to 3 months post op due to 
medical causes unrelated to 
surgery – excluded from 
published data, reported here) 
Exposure B Revision +/- 
W/C/C (n=9) 
(Revision long stem, cemented 
with cables (4) or Revision 
distally fixed long stem, 
uncemented with cables (5), 
posterior approach, implant NS, 
company NS. M:F 4:5 Mean 
age in years: 71 (Range 39-88, 
No SD reported) 
ASA 2:3/9 (33%), 3:4/9 (44%), 
4:2/9 (22%) 
Time from index to fracture 
in years median: 0.96 (Range 
0.03-17, No SD) 
Primary:Revision 7:2 
Cemented:Uncemented 9:0 
Stem  CPT: 4, Exeter: 5 
Lost to follow-up n=2 
Exposure group B (death prior 














































































Surgical time - Skin to skin 
median (Wasko and 
Kaminski)  A: 122 (SD not 
stated, Range 80-165) B: 200 
(SD not stated, Range 142-
285) p-value=0.002 
Surgical time - Skin to skin 
mean (Wasko and 
Kaminski) (generated by 
author JI) A: 125.4 (SD 
27.8, 80-165) B: 196 (SD 
51.4, 142-285) 
Surgical time - Operating 
theatre time median 
(Wasko and Kaminski) A: 
183 (SD not stated, 143-239) 
B: 270 (SD not stated, 206-
352) p-value=0.002 
Surgical time – Operating 
theatre time mean (Wasko 
and Kaminski) (generated 
by author JI) A: 199 (SD 
33.2, 143-239) 
B: 275 (SD 50.1, 206-352) 
Transfusion – Number 
packed red blood cells 
required median (units) 
A: 0 (SD not stated, 0-4) 
B: 3 (SD not stated, 0-5) 
p-value=0.008 
Transfusion – Number 
packed red blood cells 
required mean (units) 
(generated by author JI) A: 
0.4 (1.33, 0-4) B: 3 (SD 1.74, 
0-5) 
Subsidence 6mm or more 
A: 0/9 (0%) B: 1/7 (14.3%) 
Union A: 9/9 (100%) B: 6/7 






























times, as well 
as the direct 











The aim of this 











stems treated either 
by ORIF alone or 
revision surgery. 
For the sub-group of 
Vancouver B2 PFF 
around CCPT stems 
the study 
demonstrates shorter 
time in operating 
theatre and skin to 
skin surgical time. 
Having said this, 
authors did not 
account for 
confounders such as 
method of 
anaesthesia (general 






may have impacted 




anaesthesia time is 
difficult to make as 
283 
 
medical causes unrelated to 
surgery – excluded from 
published data, reported here) 
Allocation of exposure NS 
Surgeon experiential level 
Exposure A – Consultant 
surgeon or trainee under direct 
supervision by consultant. 
Exposure B – Consultant 
surgeon experienced in hip 
revision 
Weight bearing status 
Exposure A – Partial 
weightbearing 20kg for first six 
weeks progressing to full 
weightbearing 
Exposure B – Uncemented - as 
for exposure A. Cemented – 
weight bear as tolerated 








Non-union A: 0/9 (0%) B: 
Not reported 
Femoral osteolysis A: 0/9 
(0%) B: 0/7 (0%) 
Infection (DSSI or SSSI) A: 
0/9 (0%) B: 0/7 (0%) 
Infection DSSI A: 0/9 (0%) 
B: 0/7 (0%) 
Infection SSSI A: 0/9 (0%) 
B: 0/7 (0%) 
Dislocation A: 1/9 (11%) B: 
2/7 (28.6%) 
Delayed wound healing A: 
0/9 (0%) B: Not reported 
Harris Hip Score mean 
(post op) at latest follow-up 
A: 59 (SD 23, 36-96) n=5 B: 
72 (SD 11.3, 36-96) n=4 
Harris Pain score mean 
(post op) at latest follow-up 
A: 40.5 (SD 8.4, 20-44) n=8 
B: 31.1 (SD 15.2, 10-44) n=7 
Attain pre-fracture 
mobility status A: 3/8 
(37.5%) B: 5/7 (72%) 
Mortality within 3months* 
A: 3/12 (25%)  B: 2/9 (22%) 
Mortality overall* A: 3/12 























better in the 
















it was not explicitly 
studied or how the 
anaesthetic time was 





ORIF reduces direct 
cost of the 
procedure, they have 
not provided 
economic analysis to 
validate this. 
Authors conclude 
that ORIF is attracts 
lower operative risks 
when compared with 
Revision, however, 
it is not clear which 
of their outcome 
variables they are 
referring to.  
Transfusion 
requirement of 
packed red blood 
cells was lower in 
the ORIF group 
compared with 
Revision, however, 
the authors did not 
account for presence 
or absence of other 
transfusion 
approaches such as 
use of cell saver 
intra-operatively. 
Functional outcomes 
including Harris Hip 
Score and Harris 
Pain Score were 
conflicting with 
ORIF having 






superior Harris hip 
scores. Furthermore, 
the revision cohort 
was associated with 
a higher incidence 
of attaining pre-
fracture mobility 
status. It would 
appear that revision 
promoted superior 
functional outcomes 
however, in the 
absence of pre-
operative Harris hip 
and pain scores it is 
difficult to make 
such a conclusion. It 
is unclear why the 




for these outcomes.  
Mortality within 3 
months was similar 





was higher in ORIF 
group. This may be 
reflected by the 
ORIF group being 
older (mean age 8 
years greater in 
ORIF group) or 
given they received 
ORIF they are likely 
frailer and thus more 
likely to die. 
Regardless of 
exposure, the 



















Local records  
 
Participants Mixed cohort 




Indication index NS 
Index implant details NS  
Mechanism injury Mostly 
minor trauma 
Fracture diagnosis method 
Radiographs 
Setting Single-centre, 
Tertiary hospital, Verona, 
Italy 
Inclusion criteria Patients 
admitted to local hospital 
with a PFF managed 
operatively 
Exclusion criteria Non-
operatively managed PFF  
Lost to follow-up 1 patient 
died prior to follow-up 
Exposure A ORIF with plate 
(n=6) (ORIF plate and cerclage, 
approach NS, predominantly 
cable ready plate, no company 
specified) 
Index implant details 4 
straight stem (3 cemented) 2 
anatomic stem (not stated 
cemented or uncemented) 
Exposure B ORIF with 
W/C/C (n=1) 
(ORIF cerclage wires only, 
approach NS, implant NS, 
company NS 
Allocation of exposure 
Vancouver algorithm with 
deviation based on age and 
surgeon experiential level 
Surgeon experiential level NS 
Weight bearing status 
Assisted and delayed weight 






Note: Although no specific B2 
demographic data provided 
pooled data published Age at 
surgery (mean): 75.5 (no SD 




















-Pre op and 








Nil specific to 
B2.  
Pooled (n=61) 
















A+B: Pooled results only  
3.6 units packed red blood 
cells per patient 
Mortality A: 1/6 B: Not 
reported 
Aseptic loosening femur A: 
Incomplete reporting B: Not 
reported 
Re-operation A: 2/6 (33%)  
[0/4 (0%) straight stem, 2/2 
(100%) anatomic stem] B: 
0/1 (0%) 
Union A: 5/6 (83%) 
[4/4 (100%) straight stem, 
1/2 (50%) anatomic stem B]: 
0/1 (0%) 
Complications A: 3/6 (50%) 
[1/4 (25%) straight stem, 2/2 
(100%) anatomic stem] B: 
0/1 (0%) 
Beals and Towers’ criteria 
proportion of excellent 
outcome 
A: 3/6 (50%) [3/4 (75%) 
straight stem, 0/2 (0%) 
anatomic stem] B: 0/1 (0%) 
Beals and Towers’ criteria 
proportion of good outcome 
A: 1/6 (16.7%) [1/4 (25%) 
straight stem, 0/2 (0%) 
anatomic stem] B: 0/1 (0%) 
Beals and Towers’ criteria 
proportion of poor outcome 
A: 2/6 (33%) [0/4 (0%) 
straight stem, 2/2 (100%) 
anatomic stem] B: 1/1 
(100%) 
Ambulatory status post-





the results of 
the current 
study, ORIF 






(Fig. 3). As 
the straight 
stem does not 
need to fit 
and fill the 
femoral canal, 
but relies on a 
press fit 
concept, it 





The study aimed to 
report the causes of 
failure in 61 PPFs.  
 
The utility of this 
study is limited by 
its small sample 
size.  
ORIF of anatomic 
stems - terrible 
outcome 100% re-
operation rate. 
Unclear if these are 
cemented or not.  
Avoid ORIF in 






without aids A: 2/5 (40%) 
B: 0/1 (0%)  
Pain free post op (self 
assessed) A: 4/6 (66%) 
B: 0/1 (0%) 
Pre-op and post op 
perceived Quality of life 
(self assessed) A: Mean 8 
pre-op, Mean 6 post op B: 
Not reported 












Participants Mixed cohort 




Indication index OA 33/54 
(61%), NOF # 15/54 (28%), 
DDH 3/54 (5.5%), Other 
3/54 (5.5%) 
Index implant details NS  
Mechanism injury Minor 
trauma: 46/54 (85%), Major 
trauma: 2/54 (4%), 
Spontaneous: 6/54 (11%) 




Tertiary hospital Auckland, 
New Zealand.  
Inclusion criteria Patients 
suffering a post-operative 
PFF around a THA treated 
at local institution 
Exclusion criteria Intra-
operative PFFs 
Lost to follow-up 21 
patients not assessed due to 
20 deaths and 1 patient 
leaving region 
Exposure Revision +/- W/C/C 
(n=10) Revision long stem 
uncemented (9), cemented (1), 
with or without cerclage. In 
2/10 cases Acetabular cup 
revised, approach NS, implant 
NS, company NS.   
Allocation of exposure NS, 
implies Vancouver algorithm   
Surgeon experiential level NS 









































Union 10/10 (100%) 
Heterotopic ossification 
1/10 (10%) 
Aseptic loosening femur 
1/10 (10%) 
Dislocation 2/10 (20%) 
Re-operation 2/10 (20%) 
Repeat revision femoral 
component 0/10 (0%) 
Harris hip score (post-
operative) mean 
69.1 (No SD reported) n=8 
Oxford hip score (post-
operation) 
31.7 (No SD reported) n=7 
Mortality within 6 months 



















The objective of this 
study was to review 
all periprosthetic 
fractures at a single 
institution to 
identify injury and 
treatment patterns 
and their associated 
clinical outcomes. 
This study has not 
tested for the stated 
conclusion 
regarding 
Vancouver B2 PFF 
management. 












Participants Mixed cohort 




Exposure A Revision +/- 
W/C/C (n=11) Revision same 
length stem, 
cemented/uncemented NS, 











Mortality overall A: 4/11 
(36%) B: 3/9 (33%) C: 1/6 
(17%) 
 Nil specific 
to B2 
fractures.  
The purpose of this 
observational study 
was to determine the 














Stem  NS 
Fracture diagnosis method 
Radiographs and intra-
operative assessment 
Setting Multi-centre, Two 
tertiary hospitals Goningen 
and Zwolle, Netherlands 
Inclusion criteria Patients 
with a PFF treated at either 
centre with complete 
medical records and 
radiographs available 
Exclusion criteria Nil. 
Note:  
8 patient records incomplete 
hence not included 35/71 
lost to follow-up (32 deaths, 
1 migration, 2 cognitively 
impaired couldn’t answer) 
company NS M:F 9:2 Mean 
age in years: 71.4 (Range 47-
90, No SD reported) 
Time from index to fracture 
in years mean: 7.7 (Range 1-
14, No SD reported) 
Indication index OA 8/11 
(73%), NOF # 2/11 (18%), 
AVN 1/11 (0.9%) 
Cemented:Uncemented NS 
Mechanism injury Minor 
trauma 11/11 (100%) 
Exposure B Revision mixed 
methods/unspecified (n=9) 
Revision stem (length NS), 
cemented/ uncemented NS, 
ORIF with plate OR cerclage, 
approach NS, implant NS, 
company NS M:F 1:8 Mean 
age in years: 78.1 (Range 67-
86, No SD reported) 
Time from index to fracture 
in years mean: 9 (Range 0.75-
17.3, No SD reported) 
Indication index OA 6/9 
(67%), NOF # 2/9 (22%), RA 
1/9 (11%) 
Cemented:Uncemented NS  
Mechanism injury Minor 
trauma 9/9 (100%) 
Exposure C ORIF mixed 
methods/unspecified (n=6) 
ORIF, technique NS, implant 
NS, company NS M:F 2:4 
Mean age in years: 68.8 
(Range 50-82, No SD reported) 
Time from index to fracture 
in years mean: 3.8 (Range 
0.08-10.8, No SD reported) 
Indication index OA 6/6 
(100%) 
Cemented:Uncemented NS  
Mechanism injury Minor 
trauma 5/6 (83%), Major 






















Complications A: 6/11 
(55%) B: 4/9 (44%) C: 4/6 
(67%) 
Re-operation A: 3/11 (27%) 
B: 3/9 (33%) C: 2/6 (33%) 
Oxford hip score (post-
operatively) A: 28 (SD 8.5, 
18-39) n=7 B: 27 (SD 10.6, 
19-42) n=5 






over a long period of 
time. Authors state 
re-operation 
outcome (2/6 (33%)) 
amongst Vancouver 
B2 PFFs undergoing 
ORIF may have 
been better if the 
Vancouver 
algorithm was not 
deviated from.   
Mortality rate 
overall was lower in 
the ORIF exposure 
arm, however, this 
could in part be 
explained by the fact 
the mean age was 
approximately 9.3 
years less than 
exposure B and 2.6 




incidence rates of 
complications, re-
operation and mean 
Oxford hip scores 
were similar. 
For the association 
under study there 
was no attempt to 




patients more likely 
to receive ORIF and 




Note: In mixed cohorts of PFF, on most occasions demographic data (sex and age) was not stratified by fracture type and therefore global data presented in the table.  
# Denotes SD estimated by method of Hozo 
*Raw data utilised NS: Not specified 
  
Allocation of exposure 
Vancouver algorithm with some 
deviation) 
Surgeon experiential level NS 























Participants Mixed cohort of 
patients with PFF, n=66 (87%) B2  
Sampling Unclear 
Recruitment 2000-2012 
Indication index NS 




Index stem  NS 
Mechanism injury NS 
Fracture diagnosis method 
Radiographs pre-op and intra-
operative assessment by senior 
surgeon 
Setting Single-centre 
Tertiary hospital Santiago, Chile  
Inclusion criteria Vancouver B2 
or B3 PFF undergoing Revision 
THA with minimum 2 years 
follow-up 
Exclusion criteriaTumour disease 
or Active/previous surgical site 
infection. Non-operative or ORIF 
management 
Lost to follow-up 5 excluded as 
<2 year follow-up 
Exposure A Revision mixed 
methods/unspecified (n=66) 
Revision longer stem (distal press 
fit), uncemented +/- cerclage, +/- 
cortical strut allograft (n=18/76) +/- 
acetabular revision (if cup loose) 
(n=24/76), lateral approach, ETO, 
ZMR cone type modular stem (for 
B2), Zimmer 
Allocation of exposure 
Not explicit (Implies Vancouver 
algorithm) 
Surgeon experiential level 
Experienced arthroplasty surgeons 
Weight bearing status 
Touch weight bear 8-10 weeks then 




Surgical antibiotic prophylaxis NS 
Note: Although no specific B2 
demographic data provided pooled 
data published: Sex M:F 28:48 Age 



















































Mortality overall at 2 years 
(B2 only) 6/66 (10%) 
Implant survival 
5 yr (failure endpoint) 
89.6% (82.2-97 95% CI) n=29 
at risk 
Failure (any complication 
requiring revision surgery) 
7/76 (9.2%) 
Aseptic loosening femur 
5/76 (6.6%) 
PFF post-op 2/76 (2.6%) 
Infection DSSI  
3/76 (3.9%) 
Complications 4/76 (5.3%) 
Dislocation 4/76 (5.3%) 
SF-12 (Mental score) Mean  
55 (SD 8.1, 31-68) 
SF-12 (Physical score) Mean  




was low.  
Our study has 
some 
limitations. 
First, it is a 
retrospective 






















the study was 
to report 
results and 






























Participants Mixed cohort of 
patients with PFF, n=17 B2  
Sampling Unclear 
Recruitment 1995-2005 
Indication index NS 




Index stem  
Exeter polished taper stem 22/23 
(96%) 
Charnley 1/23 (4%) 
Mechanism injury NS 
Fracture diagnosis method 
Radiographs and intra-operative 
assessment (bone-cement interface 
stable except for main fracture 
lines) 
Setting Single-centre 
Tertiary hospital Portsmough, 
United Kingdom 
Inclusion criteria Patient’s with 
PFF undergoing cement in cement 
revision arthroplasty 
Exclusion criteria Unable to 
attend clinic beyond 6 weeks due 
to frailty (1) Death <6 months post 
op (prior to union) (3) 
Exposure A Revision mixed 
methods/unspecified (n=17) 
Revision same or longer stem, 
cement in cement,  
+/- Cerclage OR cables alone 
(n=10/17)  
+/- ORIF plate (n=7/17) incl 3 with 
autologous bone graft, extended 
posterior approach, Exeter stem, 
Stryker 
Allocation of exposure 
Surgeon selection based on age, 
comorbidities, radiographic and intra 
op appearance bone-cement interface 
Surgeon experiential level NS 
Weight bearing status NS (Note 
globally (n=23) mean time to partial 
weight bear 3.6 days, full weight 
bear 31 days (no range given) 
Venous thromboembolism 
prophylaxis NS 
Surgical antibiotic prophylaxis NS 
Note: Although no specific B2 
demographic data provided pooled 
data published  
ASA 1: 1/23 (4.3%), 2: 13/23 (57%), 
3: 7/23 (30%), 4: 2/23 (8.7%) 
Time from index to fracture years 




























12/13 (92%) (Note 4 not 








there is a valid 






































































Participants Mixed cohort of 
patients with PFF, n=8 B2  
Sampling Convenience  
Recruitment 2000-2009 
Indication index NS 
Fracture diagnosis method 
Pre-op radiographs and intra-
operative notes 
Setting Single-centre 
Tertiary hospital Istanbul, Turkey 
Inclusion criteria Patients with 
Vancouver B2 or B3 PFF 
undergoing revision hip 
arthroplasty 
Exclusion criteria NS  
 
Exposure A Revision +/- W/C/C 
(n=8) (Revision distally fixed long 
stem, uncemented extensively 
pourous coated 
+/- cup revision if loose 
+/- conversion to THA for pre-
existing bipolar HA, posterolateral 
approach, implant not specific 
(Eschelon, Smith and Nephew 12/17, 
ZMR, Zimmer 5/17) M:F 5:3 
Mean age in years: 71.5 (Range 49-
87, No SD reported) 
Time from index to fracture in 
years mean: 3.5 (Range 0.17-12, No 
SD reported) 































Union 8/8 (100% 
Dislocation 1/8 (12.5%) 
Infection SSSI 1/8 (12.5%) 
Harris Hip Score  
(post-operative) mean 
71.4 (SD 17, 40-85) 
Barthel ADLs index mean 
73.8 (SD 25, 30-100) 
Beals and Towers’ Criteria 
proportion of excellent 
outcome 4/8 (50%) 
Beals and Towers’ Criteria 


































4 (2 cemented, 2 uncemented):4 (3 
cemented and 1 uncemented) 
Primary:Revision NS 
Index stem  NS 
Mechanism injury Minor trauma: 
4/8 (50%) Major trauma: 1/8 (12.5%) 
Spontaneous: 3/8 (37.5%) 
Allocation of exposure NS 
Surgeon experiential level NS 
Weight bearing status NS 
Venous thromboembolism 
prophylaxis NS 




90, SD not 
reported) 
Beals and Towers’ Criteria 























Participants Cohort of patients 
with Vancouver B2 PFF, n=31 
Sampling Unclear 
Recruitment 1996-2007 
Indication index NS 
Index implant details THA:HA 




Index stem NS except AM 
Mechanism injury 
Minor trauma: 18/31 (58%) 
Spontaneous: 4/13 (13%) 
Unclear traumatic event: 9/31 
(29%) 
Fracture diagnosis method  
Pre-op radiographs  
Setting Single-centre 
Tertiary hospital Ontario, Canada 
Inclusion criteria 
Patients with Vancouver B2 PFF 
undergoing cemented long stem 
revision arthroplasty with or 
without allograft or plate fixation 
Exclusion criteria NS 
Loss to follow-up  n=11/31(35%) 
(8 deaths <6 months, 3 lost after 3 
months post op – reason NS) 
Exposure A Revision mixed 
methods/unspecified (n=31) 
(Revision long stem, cemented, 
direct lateral approach 
+/- cortical strut allografts n=24/31 
(77%) 
+/- ORIF plate n=1/31 (3.2%) 
+/- Acetabular cup revision n=6/25 
(24%) 
+/- Acetabular poly exchange n=2/25 
(8%), implant Endurance, Depuy 
(23/31(74%)), OR Eschelon, Smith 
and Nephew (8/31(26%)) 
M:F 11:20 Mean age in years: 81.8 
(SD 9.25#, 56-93) 
ASA 2: 7/31 (23%), 3: 24/31 (77%) 
Time from index to fracture in 
years mean: 8.6 (SD 7.2#, 0.25-29) 
Allocation of exposure 
Surgeon preference – if limited life 
expectancy, e.g. >80 years old with 
ASA 2 or more (n=27) OR 
Expected to be non-compliant with 
non-weight bearing (e.g. dementia or 
psychiatric diagnoses prohibiting 
(n=4) 
Surgeon experiential level NS 
Weight bearing status Protected 
weight bear as tolerated with walker 
Venous thromboembolism 
prophylaxis NS 














































Mortality within 6 months 
post op 
8/31 (26%) 
PFF post-op 1/31 (3.2%) 
Infection DSSI 2/28 (7%) 
Union (in patients with 1 year 
or more follow-up) 
14/16 (87.5%) 
SF-12 Score 
Incomplete – does not state 
mental or physical 
Harris Hip Score (post-
operatively) mean 
77.5 (No SD or range reported) 
Womac scores (mean) at 
minimum 1 year follow-up (n 
is unclear) 
Pain 3 (No SD or range 
reported) 
Function 13 (No SD or range 
reported) 
Stiffness 2 (No SD or range 
reported) 







Cortical strut ingrowth 
14/14 (100%) 






















































Participants Mixed cohort of 




Indication index NS 
Index implant details NS 
Primary:Revision NS 
Cemented:Uncemented NS 
Index stem  NS 
Mechanism injury NS 
Fracture diagnosis method 
Pre-operative radiographs (two 
consultant review) 
Setting Single-centre 
Tertiary hospital Oxford, United 
Kingdom 
Inclusion criteria Patients with 
Vancouver B2 or B3 PFF 
undergoing revision arthroplasty 
with uncemented, modular, 
tapered, conical fluted long stem 
(Restoration, Cone conical, 
Stryker)  
Exclusion criteria NS 
 
Exposure A Revision +/- W/C/C 
(n=38) Revision long stem, 
uncemented, modular, tapered, 
conical fluted + autograft at fracture 
site, Extensile posterior approach +/- 
ETO when necessary 
+/- Acetabular revision n=22/38 
(58%) 
+/- cerclage n=30/38 (79%) 
Restoration cone conical, Stryker 
Allocation of exposure Surgeon 
preference  
Surgeon experiential level 
Consultant – experienced 
arthroplasty surgeons (3) 
Weight bearing status 
Individualised Weight bear as 
tolerated n=14/38 (37%) 
Partial weight bearing for 6 weeks 
n=12/38 (32%) 
Venous thromboembolism 
prophylaxis Low molecular weight 
heparin 4 weeks 
Surgical antibiotic prophylaxis NS 
Note: Although no specific B2 
demographic data provided, pooled 
data published is as follows: 
Sex M:F 17:30 
ASA 1-2: 10/37 (27%),  
3-5: 27/37 (73%) 
































































Surgical time mins (mean) 175 
(SD 41.3#, 95-260) 
Transfusion – PRBC 
transfusion units (mean) 3 
(SD 2.5#, 0-10) 
Note: Patients with an ASA ≥ 3 
had a significantly 
higher rate of transfusion than 
those with ASA ≤ 2 (Fisher’s 
exact test, p = 0.009) but there 
was no difference between 
ASA groups in the incidence of 
complications (Fisher’s 
exact test, p = 0.4) 
Subsidence  
Mean 1.1 mm (SD 3.5#, 0-14) 
Subsidence (>5mm) 
1/38 (2.6%) 
Union 38/38 (100%)  
Length of stay days (mean) 
22 (SD 14.3#, 3-60) 




Infection DSSI 1/38 (2.6%) 
Dislocation 4/38 (10.5%) 
Re-operation 3/38 (7.9%) 
DVT 1/37 (2.7%) 
Multi-organ failure 
1/37 (2.7%) 
Leg length discrepancy 
(amount NS) 
1/38 (2.6%) 
Thigh pain 1/38 (2.6%) 
Buttock pain/Abductor 
weakness 1/38 (2.6%) 
Pressure Ulcer 1/37 (2.7%) 
Oxford Hip Score (mean) of 
surviving 24 patients at mean 
26 months 
35 (SD 8.5#, 14-48) 
Of 27 patients initially graded 
as ASA ≥ 3, 19 
The results of 
this study 





















































survived with a mean OHS of 
31 (15 to 48) which was 
significantly 
lower than the mean OHS of 43 
(36 to 48) found in patients 
assessed as ASA grade ≤ 2 
(independent samples 






















Participants Mixed cohort of 




Indication index NS 
Index implant details NS 
Primary:Revision NS 
Cemented:Uncemented 
Index stem  NS  
Mechanism injury NS  
Fracture diagnosis method 
Pre-operative radiographs  
Setting Unclear – Hospital(s) in 
Germany 
Inclusion criteria Patients with 
Vancouver B2 or B3 PFF 
undergoing revision with 
uncemented distal locking long 
stem implant 
Exclusion criteria 
Nil specified, however,  states 
contra-indications: Unsuitability 
for extensive surgical procedure, 
peri-prosthetic infection, long stem 
TKR in distal femur 
 
Exposure A Revision +/- W/C/C 
(n=8) (Revision distal locking long 
stem (20/21) OR distal press fit 
(1/21), uncemented, lateral 
transmuscular approach to femoral 
shaft + ETO, BiContact, Aesculap, 
+/- Acetabular revision n=11/21 
+/- cancellous bone graft n=8/21 
Note: Distal stem fixation removed 
once radiological evidence proximal 
femur remodelling 
Allocation of exposure Surgeon 
preference 
Surgeon experiential level NS 
Weight bearing status 
Bed rest 1 week then mob 20kg 
partial weight bear 12 weeks, From 
week 12 gradual increase 10kg/week 
with XR checks. Removal distal 




Surgical antibiotic prophylaxis 
10 days antibiotics (route NS) 
Note: Although no specific B2 
demographic data provided, pooled 
data published is as follows: 
Sex M:F 8:13 Mean age in years: 




















8/8 (100%) (at mean 5.6 months 
(SD 2#, 3-11) 
 
A summary of 
the results 


































Mixed cohort of patients with PFF, 
n=15/23 (65%) B2  
Sampling Unclear 
Recruitment NS 
Indication index NS 
Index implant details NS 
Primary:Revision NS 
Exposure A Revision +/- W/C/C 
(n=15) (Revision long stem with 
distally curved modular stem with 
cerclage or cables for ETO site 
(dorsal and ventral), modified trans-
femoral approach with extension to 

















15/15 (100%) at mean 3.6 
























Index stem NS  
Mechanism injury NS 
Fracture diagnosis method 
Pre-operative radiographs  
Setting Unclear – Hospital(s) in 
Germany 
Inclusion criteria Patients with 
Vancouver B2 or B3 PFF 
undergoing revision with 
uncemented revision curved long 
stem with cerclage 
Exclusion criteria Nil specified, 
however, states contra-indications: 
Periprosthetic joint infection, 
interprosthetic femoral shaft 
fractures needing total femoral 
replacement, Vancouver B1/C 
fractures 
 
curved modular prosthesis, Zimmer, 
cables Zimmer 
Allocation of exposure 
Surgeon preference 
Surgeon experiential level NS 
Weight bearing status 
In general, Partial weight bearing 
10kg for 6 weeks. Hip flexion 
limited top 70 deg. Gradual increase 
in weight bearing based on Xrays up 
to full WB after 3 months. If non-
compliant with partial weight bearing 
in elderly convert to WBAT.  
Venous thromboembolism 
prophylaxis 
VTE prophylaxis until more than 
30kg partial weight bearing achieved  
Surgical antibiotic prophylaxis 
Single pre-operative cefuroxime 
250mg OR if surgical time >2 hours, 
24 hours IV antibiotics (3 doses) 
Note: Although no specific B2 
demographic data provided, pooled 
data published is as follows: 
Sex M:F 8:15 Mean age in years: 

















Beals and Towers’ criteria 
proportion of Excellent 
outcome 




































Participants Mixed cohort of 




Indication index OA 26/40 (65%) 
NOF # 8/40 (20%) Post traumatic 
OA 3/40 (7.5%) RA: 2/40 (5%) 
DDH: 1/40 (2.5%) 
Index implant details NS  
Primary:Revision NS 
Cemented:Uncemented 28:22 
Index stem  Charnley:18,  
Muller: 5,  Other cemented: 5,  RM 
Isoelastic:1,  PCA (stryker): 2,  
Harris-Galante:6, Mittelmeir:2,  
Omniflex (stryker):4, Alloclassic 
(Zimmer):3, Other cementless: 4 
Mechanism injury NS 
Fracture diagnosis method 
Exposure A Revision +/- W/C/C 
(n=20) (Revision uncemented long 
stem distal press fit, with cerclage 
fixation, postero-lateral approach, 
Solution system, Depuy.  
Sex M:F 12:11 Mean age in years: 
79.2 (SD 6#, 56-80) 
Allocation of exposure 
Surgeon preference 
Surgeon experiential level NS 
Weight bearing status 
Bed rest with abduction triagular 
pillow 3-5 days then; 
Partial weight bearing with 2 
crutches for younger patients without 
neurological deficits and minor 
defects (B2s) 
Venous thromboembolism 
prophylaxis Subcutaneous heparin 



























Subsidence (10mm or greater) 
12/23 (52%) 













































Pre-operative radiographs (two 
experienced assessors) 
Setting Single-centre 
Tertiary hospital Madrid, Spain 
Inclusion criteria Patients with 
Vancouver B2 or B3 PFF 
undergoing revision with 
extensively porous coated stem 
(Solution System, Depuy) 
Exclusion criteria Nil specified, 
however, states contra-indications:  
Consideration to pre-morbid 
medical condition 
Femoral canal <18mm 
Lost to follow-up 5 patients 
excluded due to death from causes 
unrelated to the operation prior to 3 
year minimum follow-up 
Surgical antibiotic prophylaxis 
1g IV cephazolin 6 hourly for 48 
hours total 
Note: Although no specific B2 
demographic data provided, pooled 
data published is as follows: 
Time from index to fracture in 






















Participants Mixed cohort of 
patients with PFF, n=14/21 (67%) 
B2   
Sampling Unclear 
Recruitment 2006-2009 
Indication index OA 17/21 (81%) 
NOF # 1/21 (4.7%)  
Post traumatic OA 2/21 (9.5%) 
RA 1/21 (4.8%) 
Index implant details 20:1 
Primary:Revision 20:1 
Cemented:Uncemented 20:1 
Mechanism injury Traumatic 
Fracture diagnosis method 
Pre-operative radiographs (two 
authors) Illustrates identification of 
a spiral fracture pattern in patients 
with CCPT stems - needs to 
identify instability as to 
appropriately allocate as B2 NOT 
accidently B1 and thus appropriate 
revision in case of B2. 
Setting Single-centre 
Tertiary hospital Oxford, United 
Kindom 
Inclusion criteria Patients with 
PFF around collarless polished 
tapered stem undergoing revision 
Exposure A Revision +/- W/C/C 
(n=14) (Revision long stem with 
impaction bone grafting n=5/14 OR 
cerclage wires n=9/14, Lateral 
approach,  
Oxford tri-modular stem (Corin) OR 
BiMetric impaction Allograft stem 
(Biomet) OR  
Long stem CPT (Zimmer OR  
Restoration Cone Conical (Stryker) 
M:F 4:10 Mean age in years: 75.7 
(SD not reported, Range 28-89) 
Index stem  CPT: 4/14 Exeter: 10/14 
Allocation of exposure 
Surgeon preference  
Surgeon experiential level 
Consultant (5 surgeons) 
Weight bearing status 6 weeks 
Partial weight bearing then full 
weight bear as tolerated  
Venous thromboembolism 
prophylaxis NS 
Surgical antibiotic prophylaxis NS 
Note: Although no specific B2 
demographic data provided, pooled 









































the extent of 



























Exclusion criteria NS 
 
Time from index to fracture in 























Participants Mixed cohort of 




Fracture diagnosis method 
Not clear, implies radiographs 
Setting Single-centre 
Tertiary hospital Dorset, United 
Kindom 
Inclusion criteria Patients with a  
Vancouver B1 OR B2 OR B3 PFF 
undergoing ORIF with dynamnic 
compression plate 
Exclusion criteria NS 
Lost to follow-up n=4 (2 deaths 
within 2 months post op and 2 lost 
to follow-up) 
Exposure A ORIF with plate (n=6) 
ORIF with lateral dynamic 
compression plate  
+/- cerclage n=4/6 
+/- iliac crest bone graft n=1/6, 
lateral approach to femur, implant 
NS, company NS 
M:F 3:3 Mean age in years: 76 (SD 
not reported, Range 51-92) 
Index implant details 
THA:HA 5 (2 primary cemented 
THA and 3 revision):1 (AM) 
Primary:Revision 3:3 
Cemented:Uncemented 5:1 
Index stem NS 
Mechanism injury All minor trauma 
Allocation of exposure 
Surgeon preference – state deviated 
from protocol of revision for B2 sue 
to existing long stem n=3 and 
advanced age deemed not 
appropriate for revision n=2 
Surgeon experiential level NS 
Weight bearing status Early non-
weight bearing, but if couldn’t 
tolerate, progression to toe touch 
weight bearing was permitted 
Venous thromboembolism 
prophylaxis NS 







































































































Participants Mixed cohort of 




Indication index OA 31/45 (69%) 
NOF # 13/45 (29%) 
RA 1/45 (2.2%) 
Index implant details NS  
Primary:Revision 43:2 
Cemented:Uncemented 13:32 
(incl 2 uncemented revisions) 
Stem NS 
Mechanism injury NS 
Fracture diagnosis method 
Radiographic assessment  
Setting Single-centre, Tertiary 
hospital Ottowa, Canada 
Inclusion criteria Patients 
sustaining a PFF post-operatively 
managed surgically 
Exclusion criteria Pathalogical 
fractures Intra-operative PFFs 
(n=7) 
Loss to follow-up n= 3 died <3 
months4 n=8 lost to follow-up 
Exposure A Revision mixed 
methods/unspecified (n=21) 
Revision and ORIF no technique 
specified, no implants specified, no 
company specified.  
Note n=1 ORIF (NS) 
Allocation of exposure Surgeon 
preference guidance from Vancouver 
algorithm 
Surgeon experiential level NS 
Weight bearing status NS 
Venous thromboembolism 
prophylaxis NS 
Surgical antibiotic prophylaxis NS 
Note: Although no specific B2 
demographic data provided, pooled 
data published is as follows: 
Sex M:F 15:30 Mean age in years: 
























































Participants Mixed cohort of 




Indication index OA: 57/99 (58%) 
RA/JRA: 22/99 (22%) 
Post traumatic OA 13/99 (13%) 
AVN: 5/99 (5%) Other: 2/99 (2%) 
Index implant details 
THA:HA 90 (53 primary, 37 
revision):9 
Stem  NS 
Fracture diagnosis method 
Radiographs 
Setting Single-centre, Tertiary 
Hospital, San Diego, USA 
Inclusion criteria Patients 
sustaining a PFF following a THA 
managed within their unit 
Exposure A Revision +/- W/C/C 
(n=8) (Revision, cemented (4), 
uncemented (4), length stem NS, 
implant NS, company NS 
M:F 4:4 Mean age in years: 64.1 
(Range 38-86, No SD reported) 
Index implant details 
Primary:Revision 4:4 
Cemented:Uncemented 8:0 
Mechanism injury Low energy 
trauma 6/8 (75%) 
Spontaneous 2/8 (25%) 
Time-frame of outcomes 
assessment: Mean 34 months 
(Range 12-100, No SD reported) 
Exposure B Revision mixed 
methods/unspecified (n=3) 
(Revision stem (length NS), 
cemented (Bhattacharyya, Chang et 

























A: 5/8 (63%) 
B: 2/3 (67%) 
C: 6/7 (85%) 
D: 1/2 (50%) 
Re-operation 
A: 3/8 (38%) 
B: 1/3 (33%) 
C: Unclear 
D: 1/2 (50%) 
Unstable implant 
A: 1/8 (12.5%) 
B: 0/3 (0%) 




A: 1/8 (12.5%) 
Haematoma 
C: 1/7 (14%) 


















<12 months follow-up  
n=33 including  
n=25 deaths and  
n=8 uncontactable 
 
strut allograft, approach NS, implant 
NS, company NS 
M:F 1:2 Mean age in years: 62.3 
(Range 37-78, No SD reported) 




Low energy trauma 2/3 (67%) 
Spontaneous 1/3 (33%) 
Time-frame of outcomes 
assessment: 
Mean 68 months (Range 26-139, No 
SD reported) 
Exposure C Revision + cortical 
strut allograft (n=7) (Revision + 
strut allograft, cemented (5), 
uncemented (Bhattacharyya, Chang 
et al.), length stem NS, approach NS, 
implant NS, company NS 
M:F 3:4 Mean age in years: 62.9 
(Range 42-82, No SD reported) 




Low energy trauma 4/7 (57%) 
Spontaneous 3/7 (43%) 
Time-frame of outcomes 
assessment: Mean 65.9 months 
(Range 24-111, No SD reported) 
Exposure D ORIF with plate (n=2) 
(ORIF plate, approach NS, implant 
NS, company NS 
M:F 0:2 Mean age in years: 73.5 
(Range 71-76, No SD reported) 




Low energy trauma 2/2 (100%) 
Time-frame of outcomes 
assessment: Mean 69.5 months 
(Range 57-82, No SD reported) 
Allocation of exposure 
Surgeon preference 
Dislocation 
C: 2/7 (29%) 
PE 
C: 1/7 (14%) 




Surgeon experiential level NS 
Weight bearing status NS 
Venous thromboembolism 
prophylaxis NS 



















Participants Mixed cohort of 
patients with PFF, n=25/63 (40%) 
B2  
Sampling Consecutive 
Recruitment 1998-2010 (index) 
outcome data collected up to 2012 
Indication index NOF # (primary 
or due to failed internal fixation 
with non-union or AVN) 63/63 
(100%). Unit policy 80 years or 
older hemiarthroplasty vs <80 
years and lucid usually THA.  




Stem  All Exeter polished taper 
stem 
Mechanism injury NS 
Fracture diagnosis method 
Radiographs (revision hip 
surgeons, both investigators) 
SettingSingle-centre 
Karolinska Insitute, Sweden 
Inclusion criteria Patients 
sustaining a post-operative PFF 
following a THA or HA managed 
operatively by Revision or ORIF 
Exclusion criteria Pathalogical 
fractures, Intra-operative fractures, 
Vancouver A fractures 
 
Exposure A Revision +/- W/C/C 
(n=16) Revision longer stem with 
distal fixation, uncemented (distal 
fixation stem) or cemented 
Note: a maximum of 2/16 were 
treated with supplementary ORIF 
plate (unclear in publication) 
Indication index NOF # 16/16 
(100%) 
Exposure B ORIF mixed 
methods/unspecified (n=9) 
Either ORIF single lateral plate or 
screw fixation and cerclage wires 
(study states approximately 50% 
each) 
Indication index NOF # 9/9 (100%) 
Allocation of exposure NS 
Surgeon experiential level NS 
Weight bearing status Weight bear 
as tolerated from day 1 post-
operatively 
Venous thromboembolism 
prophylaxis Low molecular weight 
heparin, type NS, dose NS, duration 
NS  
Surgical antibiotic prophylaxis 
3 doses IV cloxacillin  
Note: Although no specific B2 
demographic data provided, pooled 
data published is as follows: 
Sex M:F 29:34 Mean age in years: 
83 (SD 8.5#, 63-97) 
Time from index to fracture in 












from time of 
HA/THA to 















A: 1/16 (6.3%) 





































of this study 













with a THA 













Note: for the 
association 
under study 












and are more 

















Participants Cohort of patients 
with Vancouver B2 PFF n=12  
Sampling Unclear 
Recruitment 1996-2000 
Indication index NS 
Index implant details 





Minor trauma: 5/12 (42%) 
Spontaneous: 7/12 (58%) 
Fracture diagnosis method 
Radiographs pre-op 
Setting Single-centre, Chai Wan, 
Hong Kong 
Inclusion criteria Patients with a 
Vancouver B2 PFF following a hip 
arthroplasty managed with a 
Wagner revision stem  
Exclusion criteria Management 
by other method/implant n=18, 
Under 65 years of age, < 3 years 
follow-up, Death n=2 (1 patient 
day 26 post op MRSA DSSI and 1 
patient 1 year post op due to 
sigmoid carcinoma) 
  
Exposure A Revision +/- W/C/C 
(n=12) Revision conical long stem 
distal press fit, uncemented, ETO +/- 
bone graft, Transfemoral approach, 
Wagner revision stem, Sulzer 
orthopaedics 
Note: Acetabulum revised in 5/6 
cases of THA. All HA converted to 
THA. Bone graft to proximal femur  
6/8 cemented) 
M:F 1:11 Mean age in years: 74.5 
(Range 67-83, No SD reported) 
Time from index to fracture in 
years mean: 6.8 (Range 1-10, No 
SD reported) 
Allocation of exposure 
NS – implies need for 10cm intact 
diaphyseal bone distal to fracture 
Surgeon experiential level NS 
Weight bearing status Sit in 
orthopaedic chair, start partial weight 
bearing (no weight specified) 
exercise D2-3 post op. Abduction 
pillow 5 days. Discharged when 
managing partial weight bearing with 
crutches. XRs weekly post op until 
signs of healing at which point 
upgraded to full weight bearing 
Venous thromboembolism 
prophylaxis NS 




















































A: 2/12 (17%) 
Subsidence 6mm or more A: 
0/12 (0%) 
Union 
A: 12/12 (100%) at mean 14.5 
weeks (Range 12-16, No SD 
reported)  
Osseointegration 
A: 12/12 (100%) 
Malrotation A: 0/12 (0%) 
Heterotopic ossification 
A: 0/12 (0%) 
Mortality A: 2/14 (14%) 
PFF post op 
A: 1/12 (8.3%) 
Dislocation A: 0/12 (0%) 
DVT 
A: 1/12 (8.3%) 
Leg length discrepancy 
(>2cm) A: 1/12 (8.3%) 
Thigh pain A: 0/12 (0%) 
Repeat revision femoral 
component A: 0/12 (0%) 
Harris hip score post op mean 
(n=12) 
A: 80 (SD 3#, Range 74-86) 
Beals and Towers’ Criteria 
proportion of Excellent score 
A: 7/12 (58%) 
Beals and Towers’ Criteria 
proportion of Good score 
A: 3/12 (25%) 
Beals and Towers’ Criteria 
proportion of Poor score 













patients due to 































Participants Mixed cohort of 




Indication index NS 




Stem  NS  
Mechanism injury NS 
Fracture diagnosis method 
Radiographs. Aspiration, WCC, 
ESR, CRP  
Setting Multi-centre, 
Two tertiary hospitals, University 
college London and Nottingham 
University, United Kingdom 
Inclusion criteria Patients with an 
infected Vancouver B2 or B3 PFF 
following a hip arthroplasty 
managed with revision arthroplasty 
Exclusion criteria NS 
Exposure A Revision +/- W/C/C 
(n=9) Revision long stem with distal 
fixation (non-HA coated) +/- cables, 
uncemented, approach NS, 
Cannulock (n=7), Orthodesign, or 
Kent (n=2), Biomet,  
M:F NS Mean age in years: 82.1 
(Range 70-90, No SD reported) 
Allocation of exposure Not explicit.  
Surgeon experiential level NS 
Weight bearing status Weight bear 
as tolerated with crutches 
Venous thromboembolism 
prophylaxis NS 
Surgical antibiotic prophylaxis 
Empirical antibiotics (Teicoplanin). 
Directed therapy tailored to 
microscopy, culture and sensitivity 
results continued until normalised or 



































A: 9/9 (100%) 
Harris hip score post op mean 
A: 84.2 (Range 78-89, No SD 
reported) 
Attain pre-fracture mobility 
status 













































Participants Mixed cohort of 




Indication index NS  





Mechanism injury NS 
Fracture diagnosis method 
Radiographs and intra-operative 
stability assessment 
Setting Single-centre, University 
hospital, Prague, Croatia 
Inclusion criteria Patients 
sustaining a post-operative PFF 
managed surgically within their 
unit 
Exposure A Revision +/- W/C/C 
(n=18) Revision stem (usually 
modular non-cemented stem), 
anterolateral approach, implant NS, 
company NS.  
Exposure B ORIF with plate (n=6) 
ORIF locking compression plate 
(LCP), approach NS 
Allocation of exposure Surgeon 
preference. Broadly standard was to 
revise B2 PFFs, however, was 
deviated from early in series by way 
of ORIF 
Surgeon experiential level NS 
Weight bearing status Mobilised 
from day 1 to 6 post-operatively (no 
weight bearing allowance specified) 
Venous thromboembolism 
prophylaxis Low molecular weight 
heparin based on weight (no drug 
specified) 




































A: 1/18 (5.6%) 
B: 0/6 (0%) 
Dislocation 
A: 2/18 (11%) 
B: 0/6 (0%) 
Neurovascular injury 
(femoral nerve palsy) 
A: 2/18 (11%) (resolved at 3 
months post op) 
B: 0/6 (0%) 
Femoral stem breakage 
A: 1/18 (5.6%) 
B: Not applicable 
Plate breakage  
A: Not applicable 
































Exclusion criteria Peri-prosthetic 




2 grams IV antibiotics 30 minutes 
pre-operatively, 1 gram every 2 
hours intra-operatively, 1 gram eight 
hourly for two doses post-operatively 
Note: Although no specific B2 
demographic data provided, pooled 
data published is as follows: 
Sex M:F 18:22 Mean age in years: 
72 (SD 8.5#, Range 54-88) 
Time from index to fracture in 

















Participants Mixed cohort of 
patients with PFF, n=12/17 
(70.5%) B2  
Sampling Unclear 
Recruitment 1997-2004 
Indication index NS 
Index implant details NS 
Primary:Revision NS 
Cemented:Uncemented 11:6 
Stem NS  
Mechanism injury 
Minor trauma: 15/17 (88%) 
High energy: 2/17 (12%) 
Fracture diagnosis method 
Radiographs  
Setting Single-centre 
Tertiary hospital, Illinois, USA 
Inclusion criteria Patients with a 
Vancouver B2 or B3 PFF 
undergoing Revision arthroplasty 
including extended trochanteric 
osteotomy 
Exclusion criteria Minimum 2 
year follow-up 
Loss to follow-up n=3 (Death at 9 
months not related to surgery (n=1) 
and no reason (n=2)) 
 
Exposure A Revision mixed 
methods/unspecified (n=12) 
Revision stem (length unclear), 
cemented/uncemented (unclear) + 
cables +/- acetabular revision +/- 
poly exchange +/- conversion to 
THA (if HA index) +/- cortical struts 
where necessary (unclear 
proportion), posterior approach, 
mixed implant usage.  
Allocation of exposure Surgeon 
preference 
Surgeon experiential level NS 
Weight bearing status 0-6 weeks: 
Toe touch weight bear 6 weeks,  
6-12 weeks: Full weight bearing with 
protection of walking aid depending 
on healing 12+ weeks: Wean off of 
walking aids. 
Active hip abduction restricted 6 
weeks. Resisted active hip abduction 
restricted 12 weeks 
Venous thromboembolism 
prophylaxis Warfarin, no duration 
specified 
Surgical antibiotic prophylaxis NS  
Note: Although no specific B2 
demographic data provided, pooled 
data published is as follows: 
Sex M:F 5:12 Mean age in years: 























A: 12/12 (100%) 
Union ETO 
A: 12/12 (100%) at mean 13.1 
















































Participants Mixed cohort of 




Indication index NS 




Mechanism injury NS 
Fracture diagnosis method 
Radiographs and intra-operative 
assessment 
Setting Unclear 
Inclusion criteria Patients with a 
Vancouver B1, B2 OR B3 PFF 
following THA or HA managed 
with curved non-locking plate with 
eccentric holes with or without 
revision 
Exclusion criteria <1 year follow-
up (death within a year (n=10), lost 
to follow-up (n=10)),  ORIF by 
alternative method (n=1), 
Sepsis episode prior to PFF 
 
Exposure A ORIF with plate 
(n=16) ORIF curved non-locking 
plate with eccentric holes +/- 
temporizing cerclage, posterolateral 
approach, 12, 15 or 18 hole plate, 
Aesculap  
Exposure B Revision + ORIF plate 
(n=7) Revision long stem, cemented 
and ORIF curved non-locking plate 
with eccentric holes, Arcad longue, 
Symbios, plate as above 
Allocation of exposure Unit 
preference – Generally, Revision for 
loose implants, however, ORIF if 
index femur cementless OR in very 
old patients 
Surgeon experiential level 
Consultant (senior) 
Weight bearing status Wheel chair 
mobility for day 1-2 post op. Then 
Weight bear as tolerated with two 
canes for 6 weeks with 
EXCEPTION  
Bed to wheelchair transfers only 
FOR non-compliant patients or those 
with very fragile bone 
Venous thromboembolism 
prophylaxis Prophylactic low 
molecular weight heparin 6/52 
Surgical antibiotic prophylaxis NS 
Note: Although no specific B2 
demographic data provided, pooled 
data published is as follows: 
Sex M:F 21:22 
ASA 2:8/43, 
Mean age in years: 79 (SD 13, 41-
98) 
Time from index to fracture in 





























Surgical time (Incision to 
dressing wound) mean 
(Wasko and Kaminski) 
A: 122 (SD 26, 80-165) 
B: 209 (SD 41, 165-278) 
Union (timing NS) 
A: 16/16 (100%) (worst case by 
4 months) 
B: 7/7 (100%) (worst case by 4 
months) 
Malunion 
A: 0/16 (0%) 
B: 0/7 (0%)  
Aseptic loosening femur 
A: Not reported 
B: 0/7 (0%) 
 
(Not specific 
to B2)  




















nature of the 
study led to a 
high number 
of patients 









































Participants Mixed cohort of 
patients with intra-operatively and 
post-operatively sustained PFF, 
n=8/29 (28%) post-operative B2 
Sampling Unclear 
Recruitment 2002-2003 
Indication index Not reported 
Index implant details NS 
Primary:Revision 11:4 
Cemented:Uncemented 3:12 
Stem  Not reported 
Mechanism injury NS 
Fracture diagnosis method 
Radiographs (pre and post-
operatively) and intra-operative 
notes 
Setting Single-centre, Clinic of 
joint replacement, Germany  
Inclusion criteria Patients with an 
intra-operative or post-operative 
Vancouver B2 PFF managed with 
a Wagner revision stem  
Exclusion criteria Trans-femoral 
approach for revision femoral stem 
Vancouver B1 and C PFFs 
Lost to follow-up Death prior to 
follow-up n=9/39 (23%), Revision 
for aseptic loosening prior to 
follow-up n=1 
Exposure A Revision +/- W/C/C 
(n=8) Revision long stem distal press 
fit, uncemented + cerclage +/- 
acetabular revision as indicated, 
trans-gluteal approach, Wagner 3rd 
Generation, Zimmer 
Allocation of exposure Unit 
protocol 
Surgeon experiential level NS 
Weight bearing status 0-6 weeks: 
Non-weight bear. Rehab program to 
strengthen thigh and hip.  
Venous thromboembolism 
prophylaxis NS 
Surgical antibiotic prophylaxis NS 
Note: Although no specific post-
operatively sustained Vancouver B2 
PFF demographic data provided, 
pooled data (incl intra-operative B2) 
published is as follows: M:F 3:12 
BMI 26.9 (SD 2.7#, 22.6-33.5) 




























































Participants Mixed cohort of 





Primary OA 6/14 (43%) 
NOF # 4/14 (29%) 
AVN 3/14 (21%) 
Inflammatory 1/14 (7%) 
Index Implant details 
THA:HA 12:2 
Primary:Revision  




Exposure A Revision mixed 
methods/unspecified (n=14) 
Revision stem (length NS), 
uncemented, with cortical strut or 
impaction allografting n=4/14 (29%), 
approach NS, implant NS  
M:F 8:6 
ASA: 2: 5 (36%), 3: 8 (58%), 4: 1/14 
(7%) 
Mean age in years: 75.9 (SD 7.5, 
No range specified) 
Allocation of exposure 
Vancouver algorithm  
Surgeon experiential level NS 

































A: 2/14 (14.2%) 
Harris hip score (post-
operatively) mean (n=6/14) 
A: 73 (SD 3.2, 70-85) 
Beals and Towers’ Criteria 
proportion of Excellent score 
A: 3/14 (21%) 
Beals and Towers’ Criteria 
proportion of Good score 
A: 6/14 (43%) 
Beals and Towers’ Criteria 
proportion of Poor score 
A: 5/14 (36%) 
Attain pre-fracture mobility 
status 
A: 6/14 (43%) 
No specific 
conclusions 













Minor trauma: 12/14 (86%) 
High energy: 2/14 (14%) 
Fracture diagnosis method NS 
Setting Single-centre, Spain 
Inclusion criteria Patients 
sustaining a post-operative PFF 
following THA or HA treated at 
their institution 
Exclusion criteria Death within 
10 months of follow-up (n=7) 
Lost to follow-up  
n=6 (no reason specified)  




















Participants Mixed cohort of 




Indication index NS 





Stem  NS 
Mechanism injury 
Minor trauma: 55/55 (100%) 
Fracture diagnosis method 
Radiographs pre-operatively 
Setting Single-centre, Tertiary 
hospital Canada 
Inclusion criteria Patient's 
suffering a PFF following THA or 
HA treated at their institution with 
Revision femoral arthroplasty with 
modular distal taper fluted titanium 
stems  
Exclusion criteria <2 years 
follow-up (n=9) including; 
Death <2 years (n=8) 
Moved overseas (n=1) 
 
Exposure A Revision +/- W/C/C 
(n=30) Revision long stem modular 
distally curved, uncemented +/- 
wires/cables/heavy suture, posterior 
extensile approach, ZMR 3.5 deg, 
Zimmer OR Revitan 2 deg 
(preference for smaller patients)  
Note: a maximum of 4/30 (13%) 
were treated with supplementary 
trochanteric claw plate (unclear in 
publication) 
Allocation of exposure 
Unit preference for PFF where less 
than 4cm distal diaphyseal fit 
available, expanded to all PFF unless 
no diaphysis remained 
Surgeon experiential level NS 
Weight bearing status Globally –  
0-6 weeks post op: Partial weight 
bear (50% body weight) if stem 
fixation secure. IF any doubt Toe 
touch weight bearing 0-6 weeks then 




Surgical antibiotic prophylaxis NS 
Note: Although no specific post-
operatively sustained Vancouver B2 
PFF demographic data provided, 
pooled data (incl intra-operative B2) 
published is as follows: 
















































Aseptic loosening femur 
A: 1/30 (3.3%) 
Union 
A: 30/30 (100%) 
SF-12 Mental score post-
operatively mean  
A: 53 (No SD or Range given) 
n=16/30 
SF-12 Physical score post-
operatively (mean) 
A: 41 (No SD or Range given) 
n=16/30 (53%) 
Oxford hip score post-
operatively (mean) 
A: 74 (No SD or Range given) 
n=16/30 (53%)  
Womac scores (mean) 
n=16/30 (53%) (No SD or 
Range specified) 
Global  
A: 76  
Pain  





Satisfaction score (self 














fractures is  
justified, and 
further follow-









































Subsidence (amount NS – 
includes 1 symptomatic patient 
with >10mm necessitating 
revision) 

















Participants Mixed cohort of 




Index implant details 
THA:HA 7 (4 uncemented, 2 
cemented, 1 uncemented 
revision):11 (6 uncemented bipolar 
HA and 5 AM) 
Primary:Revision 7:11 
Cemented:Uncemented 7:11 
Stem  NS 
Mechanism injury NS 
Fracture diagnosis method 
Radiographs (Trauma and hip 
surgeon) 
Setting Single-centre 
Tertiary hospital, Kobe, Japan 
Inclusion criteria Patient's with a 
PFF following THA or HA 
managed (operative or non-op) at 
their institution 
Exclusion criteria NS 
 
Exposure A Revision +/- W/C/C 
(n=2) Revision longer length stem, 
uncemented OR same length stem, 
cemented + wires, approach NS, 
implant NS, company NS  
M:F 0:2 
Mean age in years: 71 (Range 69-
73, No SD reported) 
Index implant details 
THA:HA 1:0 (1 NS) 
Primary:Revision 1:0 (1 NS) 
Cemented:Uncemented 0:1 (1 NS) 
Indication index OA 1/2 (50%) 
NS 1/2 (50%) 
Surgeon experiential level 
Consultant (hip surgeon) 
Exposure B ORIF with plate (n=3) 
ORIF Locking compression plate 
(LCP), approach NS, LCP Synthes. 
M:F 0:3 
Mean age in years: 82.7 (Range 80-
86, No SD reported) 
Index implant details NS 
Surgeon experiential level 
Consultant (Trauma surgeon) 
Exposure C Non-operative (n=1) 
M:F NS Age in years: 91 
Index implant details NS 
Allocation of exposure 
Vancouver algorithm +/- 
modification with surgeon judgement 
(patient physiology and experience). 
Surgeon experiential level 
Consultant (hip surgeon) 



















































Surgical time (Operation 
time) mean (Wasko and 
Kaminski) 
A: 146 (SD 8.49, No Range 
specified) 
B: 152.7 (SD 71.7, No Range 
specified) 
Blood loss (intra-operative) 
mean (mL) 
A: 1502mL (SD NS, Range 
535-2470) 
B: 390mL (SD 232, 150-615) 
Transfusion requirement 
(Units packed red blood cells) 
mean 
A: 7 (SD 7.07, No Range given) 
B: 3 (SD 1.15, 2-4) 
C: NS 
Union 
A: 2/2 (100%) 
B: 3/3 (100%) 
C: 1/1 (100%) 
Malunion 
A: 0/2 (0%) 
B: 0/3 (0%) 
C: NS 
Loss of reduction (fracture) 
A: 0/2 (0%) 
B: 0/3 (0%) 
C: N/A 
Intra-operative mortality 
A: 0/2 (0%) 
B: 0/3 (0%) 
C: N/A 
Infection DSSI 
A: 0/2 (0%) 



























a loose stem. 
Cooperation of 
a trauma 
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Surgical antibiotic prophylaxis NS 
Note: Although no specific post-
operatively sustained Vancouver B2 
PFF demographic data provided, 
pooled data (incl intra-operative B2) 
published is as follows: 
Time from index to fracture in 










A: 0/2 (0%) 
B: 0/3 (0%) 
Parker mobility score post-
operatively mean 
A: 6 (SD 4.24, Range 3-9) 
B: 2 (SD 2.65, Range 0-5) 
C: 4  
*Note: Parker mobility score 
pre-operatively  
A: 6 (SD 4.24, Range 3-9) 




A: 1/2 (50%) with walker, 1/2 
(50%) no aids 
B: 2/3 (66%) non-ambulatory, 
1/3 (33%) with crutch 
C: 1/1 (100%) with cane 
Attain pre-fracture mobility 
status 
A: 2/2 (100%) 
B: 3/3 (100%) 
C: 1/1 (100%) 
Attain pre-fracture social 
status 
A: 2/2 (100%) 
B: 3/3 (100%) 
















Participants Mixed cohort of 




Indication index NS 




Stem  NS 
Mechanism injury 
Minor or no trauma 10/45 (22%) 
‘Substantial’ trauma 35/45 (78%) 
Fracture diagnosis method 
Exposure A Revision +/- W/C/C 
(n=36) Revision distal press fit long 
stem, uncemented +/- Cables (n=14), 
approach NS, implant NS, company 
NS 
Allocation of exposure 
Not explicit, implies Vancouver 
algorithm 
Surgeon experiential level NS 
Weight bearing status NS 
Venous thromboembolism 
prophylaxis NS 
Surgical antibiotic prophylaxis NS 
Note: Although no specific post-
operatively sustained Vancouver B2 






























A: 36/36 (100%) 
Infection DSSI 
A: 0/36 (0%) 
Infection SSSI 
A: 0/36 (0%) 
Union  






















Radiographs (pre-operative) and 
intra-operative assessment 
Setting Single-centre 
Tertiary hospital, Parma, Italy 
Inclusion criteria Patients with 
post-operative PFF following 
primary THA undergoing surgical 
treatment at Ortho clinic 
University of Parma 
Exclusion criteria 
Death (n=19), inability to attend 
follow-up visit (n=6) 
pooled data (incl intra-operative B2) 
published is as follows: 
Sex M:F 12:33 
Mean age in years: 78.5 (SD 12.3#, 
43-92) 
Time from index to fracture in 
































Participants Mixed cohort of 




Indication index NS 
Index implant details NS 
Primary:Revision NS 
Cemented:Uncemented 22:4 
Stem  NS 
Mechanism injury NS 
Fracture diagnosis method 
Radiographs (pre-operatively by 
clinical fellow) and intra-operative 
assessment 
Setting 
Single-centre, University college 
London, United Kingdom 
Inclusion criteria 
Patients with Vancouver B2 OR 
B3 PFF after femoral arthroplasty 
managed with uncemented revision 
arthroplasty in the unit 
Exclusion criteria NS 
 
Exposure A Revision mixed 
methods/unspecified (n=14) 
Revision long stem, uncemented 
with cables, +/- cortical strut 
allograft (unclear proportion) +/- 
acetabular revision (unclear 
proportion), posterior approach, 
Eschelon (250mm), Smith and 
Nephew 
Allocation of exposure 
Vancouver algorithm 
Surgeon experiential level 
Consultant (Senior surgeon) 
Weight bearing status 
0-6 weeks: Touch weight bear, then 




Surgical antibiotic prophylaxis NS 
Note: Although no specific post-
operatively sustained Vancouver B2 
PFF demographic data provided, 
pooled data (incl intra-operative B2) 
published is as follows: 
Sex M:F 16:10 Mean age in years: 
68.4 (SD 7.76, 46-81) 
Time from index to fracture in 



























A: 14/14 (100%) 
Neurovascular injury 
A: 1/14 (7.1%) (sciatic nerve 
palsy which resolved 
completely, no time-frame) 
Subsidence 
A: 0/14 (0%) 
Malunion 
























































Participants Mixed cohort of 




Indication index NS 
Index implant details NS 
Primary:Revision NS 
Cemented:Uncemented NS 
Stem  NS 
Mechanism injury (for PFF) 
Minor trauma: 33/36 (92%) 
Major trauma: 2/36 (5%) 
‘No obvious cause’: 1/36 (3%) 
Fracture diagnosis method 
Radiographs pre-operatively 
Setting Multi-centre, Two tertiary 
hospitals, University College 
London, Maidstone district general 
hospital, Maidstone, United 
Kingdom 
Inclusion criteria Patients 
undergoing Revision hip surgery 
using Kent prosthesis at either 
institution for any indication.  
Exclusion criteria Nil 
 
Exposure A Revision +/- W/C/C 
(n=25) Revision long stem with 
distal locking, uncemented non-HA 
coated, posterior approach, Kent hip 
revision, Biomet  
Allocation of exposure Vancouver 
algorithm  
Surgeon experiential level 
Consultant  
Weight bearing status 3 days: 
Partial weight bear (no weight 
specified) then progressing to Full 
weight bear  
Venous thromboembolism 
prophylaxis NS 
Surgical antibiotic prophylaxis NS 
 
Note: Although no specific post-
operatively sustained Vancouver B2 
PFF demographic data provided, 
pooled data (incl intra-operative B2) 
published is as follows: 
Sex M:F 20:16 
Mean age in years: 66 (No SD 
specified, Range 52-79) 





































A: 0/25 (0%) 
Attain pre-fracture mobility 
status 
A: 25/25 (by 18 months post 
op) 
Non-union 
A: 1/25 (4%) 
Malunion 





















by 18 months 
(*Functional 
level by 12 
months - they 
don't define 






























Participants Cohort of patients 




Indication index NS 
Index implant details NS 
Primary:Revision 
5 (3 cemented, 2 non-cemented): 2 
(2 uncemented) 
Cemented:Uncemented 3:4 
Stem  NS 
Mechanism injury 
Minor trauma: 6/7 (86%) 
Major trauma: 1/7 (14%) 
Exposure A Revision + cortical 
strut allografts (n=7) Revision long 
stem, uncemented + cerclage wires 
and cortical strut allografts (2 per 
patient) + 3-4 cables tightened with 
stem inside +/- acetabular revision if 
indicated, Kocher-Langenbeck 
incision, S-Rom stem (n=3), Johnson 
and Johnson, Restoration stem (n=4), 
Stryker  
M:F 5:2 Mean age in years: 63 
(Range 54-71, No SD reported) 
Allocation of exposure 
Unit algorithm 




























Surgical time mean (Wasko 
and Kaminski) 
A: 215 (no SD or range 
specified) 
Transfusion mean (Units 
Packed red blood cells) 
A: 2 (no SD or range specified) 
Length of stay (days) 
A: 6 (no SD or range specified) 
Aseptic loosening femur 
A: 0/7 (0%)  
PFF post-operatively 
A: 0/7 (0%)  






















Fracture diagnosis method 
Radiographs pre-operatively 
Setting Single-centre 
Tertiary hospital, Massachusetts, 
USA 
Inclusion criteria Patient's 
suffering a Vancouver B2 PFF 
treated using local algorithm 
Exclusion criteria NS 
 
Weight bearing status 
0-3 months Partial weight bear with 
walker or crutches 
Venous thromboembolism 
prophylaxis NS 

















A: 83 (no SD or range 
specified) 
Attain pre-fracture mobility 
status 
A: 6/7 (86%) 
Subsidence (any) 
A: 2/7 (29%) 
Cortical strut ingrowth 


















Participants Mixed cohort of 




Indication index NS 
Index implant details NS 
Primary:Revision NS 
Cemented:Uncemented NS 
Stem  NS 
Mechanism injury NS 
Fracture diagnosis method 
Radiographs pre-operatively 
Setting Single-centre, Tertiary 
Hospital, Zhejiang, China 
Inclusion criteria 
Patients admitted to local hospital 
with Vancouver B2 or B3 PFF 
around THA 
Exclusion criteria NS 
Exposure A Revision + cortical 
strut allograft (n=5) Revision 
extensively porous coated stem, 
uncemented + cortical strut allografts 
(1 or 2), mixed approach either 
posterolateral or trochanteric 
osteotomy (not clear proportion), 
Solution stem (Depuy) 
M:F 3:2 
Mean age in years: 61.6 (Range 55-
72, No SD reported) 
Allocation of exposure NS 
Surgeon experiential level NS 
Weight bearing status 
For ‘most hips’ 







































A: 5/5 (100%) at mean 5.6 
months (Range 3-9) 
Harris Hip score post-
operatively (mean) 
A: 70 (SD 9.3, 62-82) 
Satisfaction score pain VAS 
(0-100) 
A: Mean 18.4 (SD 6.07, 11-25) 
Cortical strut ingrowth 
A: 5/5 (100%) 
 
Revision with 
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Appendix V: Critical appraisal scores 
 
Table **- Critical appraisal scores for included cohort studies – Questions in appendix X. Y 
= Yes, N = No, N/A = Not applicable, U = Unclear 
 
Study Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10 Total 
Bhattacharyya, 2007 Y Y Y U Y Y Y Y N/A Y 89% 
Joestl, 2016 Y Y Y N Y Y Y N/A N/A U 75% 
Lindahl, 2006 Y Y Y U Y Y Y Y U Y 80% 
Mukka, 2016 Y Y Y N Y Y Y N/A N Y 78% 
Mukundan, 2010 Y Y Y U Y Y Y U N/A Y 78% 
Pavlou, 2011 Y Y Y U Y Y Y N U Y 70% 
Solomon, 2015 Y Y Y N Y Y Y Y Y Y 90% 
Spina, 2014 Y Y Y U Y Y U Y U Y 70% 
Young, 2007 Y Y Y N Y Y Y Y U Y 80% 





Table x.x– Critical appraisal scores for included descriptive studies – Questions in appendix 
X. Y = Yes, N = No, N/A = Not applicable, U = Unknown 
 
Study Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Total 
Amenabar, 2015 Y Y N Y Y Y Y U Y 78% 
Briant-Evans, 2009 Y Y N N Y Y Y N N/A 63% 
Canbora, 2013 Y Y Y Y Y Y Y N Y 89% 
Corten, 2012 Y Y U Y Y N Y N Y 67% 
Da Assunção, 2015 Y Y Y Y Y Y Y N Y 89% 
Eingartner, 2006 Y Y U N Y N Y N N/A 50% 
Fink, 2014 Y Y U Y N Y Y N Y 56% 
Garcia-Rey, 2013 Y Y Y Y Y N Y N Y 78% 
Grammatopoulos, 2011 Y Y Y Y Y Y Y N N/A 88% 
Haidar, 2005 Y Y Y Y Y N Y N Y 78% 
Holder, 2014 Y Y Y Y Y N Y Y Y 89% 
Holley, 2007 Y Y Y Y Y N Y Y Y 89% 
Inngul, 2015 Y Y Y Y Y Y Y Y Y 100% 
Ko, 2003 Y Y Y Y Y N Y Y Y 89% 
Konan, 2011 Y Y Y Y Y Y Y Y Y 100% 
Korbel, 2013 Y Y U Y Y Y Y Y Y 89% 
Levine, 2008 Y Y Y Y Y Y Y Y Y 100% 
Lunebourg, 2015 Y Y Y Y Y Y Y N Y 89% 
Marx, 2012 Y Y Y Y Y Y Y Y Y 100% 
Moreta, 2014 Y Y Y Y Y Y Y Y Y 100% 
Munro, 2014 Y Y Y Y Y Y Y Y Y 100% 
Niikura, 2014 Y Y Y Y Y Y Y Y Y 100% 
Pogliacomi, 2014  Y Y Y Y Y Y Y Y Y 100% 
Rayan, 2010 Y Y U Y Y Y Y Y Y 89% 
Sexton, 2006 Y Y Y Y Y Y Y Y Y 100% 
Sledge, 2002 Y Y Y Y Y Y Y Y Y 100% 
Wu, 2009 Y Y U Y Y Y Y Y Y 89% 
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